TW201204728A - Condensed-cyclic compound and organic light-emitting device including the same - Google Patents

Condensed-cyclic compound and organic light-emitting device including the same Download PDF

Info

Publication number
TW201204728A
TW201204728A TW100111378A TW100111378A TW201204728A TW 201204728 A TW201204728 A TW 201204728A TW 100111378 A TW100111378 A TW 100111378A TW 100111378 A TW100111378 A TW 100111378A TW 201204728 A TW201204728 A TW 201204728A
Authority
TW
Taiwan
Prior art keywords
group
aryl
substituted
unsubstituted
substituent
Prior art date
Application number
TW100111378A
Other languages
Chinese (zh)
Other versions
TWI491611B (en
Inventor
Hee-Yeon Kim
Seung-Gak Yang
Jeoung-In Yi
Jae-Yong Lee
Yoon-Hyun Kwak
Original Assignee
Samsung Mobile Display Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Samsung Mobile Display Co Ltd filed Critical Samsung Mobile Display Co Ltd
Publication of TW201204728A publication Critical patent/TW201204728A/en
Application granted granted Critical
Publication of TWI491611B publication Critical patent/TWI491611B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K11/00Luminescent, e.g. electroluminescent, chemiluminescent materials
    • C09K11/06Luminescent, e.g. electroluminescent, chemiluminescent materials containing organic luminescent materials
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/10Non-macromolecular compounds
    • C09K2211/1018Heterocyclic compounds
    • C09K2211/1025Heterocyclic compounds characterised by ligands
    • C09K2211/1029Heterocyclic compounds characterised by ligands containing one nitrogen atom as the heteroatom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Electroluminescent Light Sources (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

A condensed-cyclic compound and an OLED including the same, the condensed-cyclic compound represented by Formula 1 below.

Description

201204728 六、發明說明: 【發明所屬之技術領域】 [0001] 本發明之實施例係有關於一種縮合環狀化人物 縮合環狀化合物之有機發光裝置。 及I3該 削文 _2]有機發光裝置(OLEDs),其為自發光裂置,1 ,例如:寬廣的視角、優越的對、下優點 對比度、快速響應、高意 [0003]201204728 VI. Description of the Invention: [Technical Field of the Invention] [0001] Embodiments of the present invention relate to an organic light-emitting device for condensing a cyclic condensed cyclic compound. And I3 the text _2] organic light-emitting devices (OLEDs), which are self-luminous cracking, 1, for example: wide viewing angle, superior pair, lower advantage contrast, fast response, high meaning [0003]

度、優越的驅動電壓特性以及可提供多色的影像。4 代表性的有機發光裝置可且有— 上 ^ 有結構,此結構包含:例 如一基材以及依序堆疊在此基材上 J 研蚀、—雷、、π精 輸層(HTL)、一發射層⑽)、—電子傳輪層(ETL)及 陰極。就這一點而言,電洞傳輸層、發射層 層可為有機化合物形成的有機薄膜。 碍輸 闺具有上述結構之有機發光裝置的操作原理係如下所述。 闕當-電壓施加至陽極與陰極之間,從陽極注人的電洞經 由電洞傳輸層移至發射層,且從陰極注人的電子經由電 子傳輸層移至發射層1些電洞和該些電子在發射層再 組合以產生激子。當該些激子從激態降至基態時,就會 發出光。 【發明内容】 闺纟發明之實施例之特徵是提供一種縮合環狀化合物及包 含該縮合環狀化合物之有機發光裝置。 由以下式1 [0007]上述及其它特徵與優點之至少之〆町透過提供 所表示的一縮合環狀化合物而實現: 州妙切4一0 100111378 表單編號A0101 第3頁/共88頁 201204728Degree, superior drive voltage characteristics and multi-color images. 4 A representative organic light-emitting device may have an upper structure, such as: a substrate and sequentially stacked on the substrate, J-etching, lightning, and π fine transport layer (HTL), Emissive layer (10)), electron transport layer (ETL) and cathode. In this regard, the hole transport layer and the emissive layer may be organic thin films formed of organic compounds. The operation principle of the organic light-emitting device having the above structure is as follows. a --voltage is applied between the anode and the cathode, the hole injected from the anode is moved to the emissive layer via the hole transport layer, and the electrons injected from the cathode are moved to the emissive layer via the electron transport layer and the hole These electrons are recombined at the emissive layer to generate excitons. When the excitons drop from the excited state to the ground state, light is emitted. SUMMARY OF THE INVENTION An embodiment of the invention is characterized by providing a condensed cyclic compound and an organic light-emitting device comprising the condensed cyclic compound. The above-mentioned and other features and advantages of the following formula 1 [0007] are achieved by providing a condensed cyclic compound represented by the following formula: 州妙切4一0 100111378 Form No. A0101 Page 3 of 88 201204728

式1 其中,在式1中: A環係由以下的式2或式3所表示:Wherein, in Formula 1: The A ring system is represented by the following Formula 2 or Formula 3:

R 11 R 12 R#R12係自為—氫原子、—重氫原子(氣)、—南素 原子'一羥基'一氰基、—經取代或未經取代的 烧基經取代或未經取代的c2-c3G稀基、-經 未,·二取代的C2-C3G块基、—經取代或未經取代的c〜c 烷氧基、一由-(Ar ) _ 1 30 1 a A II所表不的第一取代基、一由_ Nf-(Ar2)b-Ar]2Jf.(A } _ 3 c ΛΓ】3_Ι所表不的第二取代基 100111378 表單編號AOJOl 1003273214-0 201204728 或一由-(Αι·4)(1-Ν[-(Αγ5)γΑΓι5][_(Αγ6)厂ΑΓι6]所表 示的第三取代基,\至1?12之至少之一者為第三取代基; 第一取代基至第三取代基中的人^至人^係各獨自為一經 取代或未經取代的伸烷基(aikylene gr〇up)、 一經取代或未經取代的(:2-(:3()伸烯基(aikenyiene group)、一經取代或未經取代的^乂別伸芳基(arylene group)、一經取代或未經取代的c c雜伸芳基 3 3 0 (heteroarylene group);R 11 R 12 R#R12 is a hydrogen atom, a heavy hydrogen atom (gas), a sulfhydryl group of a sulfhydryl group, a substituted or unsubstituted alkyl group. a c2-c3G dilute group, a di- or di-substituted C2-C3G block group, a substituted or unsubstituted c-c alkoxy group, and a -(Ar) _ 1 30 1 a A II The first substituent represented by _ Nf-(Ar2)b-Ar]2Jf.(A } _ 3 c ΛΓ] 3_Ι represents the second substituent 100111378 Form No. AOJOl 1003273214-0 201204728 or one by a third substituent represented by -(Αι·4)(1-Ν[-(Αγ5)γΑΓι5][_(Αγ6)厂ΑΓι6], at least one of \ to 1?12 is a third substituent; From the substituents to the third substituents, the human to the human are each a substituted or unsubstituted aikylene gr〇up, a substituted or unsubstituted (: 2-(:3) () an akenenyiene group, a substituted or unsubstituted arylene group, a substituted or unsubstituted cc heteroaryl group 3 3 0 (heteroarylene group);

100111378 第一取代基至第三取代基中的A。】、Αι·ι2、Ar^、Αι_ 以及Ari6係各獨自為一氫原子、一重氫原子、一鹵素原 子、一羥基、一氰基、一經取代或未經取代的c « 1 30 况 基、一經取代或未經取代的CrC3G烯基、一經取代或未 經取代的炔基、一經取代或未經取代的烷 氧基、一經取代或未經取代的C5_C3〇芳基或一“二或 未經取代的C3-C3()雜芳基; a ' b、c、e及f係各獨自為〇至1〇之一整數; d為0至10之一整數;以及 ΑΓι的‘V,群在第一取代基的_(ΑγΛ士"的基團中係 彼此相同或不同;Ar·,“b”群在第二取代基的 -(Arp^Ar〗2基團中係彼此相同或不同;Ar的 3 ^ 在第二取代基的,认士13基團中係彼此相同或不同 ;Ar^ “e”群在第三取代基的,认士”基圓中係 彼此相同或不同,· A# “f”群在第三取代基的 -(Αι·6)γΑι·16基團中係彼此相同或不同。100111378 A from the first substituent to the third substituent. 】, Αι·ι2, Ar^, Αι_ and Ari6 are each a hydrogen atom, a heavy hydrogen atom, a halogen atom, a hydroxyl group, a cyano group, a substituted or unsubstituted c « 1 30 condition base, once a substituted or unsubstituted CrC3G alkenyl group, a substituted or unsubstituted alkynyl group, a substituted or unsubstituted alkoxy group, a substituted or unsubstituted C5_C3 fluorenyl group or a "di- or unsubstituted" C3-C3()heteroaryl; a 'b, c, e, and f are each an integer from 〇 to 1〇; d is an integer from 0 to 10; and 'ι's 'V, group at first The groups of the substituent _(ΑγΛ士" are identical or different from each other; the Ar·, "b" group is the same or different from each other in the -(Arp^Ar2) group of the second substituent; 3 ^ In the second substituent, the members of the group 13 are identical or different from each other; the group of Ar^ "e" in the base of the third substituent is the same or different from each other, · A# "f The group is identical or different from each other in the -(Αι·6)γΑι·16 group of the third substituent.

Ar# Ar6可各獨自為一經取代或未經取代的c「c伸芳 基或-經取代或未經取代的W雜伸芳基。14方 表單編號A0101 第5頁/共88頁 1003273214-0 201204728 [0008] 100111378Ar# Ar6 may each be a substituted or unsubstituted c"c aryl or a substituted or unsubstituted W heteroaryl. 14 square form number A0101 page 5 / 88 pages 1003273214-0 201204728 [0008] 100111378

Ari至Ar6可各獨自為一伸笨基、一Ci_CH烷基伸苯基、 一二(CrCio烷基)伸笨基、一(C6-Cu芳基)伸苯基、一 一(%。14务基)伸苯基、一伸β卡嗤基(carbazoly 1 ene group)、一(:厂(:1()烷基伸咔唑基、一二烷基)伸 咔唑基、一crcH芳基伸咔唑基、一二(c6-c14芳基)伸 叶'嗤基、一伸苐基(fluorenylene group)、一(^-(^1(} 烷基伸荞基、一二(C -C烷基)伸薙基、一,芳基 1 1 υ 6 14 )伸苐基、一二(c6-cl4芳基)伸蕗基、一伸萘基 (naphthylene group)、一、-(:1{)烷基伸萘基、一二 (Ci-C1〇烷基)伸萘基、一(C6-Ch芳基)伸萘基、一二 (C6_C14^•基)伸萘基、一伸蒽基(anthrylene group) 、一(^-(:1〇烷基伸蒽基、一二(crc1〇烷基)伸蒽基'一 (C6_C14芳基)伸蒽基、一二(C6_C14芳基)伸蒽基、一伸 吡啶基(pyridinylene group)、一(:「(:烷基伸吡啶 基、一二烷基)伸吡啶基、一(c6-c14芳基)伸吡 咬基'一*- (Cg-Cid方基)伸°比唆基、~~伸喧嚇·基 (quinol inylene group)、一(:「(:"烷基伸喹啉基、一 二(c^-Cw烷基)伸喹啉基、一(c6-ci4芳基)伸喹啉基、 一二(C6~*C14芳基)伸0基、一伸笨並〇米〇坐基 (benzoimidazolylene group)、一(^-(:丨。烷基伸苯並 咪唑基、一二烷基)伸苯並咪唑基、一((:6-(:14芳 基)伸本並味嗅基、一·一(Cg-Ci4方基)伸苯並味11坐基、一 伸咪唑0比啶基(imidazopyrimidiny lene group) > —Ari to Ar6 may each be a stupid base, a Ci_CH alkyl phenyl group, a bis(CrCio alkyl) group, a (C6-Cu aryl) phenyl group, a one (%. 14 basis) Stretching phenyl, carbazoly 1 ene group, one (: plant (: 1 () alkyl extended carbazolyl, monoalkyl) carbazolyl, a crcH aryl carbazole, one Bis(c6-c14 aryl) stretching leaves 'fluorenylene group, fluorenylene group, one (^-(^1(} alkyl-alkyl group, one-two (C-C alkyl)), one , aryl 1 1 υ 6 14 ) anthracene, a di-(c6-cl4 aryl) fluorenyl group, a naphthylene group, a -(:1{)alkyl-naphthyl group, one or two ( Ci-C1 nonylalkyl) anthranyl, mono(C6-Ch aryl) anthranyl, one (C6_C14^•))naphthyl, an anthranylene group, one (^-(:1) Alkylalkylene, a bis(crc1 alkyl)alkyl group, a (C6_C14 aryl) thiol group, a bis(C6_C14 aryl) thiol group, a pyridinylene group, a (: "(: alkyl-pyridyl, mono-dialkyl)-pyridyl, one (c6-c14 aryl) Pyridyl group 'a*-(Cg-Cid square basis) is more than 唆 base, ~~ quinol inylene group, one (: "(:"alkyl quinolinyl, one or two ( C^-Cw alkyl) quinolinyl, one (c6-ci4 aryl) quinolinyl, one (two (C6~*C14 aryl)), a phenyl group, and a benzoimidazolylene group ), one (^-(: 丨. alkyl-benzimidazolyl, mono-dialkyl)-benzimidazolyl, one ((:6-(:14 aryl)) and tastes olfactory, one-one (Cg-Ci4 square base) benzoin 11 base, a stretch imidazopyrimidiny lene group >

Ci-C1Q烷基伸咪唑吡啶基、一二((:厂(:1()烷基)伸咪唑吡 啶基、一(c6-cl4芳基)伸咪唑吡啶基、一二(c6-cl4芳基 )伸味°坐π比咬基、一伸咪β坐0S咬基 表單編號Α0101 第6頁/共88頁 1003273214-0 201204728 (imidazopyrimidinylene group)、一(^-c 烧基伸 咪唑嘧啶基、一二(crciG烷基)伸咪唑嘧啶基、— (CrCi4芳基)伸咪唑嘧啶基或一二(CrCi4芳基)伸咪唑 嘧啶基。 [麵]Aril ' Ar!2、Ari3、Αι·ΐ5以及Ari6可各獨自為一氫原子 、一重氫原子、一鹵素原子、一羥基、一氰基、一經取 代或未經取代的(:厂(:1()烷基、一經取代或未經取代的c 一 C10烯基、一經取代或未經取代的c2_CiQ炔基 '一經取代 或未經取代的C1_C1Q烧氧基、一經取代或未經取代的C 一 C14芳基或一經取代或未經取代的(:c雜芳基。 〇 14 _] Aru、Ar12、Ari3、Arl5以及Ar16可各獨自為-氫原子 、一重IL原子' 一鹵素原子、一經基、一氰基' 一甲基 、一乙基、一丙基、一丁基、一戍基、一乙烯基、一丙 烯基、一丁烯基、—戊烯基、一乙醯基、一甲氧基、一 乙氧基、一丙氧基、一丁氧基、一戊氧基、一苯基、一 Ci-C1〇烷基笨基、一二(CrCi〇烷基)苯基、一(c^Ch芳 基)笨基、一一(C6_C14芳基)苯基 '一咔唾基 (carbazolyl group)、一〇厂(:1()烷基咔唑基 '一二 (Cl_Cio烷基)咔唑基、一C6-C"芳基咔唑基、一二 (C6-Cl4芳基)咔唑基、一苐基(flu〇renyi gr〇up) ' 一 c「c1()垸基第基、一二(crc1〇烧基)苐基、一(c6_ci4芳 基)第基、一(C6_C14芳基)第基、一萘基(naphthyl group)、一C】-C1()烷基萘基、一二(c】—^烷基)萘基、 一(C6_C14芳基)萘基、一二(C6-Cu芳基)萘基、一蒽基 (anthryl group)、一Ci_Ci〇烷基蒽基、一二(Ci_Ci〇 100111378 表單編號A0101 第7頁/共88頁 1003273214-0 201204728 烷基)蒽基、一(c6-cl4芳基)蒽基、一二(C6-C14芳基)蒽 基、一°比咬基(pyridinyl group)、一伸吡啶基、一 烷基吡啶基、一二烷基)吡啶基、一 (Cc-Ci4芳基)°比咬基、一二(Cc-C1/t芳基)°比咬基、一喧 基(quinolinyl group)、一(^-(^烧基喹嘛基、一 二αΓ(:1()烷基)喹啉基、一(c6-cl4芳基)喹啉基、一二 (Cc-C1y1芳基)喹啉基、一苯並咪唑基 D 14 (benzoimidazolyl group)、一(:丨-C1()烷基苯並咪唑基 、一二(c〖-c1()烷基)苯並咪唑基、一(c6-c14芳基)苯並 咪吐基、一二(C6_Ci4芳基)笨並味》坐基、一味唾!》比咬基 (imidazopyridinyl group)、一(^-(:丨。烷基咪唑吡啶 基、一二αΓ(:1()烷基)咪唑吡啶基'一(CrCi4芳基)咪 。坐0比咬基、一 一(C δ - C1 4 ^•基)咪唾。比咬基、一喃嗤σ密咬 基(imidazopyrimidinyl group)、一(^-C^燒基味〇坐 嘧啶基、一二(Ci_Ci〇烧基)咪唑嘧啶基、一((^-(:丨芳基 )咪嗤嘧咬基或一二(c6_c14芳基)咪。坐嘧啶基。Ci-C1Q alkyl extended imidazolium pyridyl, one (two: (1) alkyl) imidazolidine, one (c6-cl4 aryl) imidazolidine, one (two (c6-cl4 aryl)) Stretching taste ° sitting π than bite base, a stretched rice β sitting 0S bite base form number Α 0101 Page 6 / a total of 88 pages 1003273214-0 201204728 (imidazopyrimidinylene group), one (^-c burnt imidazolidine, one or two (crciG Alkyl) an imidazolyl pyridyl group, a (CrCi4 aryl) an imidazolidinyl group or a bis(CrCi4 aryl) an imidazolidinyl group. [A] Aril 'Ar! 2, Ari3, Αι·ΐ5, and Ari6 can be individually Is a hydrogen atom, a monohydric hydrogen atom, a halogen atom, a monohydroxy group, a monocyano group, a substituted or unsubstituted (: (1) alkyl group, a substituted or unsubstituted c-C10 alkenyl group a substituted or unsubstituted c2_CiQ alkynyl'-substituted or unsubstituted C1_C1Q alkoxy group, a substituted or unsubstituted C-C14 aryl group or a substituted or unsubstituted (:c heteroaryl group) 〇14 _] Aru, Ar12, Ari3, Arl5 and Ar16 can each be a hydrogen atom, a heavy IL atom, a halogen atom, , monocyano 'monomethyl, monoethyl, monopropyl, monobutyl, monodecyl, monovinyl, monopropenyl, monobutenyl, -pentenyl, monoethylidene, monomethyl Oxyl, monoethoxy, monopropoxy, monobutoxy, monopentyloxy, monophenyl, mono-Ci-C1-decylphenyl, di-(CrCi〇alkyl)phenyl, one ( C^Ch aryl) stupid, one (C6_C14 aryl) phenyl 'carbazolyl group, one 〇 factory (: 1 () alkyl oxazolyl 'two (Cl_Cio alkyl) 咔Azolyl, a C6-C" arylcarbazolyl, a bis(C6-Cl4 aryl)carbazolyl group, a fluorenyl ruthenium group, a c"c1() fluorenyl group, One or two (crc1 fluorenyl) fluorenyl, one (c6_ci4 aryl) group, one (C6_C14 aryl) group, naphthyl group, one C]-C1 () alkylnaphthyl group, one Bis(c)-(alkyl)naphthyl, mono(C6-C14 aryl)naphthyl, mono-(C6-Cu aryl)naphthyl, anthryl group, a Ci_Ci decylalkyl group, one Two (Ci_Ci〇100111378 Form No. A0101 Page 7 / Total 88 Page 1003273214-0 201204728 Alkenyl) a (c6-cl4 aryl) fluorenyl group, a bis(C6-C14 aryl) fluorenyl group, a pyridinyl group, a pyridyl group, a monoalkylpyridyl group, a dialkyl)pyridyl group , a (Cc-Ci4 aryl) ° bite base, one or two (Cc-C1/t aryl) ° bite base, a quinolinyl group, a (^-(^ burnt quinolinyl, Mono-αΓ(:1()alkyl)quinolinyl, mono(c6-cl4 aryl)quinolinyl, mono-(Cc-C1y1 aryl)quinolinyl, monobenzimidazolyl D 14 (benzoimidazolyl group ), one (: 丨-C1 () alkyl benzimidazolyl, one (two 〖c1 () alkyl) benzimidazolyl, one (c6-c14 aryl) benzimidin, one two (C6_Ci4 aryl) stupid and savoury "sit on the base, just swear!" than the imidazopyridinyl group, one (^-(: 丨. Alkyl imidazolidinyl, mono-ααΓ(:1()alkyl)imidazolidinyl'-(CrCi4 aryl) imi. Sit 0 than the bite base, one (C δ - C1 4 ^ • base). It is more than a bite base, an imidazopyrimidinyl group, a (^-C^ burnt base, a pyrimidine group, a two (Ci_Ci) group, an imidazolyl group, a ((^-(:丨) Aryl) imipenem or a bis (c6_c14 aryl) meth.

4A至4G之任何之一者所表示: 、Ar” ' Ar1t;以及Ar 16可各獨自由以下的式Any one of 4A to 4G indicates: , Ar" 'Ar1t; and Ar 16 can each be independently of the following formula

式4G 表單編號A0101 第8頁/共88頁 100111378 1003273214-0 201204728 ’2]且其中,式4A至4G的Z,、Z ' z以及7仫々, 技 1 2 以及Z12係各獨自為一 氣原子、一重氫原子、一C _c p a、 r ο 1 Ll〇坑基、一C!-、烷氧基 或—crCM芳基,P及q係各獨自為一 1至8的整數,以及木 為與Ari、Ar2、Ar3、Ar5或Ar的鍵結位置。 [0013] ArForm 4G Form No. A0101 Page 8/88 Page 100111378 1003273214-0 201204728 '2] and wherein Z, Z'z and 7仫々 of the formulas 4A to 4G, the technique 1 2 and the Z12 are each a gas atom , a heavy hydrogen atom, a C _c pa, r ο 1 Ll 〇 pit base, a C!-, alkoxy or —crCM aryl, P and q are each an integer of 1 to 8, and The bonding position of Ari, Ar2, Ar3, Ar5 or Ar. [0013] Ar

Ari2' Aris 5A至5E之任何之一者所表示:Any one of Ari2' Aris 5A to 5E is represented by:

Ari5以及Arle係各獨自由以下的式Ari5 and Arle are each by the following formula

式_5匸_5匸

式5AEquation 5A

且其中,式5A至5E中,*為—與Aq、Ar2、A、、或 Ar。的鍵結位置。 〇 [0014] a、b、c、e及f係各獨自為〇、i、2或3,以及、 2或 [0015] 第二取代基以及第三取代基的 -N[-(Ar5)e-Ar15][~(Ar6)f-Ari6]可各獨自由以下式 6A至6K之任何之一者所表示: 100111378 表單編號A0101 第9頁/共88頁 1003273214-0 201204728And wherein, in the formulae 5A to 5E, * is - and Aq, Ar2, A, or Ar. The bonding position. a[0014] a, b, c, e, and f are each independently 〇, i, 2, or 3, and 2, or [0015] a second substituent and a third substituent -N[-(Ar5)e -Ar15][~(Ar6)f-Ari6] can each be represented by any one of the following formulas 6A to 6K: 100111378 Form No. A0101 Page 9 / Total 88 Page 1003273214-0 201204728

且其中,在式&A至6Κ,2丨至24以及Zu至ZH係各獨自為 —氫原子、一重氫原子、一Ci-ci()烷基、一Ci-Cw烷氧 基或一C6-C14芳基,p、q、r以及s係各獨自為一 的 整數,以及*為一與Ar4或與一構成式1之主幹的環原子的 鍵結位置。 [0016] 100111378 \至^12可各獨自為該一氳原子、一重氫原子、一鹵素原 子、一羥基、一氰基、第一取代基、第二取代基或第三 取代基;"a”在第一取代基為〇 ; "b"及” c"在第二取代基 各為0或1 ; d在第三取代基為1或2,以及” e"和"f"在第 二取代基係各獨自為0或1 ;在第一取代基至第三取代基 之令的△1*2至41'6係各獨自為一經取代或未經取代的 C5-Ci4伸芳基或是一經取代或未經取代的c c雜伸芳 3 14And wherein, in the formulas & A to 6Κ, 2丨 to 24 and Zu to ZH each are independently a hydrogen atom, a heavy hydrogen atom, a Ci-ci () alkyl group, a Ci-Cw alkoxy group or a C6 -C14 aryl, p, q, r and s are each an integer of one, and * is a bonding position with Ar4 or a ring atom of a backbone of formula 1. [0016] 100111378 \ to ^ 12 may each be the one atom, one heavy hydrogen atom, one halogen atom, one hydroxyl group, one cyano group, the first substituent, the second substituent or the third substituent; "a "In the first substituent is 〇; "b" and "c" in the second substituent are each 0 or 1; d in the third substituent is 1 or 2, and "e" and "f" The disubstituted groups are each independently 0 or 1; the Δ1*2 to 41'6 in the order of the first substituent to the third substituent are each a substituted or unsubstituted C5-Ci4 aryl group or Is a substituted or unsubstituted cc heterosexual 3 14

基;以及在第一取代基至第三取代基之中的A A 11 1 ί· 、Ari3、Ar15及Ar16係各獨自為一氫原子、一重氫原子 、一鹵素原子、一羥基、一氰基、一經取代或未經取代 的Ci—Cio烷基、一經取代或未經取代的C2-ClQ烯基、一 經取代或未經取代的c2-ciq炔基、一經取代或未經取代 的Ci_Ci〇烷氧基、一經取代或未經取代的C5-C芳基或 表單編號 A0101 第 10 頁/共 88 頁 5 14 ι〇〇3273214-0 201204728 一經取代或未經取代的^乂雜芳基。 〇 14 t0017] Ri至Ri2可各獨自為一氫原子、一重氫原子、一鹵素原子 、一羥基'一氰基、第一取代基、第二取代基或第三取 代基;"a"在第一取代基為〇 ; "b"及” c"在第二取代基各 為0或1 ; d在第三取代基為丨或2,以及"e”和” f”在第三 取代基係各獨自為〇或1 ;在第一取代基至第三取代基之 中的Αι~2至Ar6係各獨自為一伸苯基、一(^-(^〇烧基伸苯 基、一二(CrCi〇烷基)伸苯基、一(C6-Cu芳基)伸苯基 一(C6_C14^•基)伸苯基、一伸味吐基、一Ci_Ci〇烧 基伸味咬基、一 一(Cl- CiQ烧基)伸啼唾基、一 (^-C芳 基伸咔唑基、一二(C6-CI4芳基)伸咔唑基、一伸薙基、 ; 一Ci_C10院基伸苐基、一二(^-C1()炫基)伸第基、一 (C6_C14芳基)伸第基、一二(C6-CH芳基)伸苐基、一伸 萘基、一(:厂(:1()烷基伸萘基、一二(C厂C1Q烷基)伸萘基 、一(CrCi4芳基)伸萘基 '一二(C6-C14芳基)伸萘基、 一伸蒽基、一烷基伸蒽基、一二((^-'0烷基)伸 〇 蒽基、一(C6_C14芳基)伸蒽基、一二(C6-C14芳基)伸蒽 基、一伸吡啶基、一烷基伸吡啶基、一二(Ci_Ci() 烷基)伸吡啶基、一(C6-C14芳基)伸吡啶基、一二 (C6_Ci4芳基)伸°比咬基、一伸喹啦基、一炫基伸 喹淋基、一二(C^-Cb烧基)伸喹琳基、一(C6-Cl4芳基) 伸喹啉基、一二(C6-C14芳基)伸喹啉基、一伸苯並咪唑 基、一C1_C1G烷基伸笨並咪唑基、一二(Ci_C1G烷基)伸 笨並咪唑基、一(C6-C14芳基)伸笨並咪唑基、一二 (Cg_Cl4芳基)伸笨並味嗅基、一伸味唾η比咬基、一 100111378 表單編號Α0101 第11 1/共88頁 1003273214-0 201204728 10烷基伸咪唑吡啶基、一二(CrCiQ烷基)伸咪唑吡啶基 、一(crcM芳基)伸咪唑吡啶基、一二(\_Ci4芳基)伸 味唾錢基、—伸㈣較基、-c1-ci(^基伸咪, 啶基、一二(CrCi〇烷基)伸咪唑嘧啶基、一(C6-C14芳基 )伸米坐嘴咬基或—二(Ά4芳基)伸味嗤嘴咬基;在第And AA 11 1 ί· , Ari 3 , Ar 15 and Ar 16 among the first substituent to the third substituent are each a hydrogen atom, a mono hydrogen atom, a halogen atom, a hydroxyl group, a cyano group, a substituted or unsubstituted Ci-Cio alkyl group, a substituted or unsubstituted C2-ClQ alkenyl group, a substituted or unsubstituted c2-ciq alkynyl group, a substituted or unsubstituted Ci_Ci decyloxy group A substituted or unsubstituted C5-C aryl group or Form No. A0101 Page 10 of 88 5 14 ι〇〇3273214-0 201204728 A substituted or unsubstituted aryl group. 〇14 t0017] Ri to Ri2 may each independently be a hydrogen atom, a monohydric hydrogen atom, a halogen atom, a monohydroxyl-cyano group, a first substituent, a second substituent or a third substituent; "a" The first substituent is 〇; "b" and "c" in the second substituent are each 0 or 1; d in the third substituent is 丨 or 2, and "e" and "f" in the third substitution Each of the base systems is 〇 or 1; the Αι~2 to Ar6 series among the first substituent to the third substituent are each a phenyl group, a (^-(^ 〇 基 phenyl), a bis ( CrCi 〇 alkyl) phenyl, mono(C6-Cu aryl) phenyl-(C6_C14^•) phenyl, a stimulating thiol, a Ci_Ci 〇 伸 base, one by one (Cl- CiQ is based on a sulfhydryl group, a (^-C aryl carbazolyl group, a bis(C6-CI4 aryl) carbazole group, a thiol group, a Ci_C10 yard base, a bis (^) -C1() 炫基)Extended base, one (C6_C14 aryl) extended base, one (two (C6-CH aryl)) thiol, one extended naphthyl, one (: factory (: 1 () alkyl Base, one two (C plant C1Q alkyl) stretching naphthyl, one (CrCi4萘Naphthyl '-di(C6-C14 aryl)-naphthyl, a fluorenyl group, a monoalkyl fluorenyl group, a bis((^-'0 alkyl) fluorenyl group, a (C6_C14 aryl group) a fluorenyl group, a bis(C6-C14 aryl) thiol group, a pyridine group, a monoalkylpyridyl group, a bis(Ci_Ci() alkyl) pyridine group, a (C6-C14 aryl group) Pyridyl, mono-(C6_Ci4 aryl) extension ratio bite group, hexakila group, thiophene quinolyl group, 1-2 (C^-Cb alkyl group) quinolinyl group, one (C6-Cl4 aryl group) a quinolinol group, a bis(C6-C14 aryl) quinolinol group, a benzzimidazolyl group, a C1_C1G alkyl group, a strepinium imidazolyl group, a bis(Ci_C1G alkyl group), a streptozolyl group, and an imidazole group. C6-C14 aryl) is stupid and imidazolyl, one or two (Cg_Cl4 aryl) is stupid and smells olfactory, a taste is more than a bite base, a 100111378 Form No. 1010101 No. 11 1/ Total 88 pages 1003273214-0 201204728 a 10 alkyl extended imidazolium pyridyl group, a di(CrCiQ alkyl) imidazolidine pyridyl group, a (crcM aryl) imidazolidine pyridyl group, a bis(\_Ci4 aryl group) extensible salivary group, a stretching (four) base group, -c1-ci(^基伸咪, pyridine, one or two (CrCi 〇 alkyl) imidazolyl pyridyl, one (C6-C14 aryl) stretching rice sitting bite base or - two (Ά 4 aryl) stretching taste mouth bite base;

一取代基至第三取代基之中的A Ar 、Ar 、A 1 1 12 13 ΛΓ15 以及Aru係各獨自為—氫原子、—重氫原子、一齒素原 子、一羥基、一氰基、一甲基、—乙基、一丙基一丁 基、一戊基、一乙烯基、一丙烯基、一丁烯基、一戊烯 基、-乙酿基、-曱氧基、一乙氧基'一丙氧基、一丁 氧基、-戊氧基、-苯基、烧基苯基、一二 (Ci_C1()烧基)苯基、—(C6-CH芳基)笨基、—二 芳基)苯基、…卡唾基、-crCi〇烧基味峻基、一二(c「4 c1〇烧基)咔唾基、一c6-ci4芳基味唾基、一二(c6_c^^ 基)咔唑基、一苐基、一C厂Cl〇烷基第基、一二(Cl—Ci〇 烷基)第基、一(C6-C14芳基)荞基、一二(c c芳基)第 b 14 基、一萘基、一 C1-C1G烷基萘基、一二((:厂(:1()烷基)萘 基、一(C6_CI4芳基)萘基、一二(C6-C14芳基)萘基、一 蒽基、一(:厂(:1〇烧基蒽基、一二(c厂L炫基)蒽基、一 (C6-C14芳基)蒽基、一二(Crci4芳基)蒽基、…比交基 、一Ci_C1Q烧基°比咬基、一二(C厂C1G垸基比咬基、一 (CrCi4芳基)吡啶基、一二(CrCl4芳基)吡啶基、一喹 啉基、一烷基喹啉基、一二(C1_CB烷基)喹啉基 、一(C6-C14芳基)喹啉基、一二(C6-C14芳基)喹啉基、 一苯並咪唑基、一 C1_C1Q烷基笨並咪唑基、一二((:丨-(:1{) 烷基)苯並咪唑基、一(c6-cl4芳基)笨並咪唑基、一二 100111378 表單編號A0101 第12頁/共88頁 1003273214-0 201204728 厂C 芳基)苯並17米唾基、一味°坐σ比淀基、一 C_C 院基 6 14 110 口米嗅吼淀基〜一二^-^烧基丨味唾吼咬基、一(c _c 110 6 14 芳基)味峻α比淀基、一二(C _ C 芳基)p米。坐σ比唉基、一味 6 14 °坐嘴淀基、一烧基味°坐嘴咬基、一二燒基 )味。坐喊淀基、一(c c 芳基)味吐哺咬基或一二 6 14 (C-Cl4芳基)味。坐嘯淀基。 Ό [0018] Ο 由式1所表示的該縮合環狀化合物可由以下的式2a至2d之 任何之一者所表示: c r2Among the one substituent to the third substituent, A Ar , Ar , A 1 1 12 13 ΛΓ 15 and Aru are each independently a hydrogen atom, a heavy hydrogen atom, a dentate atom, a hydroxyl group, a cyano group, and a Methyl, -ethyl, monopropyl-butyl, monopentyl, monovinyl, monopropenyl, monobutenyl, monopentenyl, -ethyl, methoxy, monoethoxy '-propoxy, monobutoxy, -pentyloxy, -phenyl, alkylphenyl, mono-(Ci_C1()alkyl)phenyl, -(C6-CHaryl)phenyl, -di Aryl) phenyl, ... carbyl, -crCi oxime, succinyl, bis (c "4 c1 fluorenyl" oxime, a c6-ci4 aryl sulphate, one or two (c6_c^ ^ base) carbazolyl, a fluorenyl group, a C plant Cl 〇 alkyl group, a bis (Cl-Ci 〇 alkyl) group, a (C6-C14 aryl) fluorenyl group, a two (cc fang a b14 group, a naphthyl group, a C1-C1G alkylnaphthyl group, a bis ((: (1) alkyl) naphthyl group, a (C6_CI4 aryl) naphthyl group, a bis (C6) -C14 aryl)naphthyl, anthracenyl, one (: factory (: 1 〇 蒽 base, one two (c plant L Hyun) sulfhydryl, one (C6- C14 aryl) fluorenyl, bis(Crci4 aryl) fluorenyl, ... specific crosslink, a Ci_C1Q base, bite base, one or two (C plant C1G 垸 base bite base, one (CrCi4 aryl) pyridine , bis(CrCl4 aryl)pyridinyl, monoquinolyl, monoalkylquinolinyl, mono-(C1-CB alkyl)quinolinyl, mono(C6-C14 aryl)quinolinyl, one or two ( C6-C14 aryl)quinolinyl, monobenzimidazolyl, a C1_C1Q alkyl benzoimidazolyl, a bis((: 丨-(:1{) alkyl) benzimidazolyl, a (c6-cl4) Aryl) stupid imidazolyl, one or two 100111378 Form No. A0101 Page 12 / 88 pages 1003273214-0 201204728 Factory C aryl) benzo 17 m saliva, one taste ° σ than the base, a C_C yard 6 14 110 米 吼 吼 吼 〜 一 一 一 一 一 一 一 一 一 一 一 〜 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 Rice. Sitting on the σ 唉 base, one taste 6 14 ° sitting mouth deciduous base, a burning base taste ° sitting mouth bite base, one or two base) taste. Sitting on the base, one (cc aryl) taste spit bite base Or one or two 6 14 (C-Cl4 aryl) taste. Sit down the base. Ό [0018] Ο by Formula 1 The condensed cyclic compound represented by any one of the following formulas 2a to 2d of those represented by: c r2

式2dEquation 2d

其中,在式2a至式2d,1^至1?12係各獨自為一氫原子、一 重氫原子、一鹵素原子、一經基、一氰基、一經取代或 未經取代的C^-C^烷基、一經取代或未經取代的C2-C3() 100111378 表單編號A0101 第13頁/共88頁 1003273214-0 201204728 稀基、—經取代或未經取代㈣炔基、—經取代或 未經取代的crc3#氧基、第—取代基、第二取代基或 第二取代基;第—取代基至第三取代基中的、至紅6係 各獨自為峰代或未經取代的c】_C3〇伸燒基、一經取 代或未經取代的W情基、-經取代或未經取代的 C5^3G伸芳基' _經取代或未經取代的^雜伸芳基 第取代基至第二取代基中的A 、 . 11 12 Λ1ΐ3 15以及Arl6係各獨自為—氫原子、一重氫原子、一鹵 素原子、—經基、—氰基、—經取代或未經取代的Wherein, in the formula 2a to the formula 2d, 1^ to 1?12 each is a hydrogen atom, a monohydrogen atom, a halogen atom, a mono-, a cyano group, a substituted or unsubstituted C^-C^ Alkyl, monosubstituted or unsubstituted C2-C3() 100111378 Form No. A0101 Page 13 of 88 1003273214-0 201204728 Dilute, substituted or unsubstituted (tetra) alkynyl, substituted or unsubstituted a substituted crc3#oxy group, a first substituent, a second substituent or a second substituent; wherein the first to the third substituents to the red 6 series are each a single or unsubstituted c] _C3 〇 烧, a substituted or unsubstituted W group, a substituted or unsubstituted C5^3G extended aryl ' _ substituted or unsubstituted aryl extended substituent to The A, .11 12 Λ1ΐ3 15 and Arl6 systems in the disubstituted group are each independently a hydrogen atom, a monohydric hydrogen atom, a halogen atom, a thiol group, a cyano group, a substituted or unsubstituted group.

CrC3()麟、-經取代或未經取代的烯基、一經 取代或未經取代的c2-c3()絲一經取代或未經取代的CrC3(), substituted or unsubstituted alkenyl, substituted or unsubstituted c2-c3() silk, once substituted or unsubstituted

Cl 烷氧基、一經取代或未經取代的C5_CM芳基或一 經取代或未經取代的CrC3〇雜芳基;a、b、Γ、⑻係各 獨自為0至1G之-整數;㈣之_整數;以及紅1的 "a”群在第-取代基的—(Ί、的基團中係彼此二 同或不同;As的"b"群在第二取代基的—(a、)厂基 團中係彼此相同或不同;八^的、"群在第二取代基的_ (Ar3)c-Aru基團中係彼此相同或不同;的"e,,群在 第三取代基的_(Αγ5)ΓΑγ15基團中係彼此相同或不同; f-Ar16基團中係彼此Cl alkoxy, a substituted or unsubstituted C5_CM aryl or a substituted or unsubstituted CrC3 doped aryl; a, b, Γ, (8) are each independently 0 to 1G-integer; (d) _ An integer; and the "a" group of red 1 is the same or different from each other in the - substituent group; the "b" group of As in the second substituent - (a,) The groups in the plant group are the same or different from each other; the groups of the group are in the same or different from each other in the _ (Ar3)c-Aru group of the second substituent; the "e, group is in the third substitution The _(Αγ5)ΓΑγ15 groups in the group are the same or different from each other; the f-Ar16 groups are in each other

Ar6的”f"群在第三取代基的_(Ar ) 6 相同或不同。 [0019]The "f" group of Ar6 is the same or different in _(Ar)6 of the third substituent. [0019]

Ar4可包含一伸苯基、一烷基伸笨基 '一二 (C^Cio烷基)伸苯基、一(c6-ci4芳基)伸苯基、—二 (crcH芳基)伸苯基、一伸咔唑基、一Ci_Ci〇烷基伸咔 唑基、一二(crc1()烷基)伸咔唑基、一C6_C"芳基伸咔 100111378 表單編號A0101 第14頁/共88頁 1003273214-0 201204728 唑基、一二(c6-c14芳基)伸咔唑基、一伸第基、_ q-Cio烷基伸蕗基、一二(c^Ch烷基)伸第基、— (C6-Ci4芳基)伸苐基、一二(C&-C14芳基)伸荞基、一伸 萘基、一crclG烷基伸萘基、一二(crc1()烷基)伸萘基 、一(c6-c14芳基)伸萘基、一二(c6—ci4芳基)伸萘基、 一伸蒽基、一Crcl0烷基伸蒽基、一二(crcl()烷基)伸 蒽基、一(c6-cl4_基)伸蒽基及一二(c6-ci4芳基)伸蒽 基之至少之一者;以及d可為1、2或3。 [0020] 第二取代基以及該第三取代基的 -N[-(Ar5)e-Ar15][-(Ar6)f-Aru]係各獨自由以下式 6A至6K之任何之一者所表示:Ar4 may comprise a phenyl group, a monoalkyl group, a bis(C^Cio alkyl) phenyl group, a (c6-ci4 aryl) phenyl group, a bis (crcH aryl) phenyl group, a stretch Benzazolyl, a Ci_Ci 〇 alkyl carbazolyl, a bis (crc1 () alkyl) oxazolyl, a C6_C" aryl extension 100111378 Form No. A0101 Page 14 of 88 1003273214-0 201204728 Azolyl , a bis(c6-c14 aryl) carbazolyl group, a stretching group, a _q-Cio alkyl group, a bis(c^Ch alkyl) group, and a (C6-Ci4 aryl group) Sulfhydryl, bis(C&-C14 aryl) anthracene, an extended naphthyl group, a crclG alkylnaphthyl group, a di(crc1()alkyl)naphthyl group, a (c6-c14 aryl) group Naphthyl, bis(c6-ci4 aryl)naphthyl, an extended fluorenyl group, a Crcl0 alkyl hydrazino group, a bis(crcl()alkyl) thiol group, a (c6-cl4_ group) hydrazine And at least one of a bis(c6-ci4 aryl) thiol group; and d can be 1, 2 or 3. [0020] The second substituent and the -N[-(Ar5)e-Ar15][-(Ar6)f-Aru] of the third substituent are each represented by any one of the following formulas 6A to 6K; :

且在式6A至6K中,冗丨至?4以及Zu至Zu係各獨自為一氫 原子、一重氫原子、一(:厂(:1()烧基、一Ci-ci{)燒氧基或 一C6_C14芳基’ P ' q、Γ以及S係各獨自為一 1至8的整數 ,以及*為一與Ar4或與一構成式1之主幹的環原子的鍵結 位置。 [0021] 由式1所表示的縮合環狀化合物可由以下式3a至3e之任何 100111378 表單編號A0101 第15頁/共88頁 1003273214-0 201204728 之一所表示:And in the formulas 6A to 6K, is it verbose? 4 and Zu to Zu are each a hydrogen atom, a heavy hydrogen atom, a (: (1) pyrolyzed, a Ci-ci {) alkoxy group or a C6_C14 aryl 'P' q, Γ and Each of the S series is an integer of 1 to 8, and * is a bonding position with a ring atom of Ar4 or a backbone of the formula 1. [0021] The condensed cyclic compound represented by Formula 1 may be represented by the following formula: Any 100111378 of 3a to 3e Form No. A0101 Page 15 / Total 88 Page 1003273214-0 201204728 One of the:

式3c 其中,在式3a至3e,^至尺^係各獨自為一氫原子、一重 氫原子、一鹵素原子 '一羥基、一氰基、一經取代或未 經取代的(^-(:3()烷基、一經取代或未經取代的c2-c3()烯 基、一經取代或未經取代的c2-c3()炔基、一經取代或未 經取代的(^-(:3()烷氧基、第一取代基、第二取代基或第 三取代基;第一取代基至第三取代基中的係各 1 0 獨自為一經取代或未經取代的(^-(:3()伸烷基、一經取代 或未經取代的C2-C3()伸烯基、一經取代或未經取代的C5-C3()伸芳基或是一經取代或未經取代的C3-C3(J雜伸芳基; Ar,,、Ar1()、Ar 、Ar 以及Ar 係各獨自為一氫原子 11 IL 1 ο 1 b 1 ο 、一重氫原子、一鹵素原子、一經基、一氰基、一經取 代或未經取代的^乂%烷基、一經取代或未經取代的c2-cQn烯基、一經取代或未經取代的c9-cqn炔基、一經取代Wherein, in the formulae 3a to 3e, each of the formulae is a hydrogen atom, a heavy hydrogen atom, a halogen atom, a monohydroxy group, a cyano group, a substituted or unsubstituted (^-(:3) () an alkyl group, a substituted or unsubstituted c2-c3() alkenyl group, a substituted or unsubstituted c2-c3() alkynyl group, a substituted or unsubstituted (^-(:3()) An alkoxy group, a first substituent, a second substituent or a third substituent; each of the first substituent to the third substituent is independently substituted or unsubstituted (^-(:3() An alkyl group, a substituted or unsubstituted C2-C3()alkylene group, a substituted or unsubstituted C5-C3() extended aryl group or a substituted or unsubstituted C3-C3 (J) Heteroaryl; Ar,, Ar1(), Ar, Ar, and Ar are each a single hydrogen atom 11 IL 1 ο 1 b 1 ο , a heavy hydrogen atom, a halogen atom, a thiol group, a cyano group, Substituted or unsubstituted 乂% alkyl, substituted or unsubstituted c2-cQn alkenyl, substituted or unsubstituted c9-cqn alkynyl, once substituted

〇 U /- o U 100111378 表單編號A0101 第16頁/共88頁 1003273214-0 201204728 或未經取代的W料基、—經取代或未經取代的C _ C30芳基或-經取代或未經取代的w雜芳基;a、“ C、⑻係各獨自為G至10之-整數;<1為0至U)之-整數 :Ar!的"a,,群在第—取代基的-(AVa'的基團中係 彼此相同或不同;Ar2的"b"群在第二取代基的-(Ar ) _ Ar12基團中係彼此相同或不同;A、的„c"群在第二二二 基的-(ArPc-Ar!3基團中係彼此相同或不同;a、的 群在第三取代基的基團中係彼此相同或不 Ο [0022] 同;Ar6的"f”群在第三取代基的_(Α、)「、基團中係 彼此相同或不同。〇U /- o U 100111378 Form No. A0101 Page 16 of 88 1003273214-0 201204728 Or unsubstituted W-based, substituted or unsubstituted C _ C30 aryl or - substituted or not Substituted wheteroaryl; a, "C, (8) are each independently G to 10-integer; <1 is 0 to U) - integer: Ar!"a, group in the -substituent The groups of (AVa' are identical or different from each other; the "b" groups of Ar2 are identical or different from each other in the -(Ar)_Ar12 group of the second substituent; A, „c" In the second di-diyl-(ArPc-Ar!3 group, the same or different from each other; the group of a, in the group of the third substituent is the same or not the same as the same; [0022] the same; The "f" group is the same or different from each other in the _(Α,)" of the third substituent.

Q 八]:4可包含一伸苯基、一烷基伸笨基、一二 (h-ClO烷基)伸苯基、一(C^C14芳基)伸苯基、一二 (crci4芳基)伸笨基、一伸咔唑基、一烷基伸咔 唑基、一二(CrClQ烷基)伸咔唑基、一 (:6-(:14芳基伸咔 唑基、一二(C6_C14芳基)伸咔唑基、一伸莓基、一 C^Cio烷基伸苐基、一二(Ci_Ci〇烷基)伸第基、一 (Ce-Ci4芳基)伸苐基、一二(crCH芳基)伸第基、—伸 萘基、一C1_C1G烷基伸萘基、一二(CrC1Q烷基)伸萘基 、一(C6_C14芳基)伸萘基、一二(C6-Cu芳基)伸萘基、 一伸恩基、一C1_C10炫基伸蒽基、一二(C^-Cio烧基)伸 蒽基、一(c6-c14芳基)伸蒽基及一二(c6-ci4芳基)伸蒽 基之至少之一者;以及d為1、2或3。 [0023] 第二取代基以及第三取代基的 -N[-(Ar5)e-Ari5][_(Ar6)f-Ari6]可各獨自由以下式 6A至6K之任何之'一所表示: 100111378 表單編號A0101 第17頁/共88頁 1003273214-0 201204728Q VIII]: 4 may comprise a phenylene group, a monoalkyl group, a bis(h-ClO alkyl) phenyl group, a (C^C14 aryl) phenyl group, a bis (crci4 aryl) group. Stupid, carbazolyl, monoalkyl carbazolyl, bis(CrClQ alkyl) carbazolyl, one (: 6-(:14 aryl carbazolyl, one bis (C6_C14 aryl)) An azole group, a berry group, a C^Cio alkyl group, a di(Ci_Ci 〇 alkyl) group, a (Ce-Ci4 aryl) group, a two (crCH aryl) group — —Naphthyl, a C 1 —C 1 G alkylnaphthyl group, a bis(CrC1Q alkyl) —naphthyl group, a (C 6 —C 14 aryl) —naphthyl group, a bis(C 6 —Cu aryl) —naphthyl group, , at least one of a C1_C10 stilbene thiol group, a bis(C^-Cio alkyl group) stretching group, a (c6-c14 aryl) stretching group, and a bis(c6-ci4 aryl) stretching group And d is 1, 2 or 3. [0023] The second substituent and the third substituent -N[-(Ar5)e-Ari5][_(Ar6)f-Ari6] may each be independently represented by the following formula: Any of the 6A to 6K's one representation: 100111378 Form No. A0101 Page 17 / Total 88 Page 1003273214-0 201204 728

且在式6A至6K中,/,至乙以及冗”至/,,係各獨自為一氫 原子、一重氫原子、一 C1 - c ^烧基、一 c i - C j ^烧氧基或 — Ce-C1i(芳基,p、q、r以及s係各獨自為一1至8的整數 ,以及*為一與Al或與一構成式1之主幹的環原子的鍵結 4 位置。 [0024] 上述及其它特徵與優點之至少之一亦可由提供一包含一 第一電極、一相對於第一電極之第二電極以及介於第一 電極與第二電極之間的第一層(其包含一實施例的縮合環 狀化合物)之有機發光裝置而實現。 [0025] 第一層可包含一電洞注入層、一電洞傳輸層、一發射層 、一電子傳輸層以及一電子注入層之至少之一者。 [0026] 有機發光裝置可更進一步包含:一電洞注入層、一電洞 傳輸層、一發射層、一電洞阻播層、一電子傳輸層以及 一電子注入層之至少之一者介於第一電極與第二電極之 間。 【實施方式】 [0027] 韓國專利申請號NO. 1 0-201 0-0029992號,於2010年4月 100111378 表單編號A0101 第18頁/共88頁 1003273214-0 201204728 1曰於韓國智慧財產局申請,且標題為,縮合環狀化合 物及包含該縮合環狀化合物之有機發光裝置"的全部内容 ,請完全併入後文參考。 [0028] 後文將更完整的描述例不性實施例及其附圖,然而其亦 可透£§不胃的形“被具體實施’並且不應被解釋為偈 限於下述之實施例°進-步的說’提供此些實施例係為 了撤底及完整揭露本發明,並將本發明的範圍完全傳達 給此領域之技術人士。 Ο [0029] 在圖式中,為了清楚起見,層的尺寸和區域可誇大的表 示。當一層或元件可描述為在其它層或基板,,上"時可 解讀為其可直接地位於其它層上或基板上,或可表示為 中間層。此外,當一層描述為在另一層之,,下,,時,可解 讀為其直接的位於一層的下面’且可表示為一或多個中 間層。此外,當一層表示為兩層"之間"時,可解讀為其 可單一層介於兩層之間,或可表示為一或多個中間層。 於本文早中’相似的標被係描述相似的元件。 [0030] 根據一實施例’一縮合環狀化合物係由以下的式1所表示And in the formulae 6A to 6K, /, to B and verbose to /, each is a single hydrogen atom, a heavy hydrogen atom, a C1 - c ^ alkyl group, a ci - C j ^ alkoxy group or - Ce-C1i (aryl, p, q, r, and s are each an integer from 1 to 8, and * is a bond 4 position with a ring atom of Al or a backbone of formula 1. [0024] At least one of the above and other features and advantages may also provide a first layer including a first electrode, a second electrode relative to the first electrode, and a first electrode and a second electrode (including [0025] The first layer may include a hole injection layer, a hole transport layer, an emission layer, an electron transport layer, and an electron injection layer. At least one of the organic light-emitting devices may further include: a hole injection layer, a hole transport layer, an emission layer, a hole blocking layer, an electron transport layer, and an electron injection layer. One of them is between the first electrode and the second electrode. [Embodiment] [0027] Korean Patent Application No. 1 0-201 0-0029992, in April 2010, 100111378 Form No. A0101 Page 18 of 88 1003273214-0 201204728 1曰Application from Korea Intellectual Property Office, and titled Condensed Cyclic Compound And the entire contents of the organic light-emitting device including the condensed cyclic compound, please refer to the following for a full reference. [0028] Hereinafter, the exemplary embodiment and the accompanying drawings will be more completely described, but The "not smothered" form is "implemented" and should not be construed as being limited to the embodiments described below. The embodiments are provided to remove the invention and to fully disclose the present invention. The scope of the invention is fully conveyed to those skilled in the art. [0029] In the drawings, the size and regions of the layers may be exaggerated for clarity. When a layer or element can be described as being on another layer or substrate, " can be interpreted as being directly on other layers or on a substrate, or can be represented as an intermediate layer. Further, when one layer is described as being in another layer, below, it can be interpreted as being directly on the layer. Below and can be expressed In the case of one or more intermediate layers, in addition, when a layer is expressed as a two-layer "between", it can be interpreted as a single layer between two layers, or can be represented as one or more intermediate layers. [0030] According to an embodiment, a condensed cyclic compound is represented by the following formula 1.

式1 在式1中,一Α環係由以下式2或式3所表示: 100111378 表單編號A0101 第19頁/共88頁 1003273214-0 201204728In Formula 1, one ring system is represented by the following Formula 2 or Formula 3: 100111378 Form No. A0101 Page 19 of 88 1003273214-0 201204728

ΟΟ

[0031] [0032] 在式1中,C1與式2中的\以及式3中的q相同。此外’在 式1中、與式2中的C2以及式3中的C2相同。在式卜2以 及3中ΉΙ2可各獨自為,例如:一氫原子、—重氫 一函素原子、一經基、一氛基、一經取代或未經 Γ的\、絲、—經取代或未經取代 、—經取代或未經取代%、块基一經取代^經 、烧氧基、-由-(AriV、所表示的第一 卜(Ar2VA、]['(w13]所表 不的第二取代基及/或一由 '(AVdKAVe-'5][-(AVf_Ari6]所表示的第 二取代基,其%至1?12之至少之—者為_(^)「[0032] In Formula 1, C1 is the same as \ in Formula 2 and q in Formula 3. Further, in the formula 1, it is the same as C2 in the formula 2 and C2 in the formula 3. In the formulas 2 and 3, ΉΙ2 may be each independently, for example: a hydrogen atom, a hydrogen atom, a radical, an aryl group, a substituted or untwisted \, silk, - substituted or not Substituted, substituted or unsubstituted %, block group once substituted, alkoxy, - by - (AriV, represented by the first b (Ar2VA,] [' (w13] a substituent and/or a second substituent represented by '(AVdKAVe-'5][-(AVf_Ari6), which is at least _(^) from % to 1?12"

Nf (Ar5)e-ArJ5]f-(Ar6)厂Ary,即為,第三取代基 100111378 表單編號AOiOi 第20頁/共88頁 1003273214-0 201204728 [0033] 第一取代基至第三取代基中的'至、可錢自為一經 取代或未經取代的C1_C30伸烷基(alkylene gr*Qup)、 一經取代或未經取代的^气扣伸稀基(alkenylene group)、一經取代或未經取代的W伸芳基(㈣丨咖 group)及/或一經取代或未經取代的%^雜伸芳基 (heteroarylene group)。舉例來說’ ^丨至釺6可各獨 自為-經取代或未經取代的W伸芳基及/或二取代 或未經取代的伸芳基,但不限於i在實施時 Ο [0034] Αι:2至Ar&可各獨自為一經取代或未經取代的〇_c伸 t 5 14 τ ^基。 舉例來說,在第一取代基至第三取代基之中,人^至八、 可各獨自為一經取代或未經取代的伸笨基、一經取代或 未經取代的並環伸戍二烯基(pentalenylene gr〇up)、 一經取代或未經取代的伸茚基(indenylene gr〇up)、 ❹ 一經取代或未經取代的伸萘基、一經取代或未經取代的 伸奠基(azulenylene group)、一經取代或未經取代的 並環伸庚二烯基(heptalenylene group)、一經取代或 未經取代的伸笨並二節基(indacenylene gr〇up)、一 經取代或未經取代的伸乙烯合萘基(acenaphthylene group)、一經取代或未經取代的伸第基、一經取代或未 經取代的伸蔽基(phenalenylene group)、一經取代或 未經取代的伸菲基(phenanthrenylene group)、一經 取代或未經取代的伸蒽基、一經取代或未經取代的伸丙 一稀合苐基(fluoranthenylene group)、一經取代或 未經取代的聯伸二苯基(triphenylenylene group)、 100111378 表單編號A0101 第21頁/共88頁 1003273214-0 201204728 一經取代或未經取代的伸祐基(pyrenyleny lene grc)up)、一經取代或未經取代的伸筷基(chrysenylene group)、一經取代或未經取代的伸稠四苯基 (naphthacenylene group)、一經取代或未經取代的伸 起基(picenylene group)、一經取代或未經取代的伸 花基(perylenylene group)、一經取代或未經取代的 伸五苯基(pentaphenylene group)、一經取代或未經 取代的伸稠六笨基(hexacenylene group)、一經取代 或未經取代的伸吡咯基(pyrrolylene group)、一經取 代或未經取代的伸吡唑基(pyraz〇1ylene group)、一 經取代或未經取代的伸咪嗤基(imidazoly lene group) 、一經取代或未經取代的伸咪唑啉基 (imidazolinylene group)、一經取代或未經取代的伸 咪0坐°比咬基(imidazopyridinylene group)、一經取 代或未經取代的伸味n坐碟淀基 (imidazopyrimidinylene group)、一經取代或未經 取代的伸。比啶基、一經取代或未經取代的伸吡明=基 (Pyrazinylene group)、一經取代或未經取代的伸嘴 咬基、一經取代或未經取代的伸吲哚基(indolylene group)、-經取代或未經取代的伸嘌呤基、一經取代或 未經取代的伸喹啉基(quinolinylene group)、一經取 代或未經取代的伸酞拼基(phthalazinylene group)、 —經取代或未經取代的伸吲哚畊基(indo 1 i z i ny 1 ene group)、一經取代或未經取代的伸0奈啶基 (naphthyridinylene group)、一經取代或未經取代 的伸啥唑啉基團、一經取代或未經經取代的伸D辛琳基 100111378 表單編號 A0101 第 22 頁/共 88 頁 1003273214-0 201204728Nf (Ar5)e-ArJ5]f-(Ar6) Plant Ary, ie, Third Substituent 100111378 Form No. AOiOi Page 20 of 88 Page 323273214-0 201204728 [0033] First Substituent to Third Substituent A 'C. _C30 alkylene gr*Qup, a substituted or unsubstituted alkenylene group, once substituted or unsubstituted Substituted W-aryl ((4) group coffee group) and/or substituted or unsubstituted % 杂 heteroarylene group. For example, '^丨 to 釺6 can be each independently-substituted or unsubstituted W-aryl and/or disubstituted or unsubstituted aryl, but not limited to i when implemented Ο [0034] Αι:2 to Ar& can each be a substituted or unsubstituted 〇_c stretching t 5 14 τ ^ group. For example, among the first substituent to the third substituent, each of the groups may be a substituted or unsubstituted extended, unsubstituted or unsubstituted cyclodene. Pentalenylene gr〇up, substituted or unsubstituted indenylene gr〇up, ❹ substituted or unsubstituted anthranyl group, substituted or unsubstituted azulenylene group a substituted or unsubstituted heptalenylene group, a substituted or unsubstituted, indacenylene gr〇up, a substituted or unsubstituted stretched ethylene An acenaphthylene group, a substituted or unsubstituted extended group, a substituted or unsubstituted phenalenylene group, a substituted or unsubstituted phenanthrenylene group, once substituted Or unsubstituted thiol, substituted or unsubstituted fluoranthenylene group, substituted or unsubstituted terphenylenylene group, 100111 378 Form No. A0101 Page 21 of 88 1003273214-0 201204728 A substituted or unsubstituted pyronyleny lene grc up), a substituted or unsubstituted chrysenylene group, once substituted or Unsubstituted naphthacenylene group, substituted or unsubstituted picenylene group, substituted or unsubstituted perylenylene group, substituted or unsubstituted a pentaphenylene group, a substituted or unsubstituted hexacenylene group, a substituted or unsubstituted pyrrolylene group, a substituted or unsubstituted stretch Pyrazyl 1ylene group, substituted or unsubstituted imidazoly lene group, substituted or unsubstituted imidazolinylene group, substituted or unsubstituted伸咪0 sits°Imidazopyridinylene group, once substituted or unsubstituted, imidazopyrimidinylene group, once substituted or Substituted stretch. Pyridyl group, substituted or unsubstituted pyrazinylene group, substituted or unsubstituted stretched bite group, substituted or unsubstituted indolylene group, - Substituted or unsubstituted thiol group, substituted or unsubstituted quinolinylene group, substituted or unsubstituted phthalazinylene group, substituted or unsubstituted Indo 1 izi ny 1 ene group, a substituted or unsubstituted naphthyridinylene group, a substituted or unsubstituted oxazoline group, once substituted or Unsubstituted Ding Xinlinji 100111378 Form No. A0101 Page 22 of 88 1003273214-0 201204728

(cinnolinylene group)、一經取代或未經取代的伸〇引 。坐基(丨11(132〇1716116运1'0叩)、一經取代或未經取代的 伸咔唑基、一經取代或未經取代的伸啡啡基 (phenazinylene group)、一經取代或未經取代的伸啡 咬基(phenanthridinylene group)、一經取代或未經 取代的伸派喃基(pyranylene group)、一經取代或未 經取代的伸笨並派喃基(chromenylene)、一經取代或未 經取代的伸笨並咬喃基(benzofuranyiene group)、一 經取代或未經取代的伸嗟吩基(1^丨(^1161^16116 81'011卩) 、一經取代或未經取代的伸苯並噻吩基 (benzothiophenylene group)、一經取代或未經取代 的異伸售嗤基(isothiazolylene group)、一經取代或 未經取代的伸苯並味。坐基(benzoimidazoly 1 ene group)以及一經取代或未經取代的異伸嗔峻基 (isoxazolylene group),但並不限於此。 [0035] 舉例來說,係各獨自為一伸笨基、一C,-C 烷 1 〇 1 10 Q 基伸笨基、一二烷基)伸苯基、一(C6-C14芳基) 伸笨基、一二(C6-C14芳基)伸苯基、一伸咔唑基 (carbazolylene group)、一(^-〇1()院基伸0f 唾基、一 二(C,-C,n烷基)伸咔唑基、一CR-C"芳基伸咔唑基、一 1 I U 〇 14 二(Ce-C1yl芳基)伸咔唑基、一伸第基(fluorenylene 6 14 group)、一烧基伸苐基、一二(C^-C^o烧基)伸篥 基、一(c6-c14芳基)伸第基、一二(c6-c14芳基)伸第基 、一伸萘基(naphthylene group)、一烧基伸萘 基、一二(q-c^烷基)伸萘基、一(crc14芳基)伸萘基 100111378 表單煸號A0101 第23頁/共88頁 1003273214-0 201204728 、一二(Ce-C1y)芳基)伸萘基、一伸蒽基(anthrylene 〇 14 group)、一(^-(^烧基伸蒽基、一二烧基)伸蒽 基、一(cs-c14芳基)伸蒽基、一二(c6-c14芳基)伸蒽基 、一伸吡啶基(pyridinylene group)、一(^-(:^烷基 伸吡啶基、一二(C -Cin烷基)伸吡啶基、一(C -C芳基 A 1 u 6 14 )伸°比咬基、一二(C6_C14芳基)伸。比咬基、一伸啥琳基 (quinol iny lene group)、一(^-(:1〇烷基伸喹琳基、一 二烷基)伸喹啉基、一(c6-c14芳基)伸喹啉基、 一二(C6_C14芳基)伸喧啦基、一伸苯並咪嗤基 (benzoimidazolylene group)、一(^-(:^烷基伸笨並 咪唑基、一二(C -C烧基)伸苯並咪唑基、一(c 关 1 1υ 6 14 基)伸苯並咪唑基、一二(c6-cu芳基)伸苯並咪唑基、一 伸咪唑吡啶基(imidazopyrimidinylene group)、一(cinnolinylene group), once substituted or unsubstituted exfoliation. Sitrate (丨11(132〇1716116运1'0叩), substituted or unsubstituted extended carbazolyl, substituted or unsubstituted phenazinylene group, substituted or unsubstituted a phenanthridinylene group, a substituted or unsubstituted pyranylene group, a substituted or unsubstituted chromenylene, a substituted or unsubstituted A benzofuranyiene group, a substituted or unsubstituted thiophene group (1^丨(^1161^16116 81'011卩), a substituted or unsubstituted benzothiophene group ( A benzothiophenylene group), a substituted or unsubstituted isothiazolylene group, a substituted or unsubstituted benzoin, a benzoimidazoly 1 ene group, and a substituted or unsubstituted The isoxazolylene group, but is not limited thereto. [0035] For example, each is a stupid base, a C,-C alkane 1 Q1 10 Q group, a styl group, a dialkyl group) Stretching phenyl, one (C6-C14 aryl) Base, one (two (C6-C14 aryl)) phenyl, one carbazolylene group, one (^-〇1 (), the base of the 0f sulphate, one or two (C, -C, n alkyl) An exocarbazolyl group, a CR-C" aryl carbazole group, a 1 IU 〇14 bis (Ce-C1yl aryl) carbazole group, a fluorenylene 6 14 group, a thiol thiol group, One or two (C^-C^o) bases, one (c6-c14 aryl) extended base, one (two (c6-c14 aryl) extended base, one naphthylene group, one Pyridyl-naphthyl, bis(qc^alkyl)-naphthyl, one (crc14 aryl)-naphthyl-100111378 Form No. A0101 Page 23/88 pages 1003273214-0 201204728, one-two (Ce-C1y) Aryl) anthranyl, anthranylene (14 group), one (^-(^)-based thiol-based, one-two-alkyl group), one (cs-c14 aryl) thiol group, one Di(c6-c14 aryl) anthracenyl, pyridinylene group, one (^-(:^alkyl-pyridylpyridyl, one-two (C-Cin alkyl)-extended pyridyl, one (C-C) The aryl group A 1 u 6 14 ) stretches more than the bite base, one or two (C6_C14 aryl). More than a bite base, a quinol iny lene group, a (^-(:1〇 alkyl quinolinyl, a dialkyl) quinolinyl group, a (c6-c14 aryl) stretching quinoline Base, one (two (C6_C14 aryl)) benzoyl, benzoimidazolylene group, one (^-(:^alkyl extended streptozolyl, one or two (C-C) based benzene And imidazolyl, a (c) 1 1 υ 6 14 yl) benzoimidazolyl group, a bis (c6-cu aryl) benzoimidazolyl group, an imidazopyrimidinylene group, an

Ci-C1Q烷基伸咪唑吡啶基、一二(crCiQ烷基)伸咪唑吡 啶基、一(C^-C〗4芳基)伸咪唑吡啶基、一二芳基 )伸咪吐咬基、一伸°米咬喷咬基 (imidazopyrimidinylene group)、一(:「(:烧基伸 咪唑嘧啶基、一二(crc1Q烷基)伸咪唑嘧啶基、一 (CrCi4芳基)伸咪唑嘧啶基及/或一二芳基)伸咪 唑嘧啶基,但不限於此。 [0036] 舉例來說,第一取代基至第三取代基中的Ar 、 11 Γ12Ci-C1Q alkyl extended imidazolium pyridyl, mono-(crCiQ alkyl) extended imidazolium pyridyl, mono(C^-C)4 aryl) extended imidazolium pyridyl, monodiaryl) Imidazopyrimidinylene group, one (: "(: burnt imidazolidine, 1-2 (crc1Q alkyl) imidazolyl pyridyl, one (CrCi4 aryl) imidazolyl pyridyl and / or one or two The imidazolidine group is, but is not limited thereto. [0036] For example, Ar, 11 Γ12 in the first substituent to the third substituent

Ari3、Ari5以及Aru可各獨自為一氫原子 '—重氫原子 經取代或未經取代 、一鹵素原子、一經基、一氰基、一 晞基 的C1_C30烷基、一經取代或未經取代的c -C 經取代或未經取代的C2'块基、—經取2代或未經取代 100111378 表單編號A0101 第24頁/共88頁 1003273214-0 201204728 的〜彳別烷氧基 发取代或未經取代的c ~c关其七 一經取代或未經取代^ ^ 5 30 土5 nWC3~C3。雜方基。舉例來說,ArAri3, Ari5 and Aru may each be a hydrogen atom'--a hydrogen atom substituted or unsubstituted, a halogen atom, a thiol group, a cyano group, a fluorenyl C1_C30 alkyl group, a substituted or unsubstituted C -C substituted or unsubstituted C2 'block group, - taken 2 generations or unsubstituted 100111378 Form No. A0101 Page 24 / Total 88 Page 1003273214-0 201204728 Substituted c ~ c off its seven-one substituted or unsubstituted ^ ^ 5 30 soil 5 nWC3 ~ C3. Hetero square. For example, Ar

[0037] Ο 、垃12、訐13、以及訏16可各獨自為-氫原子」 重風原子自素原子、―經基、-H基、-經取代或 未1 乂取代的Cl_Cl❶燒基、—經取代或未經取代的c 婦基…經取代或未經取代的CrCi。快基、_心 未、J·取代的h、燒氧基、_經取代或未經取代的 C5 C14方基及/或一餐取代或未經取代的%一雜芳基 ,但並不限於此。在實施時,第—取代基至第三取代基 中的Arn、Ar12、Ar13、Ari5以及Ari6可各獨自為_經 取代或未經取代的c「c3Q芳基。 舉例來說,Ar,,、Ar 、/Ατ. a a 11 12 Ari3 Ar15以及Ar16可各獨自 為一氫原子、一重氫原子'一齒素原子、一羥基'—氰 基、一曱基、一乙基、一丙基、一丁基、一戊基、一乙 烯基、一丙烯基、一丁烯基、一戊烯基、一乙醯基、一 甲氧基、一乙氧基、一丙氧基、一丁氧基、一戊氧基、 一經取代或未經取代的苯基、一經取代或未經取代的並 環戊二稀基(pentalenyl group)、一經取代或未經取 代的茚基(indenyl group)、一經取代或未經取代的萘 基(naphthyl group)、一經取代或未經取代的奠基 (azulenyl group)、一經取代或未經取代的並環庚三 烯基(heptalenyl group)、一經取代或未經取代的苯 並二節基(indacenyl group)、一經取代或未經取代的 乙烯合萘基(acenaphthyl group)、一經取代或未經取 代的苐基(fluorenyl group)、一經取代或未經取代的 100111378 表單編號A0101 第25頁/共88頁 1003273214-0 201204728 葩基(phenalenyl group)、一經取代或未經取代的菲 基(phenanthrenyl group)、一經取代或未經取代的蒽 基(anthracenyl group)、一經取代或未經取代的丙二 烯合苐基(nuoranthenyl group)、一經取代或未經取 代的聯二苯基(triphenylenyl gr〇up)、一經取代或未 經取代的芘基(pyrenylenyl gr〇up)、一經取代或未經 取代的孩基(chrysenyl group)、一經取代或未經取代 的稠四苯基(naphthacenyl gr〇Up)、一經取代或未經 取代的匹基(plcenyl gr〇up)、一經取代或未經取代的 茈基(perylenyl gr〇up)、一經取代或未經取代的五苯 基(pentaphenyl group)、一經取代或未經取代的稠六 苯基(hexacenyl group)、一經取代或未經取代的吡咯 基(pyrrolyl group) ' 一經取代或未經取代的吡唑基 (pyr^zolyl group)、一經取代或未經取代的咪唑基 (imidazolyl group)、一經取代或未經取代的味。坐你 基(imidazolinyi group)、一經取代或未經取代的咪 唑吡啶基(lmidazopyridinyl group)、一經取代或未 經取代的咪唑嘧啶基(imidaz〇pyrimidinyl 叩)、 一經取代或未經取代的吡啶基、一經取代或未經取代的 吡明1基(pyrazinyl group)、一經取代或未經取代的嘧 啶基、一經取代或未經取代的吲哚基、一經取代或未經 取代的嘌呤基、一經取代或未經取代的喹啉基 (quinolinyl group)、一經取代或未經取代的吹讲基 (phthalazinyl group)、一經取代或未經取代的吲哚 明=基(indoli zinyl gr0Up)、一經取代或未經取代的口奈 啶基(naphthyridinyl group)、一經取代或未經取代 1001JI378 表單編號A0101 第26頁/共88頁 1003273214-0 201204728[0037] Ο, 1212, 讦13, and 訏16 may each independently be a hydrogen atom. A heavy wind atom is a self-priming atom, a thiol group, a —H group, a substituted or a 1 乂-substituted Cl_Cl oxime group, - substituted or unsubstituted c-based ... substituted or unsubstituted CrCi. Fast radical, _xin, J. substituted h, alkoxy, _substituted or unsubstituted C5 C14, and/or a substituted or unsubstituted %-heteroaryl, but not limited to this. In practice, Arn, Ar12, Ar13, Ari5, and Ari6 in the first to third substituents may each independently be a substituted or unsubstituted c"c3Q aryl group. For example, Ar,,, Ar, /Ατ. aa 11 12 Ari3 Ar15 and Ar16 can each be a hydrogen atom, a heavy hydrogen atom, a dentate atom, a hydroxy group, a cyano group, a fluorenyl group, an ethyl group, a propyl group, and a butyl group. Base, monopentyl, monovinyl, monopropenyl, monobutenyl, monopentenyl, monoethylidene, monomethoxy, monoethoxy, monopropoxy, monobutoxy, one a pentyloxy group, a substituted or unsubstituted phenyl group, a substituted or unsubstituted pentalenyl group, a substituted or unsubstituted indenyl group, once substituted or not Substituted naphthyl group, substituted or unsubstituted azulenyl group, substituted or unsubstituted heptalenyl group, substituted or unsubstituted benzo Indacenyl group, substituted or unsubstituted vinyl naphthyl (acenaphthyl gr Oup), substituted or unsubstituted fluorenyl group, substituted or unsubstituted 100111378 Form No. A0101 Page 25 of 88 1003273214-0 201204728 phenalenyl group, once substituted or not a substituted phenanthrenyl group, a substituted or unsubstituted anthracenyl group, a substituted or unsubstituted unioranthenyl group, a substituted or unsubstituted group Triphenylenyl gr〇up, a substituted or unsubstituted pyronylenyl gr〇up, a substituted or unsubstituted chrysenyl group, a substituted or unsubstituted fused tetraphenyl Naphthacenyl gr〇Up, a substituted or unsubstituted plcenyl gr〇up, a substituted or unsubstituted perylenyl gr〇up, a substituted or unsubstituted pentaphenyl (pentaphenyl group), a substituted or unsubstituted hexacenyl group, a substituted or unsubstituted pyrrolyl group, a substituted or unsubstituted pyridyl Group (pyr ^ zolyl group), a substituted or unsubstituted imidazolyl, (imidazolyl group), a substituted or unsubstituted flavor. An imidazolinyi group, a substituted or unsubstituted lmidazopyridinyl group, a substituted or unsubstituted imidazylpyrimidinyl group, a substituted or unsubstituted pyridyl group, a substituted or unsubstituted pyrazinyl group, a substituted or unsubstituted pyrimidinyl group, a substituted or unsubstituted fluorenyl group, a substituted or unsubstituted fluorenyl group, a substituted or Unsubstituted quinolinyl group, substituted or unsubstituted phthalazinyl group, substituted or unsubstituted indoli zinyl gr0Up, once substituted or not Substituted naphthyridinyl group, once substituted or unsubstituted 1001JI378 Form No. A0101 Page 26 of 88 Page 1003273214-0 201204728

的嗜°坐淋基(quinazolinyl group) ' —經取代或未經 取代的口辛琳基(cinnoliny 1 group)、一經取代或未經 取代的吲唑基(indazolyl group)、一經取代或未經取 代的咔唑基、一經取代或未經取代的啡拼基 (Phenazinyl group)、一經取代或未經取代的啡啶基 (phenanthridinyl group)、一經取代或未經取代的哌 喃基(pyranyl group)、一經取代或未經取代的苯並旅 喃基(chromenylene group)、一經取代或未經取代的 苯並呋喃基(benzofuranyl group)、一經取代或未經 取代的嗟吩基(thiophenyl group)、一經取代或未經 取代的苯並嗟吩基(benzothiophenyl group)、一經取 代或未經取代的異嚷嗤基(isothiazolylene group)、 --經取代或未經取代的苯並。塞吩基(benzothiopheny 1 group)及/或一經取代或未經取代的異噁唑基 (isoxazolyl group),但不限於此。 [0038] Ο 舉例來說,Arn、Ar12、Aru、Aru以及人1*16可各獨自 為一氫原子、一重氫原子、一鹵素原子、一羥基、一氛 基、一甲基、一乙基、一丙基、一丁基、一戊基、一乙 烯基、一丙烯基、一丁烯基、一戊烯基、一乙醯基、一 曱氧基、一乙氧基、一丙氧基、一丁氧基、一戊氧基、 一苯基、一、-(:丨❹烷基苯基、一二(Ci_Ciq烷基)苯基、 /(C6_C14芳基)苯基、一二(C6-Cu芳基)苯基、一咔唑 基、一Ci-Cio烷基咔唑基、一二(CrC1G烷基)咔唑基、 ^C6 一 CI4芳基咔唑基、一二(C6-C14芳基)咔唑基、一苐 基、一C1_C10烷基苐基、一二(C〗-Ci〇烷基)薙基、一 100111378The quinazolinyl group' - a substituted or unsubstituted cinnoliny 1 group, a substituted or unsubstituted indazolyl group, a substituted or unsubstituted anthracene An azolyl group, a substituted or unsubstituted Phenazinyl group, a substituted or unsubstituted phenanthridinyl group, a substituted or unsubstituted pyranyl group, once substituted Or unsubstituted chromenylene group, substituted or unsubstituted benzofuranyl group, substituted or unsubstituted thiophenyl group, once substituted or not Substituted benzothiophenyl group, substituted or unsubstituted isothiazolylene group, substituted or unsubstituted benzo. A benzothiopheny 1 group and/or a substituted or unsubstituted isoxazolyl group, but is not limited thereto. Ο For example, Arn, Ar12, Aru, Aru, and human 1*16 may each independently be a hydrogen atom, a heavy hydrogen atom, a halogen atom, a hydroxyl group, an alkyl group, a monomethyl group, an ethyl group. , propyl, monobutyl, monopentyl, monovinyl, monopropenyl, monobutenyl, monopentenyl, monoethylidene, monomethoxy, monoethoxy, monopropoxy , monobutoxy, monopentyloxy, monophenyl, mono-, - (: nonylphenyl, di-(Ci_Ciq alkyl)phenyl, /(C6_C14 aryl)phenyl, one or two (C6 -Cu aryl)phenyl, monooxazolyl, mono-Cio-alkyl carbazolyl, mono-(CrC1G alkyl)carbazolyl, ^C6-CI4 arylcarbazolyl, one or two (C6-C14 Aryl) carbazolyl, monohydrazino, mono C1_C10 alkyl fluorenyl, mono-(C-Ci decyl) fluorenyl, a 100111378

表單編號A010I 第27頁/共88頁 1003273214-0 201204728 _C14^基)苐基、一二(C6_C14芳基)苐基、一萘基、一Form No. A010I Page 27 of 88 1003273214-0 201204728 _C14^Base) fluorenyl, one (two (C6_C14 aryl) fluorenyl, one naphthyl, one

烧基萘基、一二烧基)萘基、一(c6-ci4芳 基)萘基、一二(C6-C14芳基)萘基、一蒽基(anthryl group)、一(^-(^烷基蒽基、一二(CrC1〇烷基)蒽基、 一(c6-cu芳基)蒽基、一二(crCi4芳基)蒽基、一吡啶 基、一伸喹啉基、一烷基吡啶基、一二((:厂(:1〇烷 基)吡啶基、一(c6-cl4芳基)吡啶基、.一二(c6-c14芳基) 吡啶基、一喹啉基、一烷基喹啉基、一二 烷基)喹啉基、一(c6-c14芳基)喹啉基、一二((:6-(:14芳 基)啥啭基、一苯並味嗤基(benzoimidazolyl group) 、一Ci-Ciq垸基苯並咪唑基、一二烷基)苯並咪 唑基、一(crcl4芳基)苯並咪唑基、一二(crc14芳基) 笨並°米°坐基、一咪比咬基(imidazopyridinyl group)、◦烷基咪唑吡啶基、一二烷基) 咪唑吡啶基、一(C -c芳基)咪唑吡啶基、一二(c -C 0 14 6 14 芳基)咪唑吡啶基、一咪唑嘧啶基 (imidazopyrimidinyl group)、一烧基味°坐鳴 啶基、一二(crc1{)烷基)咪唑嘧啶基、一(c6-c14芳基) 咪唑嘧啶基及/或一二(c c芳基)咪唑嘧啶基。c _c 〇 14 1 1〇 燒基的例子可包含甲基、乙基、丙基、丁基、戊基,且 C5-C14*基的例子可包含笨基、萘基以及蒽基,但並不 限於此。 舉例來說,Arn、Ar12、Ar13、Arl5以及Ar16可各獨自 由以下的式4A至4G之任何之一者所表示: 100111378 表單編號A0101 第28頁/共88頁 1003273214-0 [0039] 201204728Naphthyl, pyridyl)naphthyl, mono(c6-ci4aryl)naphthyl, mono-(C6-C14 aryl)naphthyl, anthryl group, one (^-(^) Alkyl fluorenyl, bis(CrC1 decyl) fluorenyl, mono(c6-cu aryl) fluorenyl, mono-(crCi4 aryl) fluorenyl, monopyridyl, mono-quinolinyl, monoalkylpyridine Base, one or two ((: (1) alkyl) pyridyl, mono(c6-cl4 aryl)pyridyl, di-(c6-c14 aryl)pyridyl, monoquinolinyl, monoalkyl Quinolinyl, mono-dialkyl)quinolinyl, mono(c6-c14 aryl)quinolinyl, mono-((:6-(:14aryl)) fluorenyl, benzoimidazolyl Group), a Ci-Ciq mercaptobenzimidazolyl, monodialkyl) benzimidazolyl group, a (crcl4 aryl) benzimidazolyl group, a di(crc14 aryl) stupid Imidazopyridinyl group, decyl imidazolidinyl, monoalkylidene imidazolidinyl, mono(C-caryl)imidazolidinyl, mono-(c-C 0 14 6 14 aryl Imidazopyrididinyl group a base-based succinyl group, a succinyl group, a bis(crc1{)alkyl group), an imidazolyl group, a (c6-c14 aryl) imidazolidinyl group and/or a bis(cc aryl)imidazolidinyl group. c _c Examples of the fluorene group may include a methyl group, an ethyl group, a propyl group, a butyl group, a pentyl group, and examples of the C5-C14* group may include a strepyl group, a naphthyl group, and an anthracenyl group, but are not limited thereto. For example, Arn, Ar12, Ar13, Arl5, and Ar16 may each be represented by any one of the following Formulas 4A to 4G: 100111378 Form No. A0101 Page 28/88 Page 1003273214-0 [0039] 201204728

式4BEquation 4B

式4AFormula 4A

式4CFormula 4C

式4DFormula 4D

式4GFormula 4G

在式4A至4G中,Zi、Z2、Zn以及Z12可各獨自為,例如 :一氫原子、一重氫原子、一烧基、一CfCn烧 氧基及/或一L-Ch芳基,p及q可各獨自為1至8的整數, 〇 14 且*為一與Ar 、Ar 、Ar,、八1'[;或八1'<;的鍵結位置。當在 第一取代基中a為0時,Arn可由式4Α至4G之任何之一者 所表示,*在4A至4G為構成式1主幹的環原子之其中之一 者的鍵結位置,其係容易地被熟悉此領域之技術人士所 理解。 [〇〇4〇] 舉例來說,Zi、z2、zn以及z12可各獨自為一氫原子、一 重氫原子、一甲基、一乙基、一丙基、一丁基、一甲氧 基、一乙氧基、一丙氧基、一笨基、一萘基及/或一蒽基 [0041] 舉例來說,Ar 、Ar 、Ar1Q、Ar1c以及人犷”可各獨自 11 11 13 15 16 由以下的式5A至5E之任何之一者所表示,但不限於此: 100111378 表單編號A0101 第29頁/共88頁 1003273214-0 201204728 [0042] [0043] [0044] [0045] [0046] 100111378In Formulae 4A to 4G, Zi, Z2, Zn, and Z12 may each be independently, for example, a hydrogen atom, a heavy hydrogen atom, a monoalkyl group, a CfCn alkoxy group, and/or an L-Ch aryl group, p and q may each be an integer of 1 to 8, 〇14 and * is a bonding position with Ar, Ar, Ar, 八1'[; or 八1'<; When a is 0 in the first substituent, Arn may be represented by any one of the formulae 4A to 4G, and *4A to 4G is a bonding position of one of the ring atoms constituting the trunk of the formula 1, It is readily understood by those skilled in the art. [〇〇4〇] For example, Zi, z2, zn, and z12 may each independently be a hydrogen atom, a monohydric hydrogen atom, a monomethyl group, a monoethyl group, a monopropyl group, a monobutyl group, a monomethoxy group, Monoethoxy, monopropoxy, a phenyl, a naphthyl and/or a fluorenyl group [0041] For example, Ar, Ar, Ar1Q, Ar1c, and human 犷" may each be 11 11 13 15 16 by It is represented by any one of the following formulas 5A to 5E, but is not limited thereto: 100111378 Form No. A0101 Page 29 / Total 88 Page 1003273214-0 201204728 [0043] [0044] [0046] [0046] 100111378

式5AEquation 5A

式5DEquation 5D

式5B 式5CEquation 5B Equation 5C

式5E 式5A至5E中’ *為一與Ar〗、Αι·ζ、A%、a、或a%的鍵結 位置。 舉例來說,當a在第一取代基為〇時,A]:n可由式5八至5£ 之任何之一者所表示,*在^至5£;為構成Si主幹的環原 子之其中之一者的鍵結位置,其係容易地被熟悉此領域 之技術人士所理解。 a、b、c、e及f可各獨自為〇至1〇之一整數。舉例來說, a、b、c、e及f可各獨自為〇、i、2或3,但並不限於此 舉例來說,當a = 0時,第一取代基可為Al_ii,且奸11可直 接連結至構成式1主幹的環原子。當a = 〇時,第一取代基 可為,例如:一經取代或未經取代的〜乂⑽芳基或一經 取代或未經取代的crc3()雜芳基。 舉例來說’當b = G時’ a、在第二取代基可直接連結至N ’類似於當c、e及f = 〇的案例中。 d可為整數1至1〇。舉例來說,d可為1、2或3,但並不限 表單鳊號A0101 第30頁/共88頁 1003273214-0 201204728 於此。 [0047] 第二取代基以及第三取代基的 -Ν[-(Αι·5),Αγ15][-(Α、)γΑΓι6]係各獨自由 6Α至6Κ之任何之一者所表示: ΧIn the formula 5E, the term "*" in the formulae 5A to 5E is a bonding position with Ar, Αι·ζ, A%, a, or a%. For example, when a is 〇 in the first substituent, A]: n can be represented by any one of Formulas 5-8 to 5, * in the range of ^ to 5; which is the ring atom constituting the Si trunk. One of the bonding locations is readily understood by those skilled in the art. a, b, c, e, and f may each be an integer of one to one. For example, a, b, c, e, and f may each be 〇, i, 2, or 3, but are not limited thereto. When a = 0, the first substituent may be Al_ii, and 11 can be directly linked to the ring atom constituting the backbone of Formula 1. When a = 〇, the first substituent may be, for example, a substituted or unsubstituted ~?(10)aryl group or a substituted or unsubstituted crc3()heteroaryl group. For example, 'when b = G' a, where the second substituent can be directly linked to N ' is similar to the case when c, e, and f = 〇. d can be an integer from 1 to 1 〇. For example, d can be 1, 2, or 3, but is not limited to Form No. A0101 Page 30 / Total 88 Page 1003273214-0 201204728 Here. The second substituent and the third substituent - Ν[-(Αι·5), Αγ15][-(Α,)γΑΓι6] are each represented by any one of 6Α to 6Κ: Χ

在式6Α至6Κ中,\至24以及Zu至Ζ14可各獨自為,例如 :-氫原子、-重氫原子、一。烷基(例如:—甲基 、一乙基、一丙基、一丁基以及一戊基)、一c 1 10%礼 ❹ 基(例如:一甲氧基、一乙氧基、一丙氧基、—丁氧基以 及一戊氧基)及/或(:6_(:14芳基(例如:一笨基、一萘基以 及一蒽基),p、q、r以及s可各獨自為1至8的整數,*為 一與A%或與一構成式丨主幹的環原子的鍵結位置。在實 施時’ q可為整數1至7,且1*與5可為整數1至4。 [0048] 式1中,八^的、"群在該第一取代基的_(Ar ) _Ar的In the formulas 6A to 6Κ, \ to 24 and Zu to Ζ14 may each be independently, for example: - a hydrogen atom, a - a heavy hydrogen atom, or one. An alkyl group (for example: -methyl, monoethyl, monopropyl, monobutyl and monopentyl), a c 1 10% sulfhydryl group (for example: monomethoxy, monoethoxy, monopropoxy) , —butoxy and monopentyloxy” and/or (6-(:14 aryl) (eg, a stupyl, a naphthyl, and a fluorenyl), p, q, r, and s may each be An integer from 1 to 8, * is a bonding position with A% or a ring atom of a constituent 丨 backbone. In practice, 'q can be an integer from 1 to 7, and 1* and 5 can be an integer from 1 to 4. [0048] In Formula 1, the group of _(Ar)_Ar of the first substituent

la 11 J 基團中可彼此相同或不同;Ar2的” b”群在該第二取代基 的(Α『2)ι>_Α『ΐ2基團中可彼此相同或不同;Ar的” c"群 3 在該第二取代基的-(Ar3)c-Ar13S團中可彼此相同或不 同;Ar的"e"群在該第三取代基的—(A ) _Ar基團中 5 e 15 100111378 表單編號A0101 第31頁/共88頁 1003273214-0 201204728 :此相同响;、心"物“三取代基的 气計6)厂訏]6基團中可彼此相同或不同。 _9] [0050] ^佳地’ Μ、之至少之—者在縮合環狀化合物係由式 -::士:卜(Ar5)e_Ari5][—(α'Ά]所表示(第 代基)’其中d為整數1幻〇。因此,較佳地,Ar存 在於實施例的縮合環狀化合物。即表示,包含結合式^與 式2之主幹或包含結合式1與式3之主幹係較佳地連結至透 過纤4由-町-“!*5)6士15]卜("6)厂八、]所表示的基 團。電子的缺乏或不足可藉由構成三笨環的碳位置所預 P方,該三笨環係藉由Ar4融合於以的主幹,驗在碳位 置可預防氧化。因此,雖然由式1所表示的縮合環4狀化合 物可被親核錄子攻擊,但可實質上預防縮合環狀化合 物的劣化。因此,包含由式1所表示的縮合環狀化合物的 有機發光裝置(OLED)可具有已改善的功效,例如:電流 密度、功率、亮度以及壽命。 在式1中,R#Ri2可各獨自為,例如:一氯原子、一重 氫原子、—較原子、-誠、-氰基、第-取代基、 第二取代基及/或第三取代基;"a"在第一取代基為〇(即 表示’當rjr12之任何之-可為第一取代基,可直 接連結至一構成式1主幹之環原子);Wc在第二丄1 代基 可各為0或1 ; d在第三取代基可為丨或2,以及"e"和 在第三取代基可各獨自為0或1;在第一取代基至第三取 代基之中的至Are可各獨自為一經取代或未經取代的 C5-C14伸芳基或是-經取代或未經取代的C「C14雜伸芳 基;以及在第一取代基至第三取代基之中 14、 1 1 ΛΓ1 〇 100111378 表單編號Α0101 第32頁/共88頁 1003273214-0 201204728 、标13士15物16可各獨自為,例如 重氫原子、—鹵素原子、一羥基、 ’、、- 未經取代的W基、-經取代或未:取:::或 烯基、一經取代或未經取代的c Ά 2 10 2 ι〇块基、一經取代或 !取[Mrc1(^氧基、—經取代或未經取代的/ =4芳基及/或-經取代或未經取代的w雜芳基。 在實施時士2至^可各獨自為—經取代或未經取代的 C6-C14芳基。The la 11 J groups may be the same or different from each other; the "b" group of Ar2 may be the same or different from each other in the (Α『2)ι>_Α『ΐ2 group of the second substituent; the "c" group of Ar 3 may be the same or different from each other in the -(Ar3)c-Ar13S group of the second substituent; the "e" group of Ar in the -(A)_Ar group of the third substituent 5 e 15 100111378 No. A0101 Page 31 / 88 pages 1003273214-0 201204728: This same sound;, heart " matter "three-substance gas meter 6" factory 訏] 6 groups can be the same or different from each other. _9] [0050] ^佳地' 至少, at least - in the condensed cyclic compound is represented by the formula -::士:卜(Ar5)e_Ari5][-(α'Ά] (the first generation) Wherein d is an integer 1 phantom. Therefore, preferably, Ar is present in the condensed cyclic compound of the embodiment, that is, it is preferred that the backbone comprising the combination formula and formula 2 or the backbone system comprising the combination formula 1 and formula 3 is preferred. The ground is linked to the group indicated by the fiber 4 by -machi-"!*5)6士15]卜("6)厂八,]. The lack or deficiency of electrons can be achieved by the carbon position of the three stupid rings. The pre-P side, which is fused to the stem by Ar4, can prevent oxidation at the carbon position. Therefore, although the condensed ring 4-form compound represented by Formula 1 can be attacked by the nucleophile, The deterioration of the condensed cyclic compound can be substantially prevented. Therefore, an organic light-emitting device (OLED) comprising the condensed cyclic compound represented by Formula 1 can have improved effects such as current density, power, brightness, and lifetime. In Formula 1, R#Ri2 may be each independently, for example, a chlorine atom, a heavy hydrogen atom, a relatively atom, a -, a -cyano group, a first-substituted a base, a second substituent, and/or a third substituent; "a" in the first substituent is 〇 (ie, 'when any of rjr12' may be the first substituent, which may be directly linked to a constituent 1 The ring atom of the backbone); Wc may be 0 or 1 in the second 丄 1 generation; d may be 丨 or 2 in the third substituent, and "e" and the third substituent may each be 0 or 1; among the first substituent to the third substituent, each of which may be a substituted or unsubstituted C5-C14 aryl group or a substituted or unsubstituted C"C14 hetero aryl group And; among the first substituent to the third substituent, 14, 1 1 ΛΓ 1 〇 100111378 Form No. 101 0101 Page 32 / Total 88 Page 1003273214-0 201204728, Standard 13 士 15 16 can be individually, for example heavy a hydrogen atom, a halogen atom, a monohydroxy group, a ',, an unsubstituted W group, a substituted or unsubstituted::: or an alkenyl group, a substituted or unsubstituted c Ά 2 10 2 ι〇 block Or a substituted or unsubstituted w heteroaryl group. To 2 ^ can each independently is - C6-C14 aryl, substituted or unsubstituted.

剛舉例來說,R^Ri2可各獨自為—氣原子、_重氣原子、 一函素原子、—經基、—氰基、第-取代基、第二取代 基及第三取代基;a在第—取代基可為G;⑷在第二取 代基可各為0或1 ; d在第三取代基可為1?戈2,以及咖在 該第三取代基可各獨自為〇或1;在第一取代基至第三取 代基之中的八^至八^可各獨自為一伸苯基、一c _c 1 1 〇机 基伸苯基、-二(Cl-c10絲)伸苯基、一(c6—ci4芳基) 伸笨基、一二(C6-C14芳基)伸笨基、一伸咔唑基、一 C1〇烷基伸咔唑基、一二(crCifl烷基)伸咔唑基、一 C6-Ci4芳基伸咔唑基、一二(Ce_Ci4芳基)伸咔唑基、一 伸第基、一(:厂(:1〇烷基伸苐基、一二(Ci_ci〇烷基)伸第 基、一(C6_C14芳基)伸篥基、一二(C6-C14芳基)伸薙基 、一伸萘基、一(:厂(:1()烷基伸萘基、一二烷基) 伸萘基、一(C6-C14芳基)伸萘基、一二(c6-c14芳基)伸 萘基、一伸蒽基、一Cj-Cu烷基伸蒽基、一二((^-(:^烷 基)伸蒽基、一(C6-C14芳基)伸蒽基、一二(c6-c14芳基) 伸蒽基、一伸吡啶基、一烷基伸吡啶基、一二 100111378 表單編號A0101 第33頁/共88頁 1003273214-0 201204728 -ClQ烷基)伸吡啶基、一(C6-C14芳基)伸吡啶基、一二 (Ce-Cu芳基)伸吡啶基、一伸喹啉基、一Ci_Ci〇烷基伸 喹啉基、一二((^-(:丨^烷基)伸喹啉基、一(CrCi4芳基) 伸喹啉基 '一二(c6-c14芳基)伸喹啉基、一伸苯並咪唑 基、一Ci_Ciq烷基伸苯並咪唑基、一二烷基)伸 笨並咪唑基、一(c6-c14芳基)伸苯並咪唑基、一二 (C 6 - C1 4方基)伸笨並σ米·»坐基、一伸味。坐t (比咬基、一 CrC1G烷基伸咪唑吡啶基、一二(C厂C1G烷基)伸咪唑吡 啶基、一(C6_C14芳基)伸咪唑 比啶基、一二(C6-C14芳基 )伸咪唑吡啶基、一伸咪唑嘧啶基、一烷基伸咪唑 喊咬基、一一烧基)伸味嗤η密咬基、一(c 芳 1 1 υ 6 14 π 基)伸咪唑嘧啶基或一二(c6-ci4芳基)伸咪唑嘧啶基;在 第一取代基至第三取代基之中的Ar 、Ar 、Ar 、 11 12 13For example, R^Ri2 may be independently a gas atom, a heavy gas atom, a single atom, a thiol group, a cyano group, a first substituent, a second substituent, and a third substituent; The substituent may be G; (4) each may be 0 or 1 in the second substituent; d may be 1 in the third substituent, and the third substituent may be independently 〇 or 1 in the third substituent. Between the first substituent and the third substituent, eight to eight can be each a phenyl group, a c _c 1 1 oxime base phenyl group, a bis (Cl-c10 wire) phenyl group, a (c6-ci4 aryl) group, a bis(C6-C14 aryl) group, a carbazolyl group, a C1 alkyl carbazole group, a bis(crCifl alkyl) carbazole group , a C6-Ci4 aryl extended carbazolyl group, a bis(Ce_Ci4 aryl) carbazole group, a stretching base, a (: plant (: 1 〇 alkyl thiol, a bis (Ci_ci 〇 alkyl) extension a group, a (C6_C14 aryl) fluorenyl group, a bis(C6-C14 aryl) fluorenyl group, a stilbene group, a (: plant (: 1 () alkyl-naphthyl group, a dialkyl group) Base, one (C6-C14 aryl) anthranyl, one or two (c6-c14 aryl) Naphthyl, a fluorenyl group, a Cj-Cu alkyl group, a bis((^-(:^)alkyl) group, a (C6-C14 aryl) group, a two (c6-c14) Aryl) fluorenyl, pyridine, monoalkylpyridyl, 1-2100111378 Form No. A0101 Page 33 of 88 1003273214-0 201204728 -ClQ alkyl) Pyridyl, one (C6-C14 aryl) a pyridyl group, a di-(Ce-Cu aryl)-extended pyridyl group, a quinolinol group, a Ci_Ci 〇 alkyl-extended quinolinyl group, a bis((^-(:丨^alkyl) quinolinyl group, a (CrCi4 aryl) quinolinolyl-di(c6-c14 aryl) quinolinol group, a benzzimidazolyl group, a Ci_Ciq alkyl-benzimidazolyl group, a dialkyl group , a (c6-c14 aryl) benzoimidazolyl group, a bis (C 6 - C1 4 square group) stupid and σ m ·» sit base, a stretch of taste. sit t (bite base, a CrC1G alkyl stretch Imidazolyl pyridyl, one (C C1G alkyl) ex-imidazole pyridyl, one (C6_C14 aryl) excimidazole pyridine group, one (two (C6-C14 aryl) imidazolidine pyridyl, one imidazolidinyl group, one Alkyl stretch imidazole shouting base, one by one a substrate, a (c aryl 1 1 υ 6 14 π group) imidazolidinyl group or a di-(c6-ci4 aryl) imidazolidine group; in the first substituent to the third substitution Among the bases, Ar, Ar, Ar, 11 12 13

Aris以及Ar16可各獨自為一氫原子、一重氫原子、一鹵 素原子、一羥基、一氰基、一甲基、一乙基、一丙基、 一丁基、一戊基、一乙婦基、一丙婦基、一丁烯基、一 戊烯基、一乙醯基、一曱氧基、一乙氧基、一丙氧基、 一丁氧基、一戊氧基、一苯基、一Ci_Cu烷基苯基'一 二(C1_C10烧基)笨基、—(C6_C14芳基)笨基、—二(、_ c14芳基)苯基、一咔唑基、一Ci_Cm烷基咔唑基、一二 (crc1()烷基)咔唑基、一c6_ci4芳基咔唑基、一二 (C6-Ci4芳基)咔唑基、一苐基、一Ci_Cb烷基苐基、一 二(c丨-c1〇烷基)第基、—(CrC】4芳基)篥基 '一二((:6_ c14芳基)¾基、一萘基、一烷基萘基、一二 ((^-Cio烧基)萘基、一(c _c芳基)萘基、一二(c _c b 4 6 14 芳基)萘基、一蒽基、一c _c烷基蒽基、一二(c _c 10011】378 i 1ϋ 1 10 1003273214-0 表單編號Α0101 第34頁/共88頁 201204728 Ο 院基)葱基、一(crc14芳基)蒽基、一二(C6-C14芳基)蒽 基、—吡啶基、一crclG烷基吡啶基、一二(crc1Q烷基 )比啶基、一(C6 一 C14芳基)吡啶基、一二(C6-C14芳基)吡 啶基、一喹啉基、一crcifl烷基喹啉基、一二(c「Ci〇烷 基)喹琳基、一(crc14芳基)啥琳基、一二(C6-C14芳基) 喹啉基、一苯並咪唑基、一、吒^烷基苯並咪唑基、一 二(CrCi〇烷基)苯並咪唑基、一(C6-C14芳基)苯並咪唑 基 一(Cg 方基)苯並味嗤基、一°米嗤°比咬基、一 Ci-C1G烷基咪唑吡啶基、一二(C1_C1Q烷基)咪唑吡啶基 、一(CrCi4芳基)咪唑吡啶基、一二(Ce-C1;)芳基)咪唑 b 14 吡啶基、一咪唑嘧啶基、—Ci_Cb烷基咪唑嘧啶基、一 二(CrCU)烷基)咪唑嘧啶基、一(C6-C14芳基)咪唑嘧啶 基或一一(C6_C14芳基)咪唑嘧啶基,但不限於此。 [0052] Ο 在實施時’由式1表示的縮合環狀化合物可由以下式2a至 2e之任何之一所表示(式i中的"A"環由式2所表示): 100111378 表單編號A0101 第35頁/共88頁 1003273214-0 201204728Aris and Ar16 may each independently be a hydrogen atom, a monohydric hydrogen atom, a halogen atom, a monohydroxy group, a monocyano group, a monomethyl group, a monoethyl group, a monopropyl group, a monobutyl group, a pentyl group, an ethyl group. , a propyl group, a butenyl group, a pentenyl group, an ethyl fluorenyl group, a monodecyloxy group, an ethoxy group, a monopropoxy group, a monobutoxy group, a pentyloxy group, a phenyl group, a Ci_Cu alkylphenyl 'di(C1_C10 alkyl) phenyl, -(C6_C14 aryl) phenyl, -di(, _ c14 aryl) phenyl, monooxazolyl, a Ci_Cm alkylcarbazolyl , a two (crc1 () alkyl) carbazolyl group, a c6_ci4 aryl carbazolyl group, a di-(C6-Ci4 aryl) oxazolyl group, a fluorenyl group, a Ci_Cb alkyl fluorenyl group, a two (c丨-c1 〇alkyl)diyl, —(CrC]4 aryl)indenyl'-di((:6_ c14 aryl) 3⁄4yl, mononaphthyl, monoalkylnaphthyl, one or two ((^- Cioalkyl)naphthyl, mono(c-caryl)naphthyl, mono-(c _c b 4 6 14 aryl)naphthyl, monodecyl, mono-c-alkylalkyl, one-two (c _c 10011 】 378 i 1ϋ 1 10 1003273214-0 Form No. Α0101 Page 34 of 88 201204728 院Onion, a (rcc14 aryl) fluorenyl group, a bis(C6-C14 aryl) fluorenyl group, a pyridyl group, a crclG alkyl pyridyl group, a di(crc1Q alkyl group) pyridine group, a (C6 one C14 aryl)pyridyl, mono-(C6-C14 aryl)pyridyl, monoquinolyl, a crcifl alkylquinolinyl, mono-(c"Ci〇alkyl)quininyl, one (crc14-aryl)啥), 一 基, 一 (C6-C14 aryl) quinolyl, monobenzimidazolyl, monomethyl benzoimidazolyl, bis(CrCi 〇 alkyl) benzimidazolyl, (C6-C14 aryl) benzimidazolyl-(Cg-square) benzofuranyl group, one ° 嗤 ° ratio than a bite group, a Ci-C1G alkyl imidazolidinyl group, a di(C1_C1Q alkyl) imidazole Pyridyl, mono(CrCi4 aryl)imidazolidinyl, mono-(Ce-C1;)aryl)imidazole b 14 pyridyl, monoimidazopyrimidinyl, —Ci—Cb alkylimidazopyrimidinyl, mono-(CrCU)alkyl An imidazolyl group, a mono(C6-C14 aryl)imidazopyrimidinyl group or a mono(C6-C14 aryl)imidazolidine group, but is not limited thereto. [0052] 缩合 A fused cyclic compound represented by Formula 1 when it is carried out can Any one of the following formulas 2a to 2e are represented by the (formula i is " A " ring represented by Formula 2): 100 111 378 Page 35 Form Number A0101 / 88 Total 201 204 728 1003273214-0

式2aEquation 2a

式2bEquation 2b

式2d 在式 2a 至式 2d 中,RJR19、Ar^Ar 、Ar 、Ar 、 1 1 Z 1 0 1 1 \ 2 Ar13、Ar15、Ar16、a、b、c、d、e及f可如上述定義。 [0053] 在式2a至式2d中,A。可為,例如:一伸笨基、·一c —c 4 1 伸苯基、一二(crcl()烷基)伸笨基、一(c6-c14芳基)伸 苯基 '一二(C6-C14芳基)伸苯基、一伸咔唑基、一 q-ClG烷基伸咔唑基、一二(C厂CiG烷基)伸咔唑基、— Ce-C〗4芳基伸咔唑基、一二(c^Ch芳基)伸咔唑基、— 伸苐基、一c厂cl〇烷基伸蕹基、一二(c「Ci〇烷基)伸第 基、一(C6-Cl4芳基)伸第基、 、一伸萘基、一c ίο 100111378 二(C6_C14芳基)伸苇基 10烷基伸萘基、一二(CrC1Q烷基) 伸蔡基、—(C「C14芳基)伸萘基、-二(C6-C14芳基)伸 第36頁/共88頁 表單編號A0101 1003273214-0 201204728 Ο 萘基、一伸蒽基、一c1{)烷基伸蒽基、一二(^乂“烷 基)伸蒽基、一(c6-c14芳基)伸蒽基及一二(C6-C14芳基) 伸蒽基、一伸α比咬基、一 C ^ - c μ烧基伸α比咬基、一 (C6-Ci4芳基)伸吡啶基、一二(C6-C14芳基)伸°比啶基、 一伸喹啉基、一(:厂(:1()烷基伸喹啉基、一二((:厂(:1()烷基 )伸喹啉基、一(C6-C14芳基)伸喹啉基、一二((:6-(:14芳 基)伸喹啉基、一伸苯並咪唑基、一c1()烷基伸苯並咪 唑基、一二(c^-Cu烷基)伸苯並咪唑基、一(c6-c14芳基 )伸苯並咪唑基、一二(c6-c14芳基)伸苯並咪唑基、一伸 咪唑吡啶基、一(:厂(:1()烷基伸咪唑吡啶基、一二(Ci-C^ 烷基)伸咪唑吡啶基、一芳基)伸咪唑吡啶基、一 ο 14 一4芳基)伸咪嗤比咬基、一伸味吐嘴咬基、一_ ❹ [0054] C1〇烷基伸咪唑嘧啶基、一二(C厂烷基)伸咪唑嘧啶基 、一(C6-C14芳基)伸咪唑嘧啶基或一二(C6-C14芳基)伸 咪唑嘧啶基。在式2a至式2d中,d可為1、2或3。舉例來 說,在式2a至式2d中,八1*4可為一伸苯基且d可為1或2, 但本實施例並不限於此。 在式2a至式2d中,由 (Ar4)d-N[-(Ar5)e-Ar15][-(Ar6)f-Ar16]表示的第三 取代基的-N[-( Ar ) -Ar 1「f a 、 * η Ar15U-(Ar6)f-Ari6]可由式6A 至式6K之任何之一所表示。 [0055] 在式2a至2e中’ '及、可各*,例如:第—取代基且 "a"在第-取代基中為Q。舉例來說,在式仏至式^中, RlM8可為第一取代基,"a"在第—取代基可為〇,且4 可為一經取代或未經取代 11 〜l14方基或一經取代或未 100111378 表單編號A0101 第37頁/共88頁 1003273214-0 201204728 丄取代的G3 雜芳基。詳細說來,在式2a至式2e中,Formula 2d In Formula 2a to Formula 2d, RJR19, Ar^Ar, Ar, Ar, 1 1 Z 1 0 1 1 \ 2 Ar13, Ar15, Ar16, a, b, c, d, e, and f may be as defined above . In Formula 2a to Formula 2d, A. It can be, for example, a stupid base, a c-c 4 1 phenyl group, a di-(crcl() alkyl group), a (c6-c14 aryl) phenyl group - a two (C6- C14 aryl) phenyl, oxazolyl, a q-ClG alkyl carbazole group, one (C plant CiG alkyl) carbazole group, - Ce-C 4 aryl carbazole group, one Di(c^Ch aryl) extended carbazolyl, — hydrazine group, a c plant, a hydrazide alkyl group, a bis (c "Ci 〇 alkyl"), a (C6-Cl4 aryl) Stretching base, a stretchy naphthyl group, a c ίο 100111378 bis(C6_C14 aryl) decyl 10 alkyl extended naphthyl group, a bis(CrC1Q alkyl group) stretching, a (C "C14 aryl" stretching naphthyl group ,-(C6-C14 aryl) extension 36 pages/88 pages Form No. A0101 1003273214-0 201204728 Ο Naphthyl, a fluorenyl group, a c1{) alkyl group, a bis (^ 乂 "alkyl group a thiol group, a (c6-c14 aryl) thiol group and a bis(C6-C14 aryl) thiol group, a stretch alpha ratio bite base, a C ^ - c μ burn base extension alpha ratio bite base, (C6-Ci4 aryl) extended pyridyl, mono-(C6-C14 aryl) extension ratio pyridine group, quinolinyl group, One (: plant (: 1 () alkyl quinolinolyl, one two ((: (1) alkyl) quinolinyl, one (C6-C14 aryl) quinolinyl, one or two ( (6-(:14-aryl) quinolinyl, benzoimidazolyl, a c1() alkylbenzimidazolyl, a bis(c^-Cualkyl)benzimidazolyl, one ( C6-c14 aryl) benzoimidazolyl, bis(c6-c14 aryl) extended benzimidazolyl, imidazolium pyridyl, one (: plant (: 1 () alkyl extended imidazolium pyridyl, one or two ( Ci-C^ alkyl) extended imidazolium pyridyl, monoaryl) imidazolidine, a ο14-4 aryl) 嗤 嗤 嗤 咬 、 、 、 、 、 、 、 、 、 005 005 005 005 005 005 005 005 005 005 005 005 005 005 005 a decyl imidazolidine group, a bis(C alkyl group) imidazolidinyl group, a (C6-C14 aryl) imidazolyl pyridyl group or a di(C6-C14 aryl) imidazolidine group. In the formula 2d, d may be 1, 2 or 3. For example, in the formula 2a to the formula 2d, 八1*4 may be a phenyl group and d may be 1 or 2, but the embodiment is not limited thereto. In Formula 2a to Formula 2d, -N[-( Ar ) of the third substituent represented by (Ar4)dN[-(Ar5)e-Ar15][-(Ar6)f-Ar16] -Ar 1 "fa , * η Ar15U-(Ar6)f-Ari6] can be represented by any one of Formulas 6A to 6K. [0055] In Formulas 2a to 2e, '', and each can be *, for example: - Substituent and "a" is Q in the first substituent. For example, in the formula, RlM8 may be the first substituent, "a" may be 第 in the first substituent, and 4 may be a substituted or unsubstituted 11~l14 square group or once Substituted or not 100111378 Form No. A0101 Page 37 / Total 88 Page 1003273214-0 201204728 丄 Substituted G3 Heteroaryl. In detail, in Equations 2a to 2e,

Ri及%可各獨自為,例如:一笨基。 [0056] 在式2d中’ %可為第―取代基,且、,在第—取代基可為 〇 +例來說,在式2d中,%可為第一取代基,” a„在第 取代基可為〇,且、可為—經取代或未經取代的 Cs Cu芳基或一經取代或未經取代的雜芳基,詳 細說來,在式2d中,\及1?8可各為一苯基。 [0057] 在實施時’式1所表示的縮合環狀化合物可由以下式3&至 3e之任何之—所表示:Ri and % can be individually, for example: a stupid base. In the formula 2d, '% may be a first substituent, and, in the case where the first substituent may be 〇+, in the formula 2d, % may be the first substituent," a„ The substituent may be hydrazine, and may be a substituted or unsubstituted Cs Cu aryl group or a substituted or unsubstituted heteroaryl group. In detail, in Formula 2d, \ and 1-8 may each be It is a phenyl group. The condensed cyclic compound represented by Formula 1 may be represented by any of the following Formulas 3 & to 3e:

在式3a至式3e中’ 1?,至1?10、、Ai^、Ar1t} ''1?, to 1?10, Ai^, Ar1t} ' in Equations 3a to 3e

1 iI 1 ο 11 i L1 iI 1 ο 11 i L

Ar13、Arl5、Ar16、a、b、c、d、e及f可如上述定義。 在式3a至3e中,Ar4可例如:一伸苯基、一 Ci-C^伸苯基 、一二(crcl{)烷基)伸苯基、一(c6-c14芳基)伸苯基、 100111378 表單編號A0101 第38頁/共88頁 1003273214-0 [0058] 201204728 一一(C6-C14芳基)伸苯基、一伸。卡唾基、一Ci-Cu烧基 伸咔唑基、一二((:厂(:1()烷基)伸咔唑基、一C6-C14芳基 伸吟。圭基、一二(C6_C14芳基)伸吁嗤基、一伸第基、一 Ci-C1〇烷基伸苐基、一二(Ci_Ci〇烷基)伸苐基、一 (C6-Ci4芳基)伸第基、一二(C6-C14芳基)伸苐基、一伸 萘基、一烷基伸萘基、一二(Ci-C1Q烷基)伸萘基 、一(C6_C14芳基)伸萘基、一二(C6-C14芳基)伸萘基、 Ο 〇 一伸蒽基、一(:厂(:1〇烷基伸蒽基、一二(C^-Cb烷基)伸 蒽基、一(c6-cl4芳基)伸蒽基及一二(c6-c14芳基)伸蒽 基、一伸°比咬基、一烧基伸°比咬基、一(、-(:14芳 基)伸。比咬基、一二(c6-c14芳基)伸"比啶基、一伸喹琳基 、一 C1_C1Q烷基伸喹啉基、一二(h-Cu烷基)伸喹啉基 、一(crc14芳基)伸喹啉基、一二(c6-c14芳基)伸喹啉 基、一伸苯並咪唑基、一烷基伸苯並咪唑基、一 二(crc1Q烷基)伸笨並咪唑基、一(C6-C14芳基)伸苯並 咪唑基、一二(C6-C14芳基)伸苯並咪唑基、一伸咪唑吡 啶基、一烷基伸咪唑吡啶基、一二烷基) 伸咪唑吡啶基、一(C6-C14芳基)伸咪唑吡啶基、一二 (C6-C14芳基)伸咪唾α比咬基、一伸σ米吐嘴咬基、一 q-Cio烷基伸咪唑嘧啶基、一二烷基)伸咪唑嘧 啶基、一(C -C芳基)伸咪唑嘧啶基或一二(c _Cu芳基 υ 1^ 614 )伸咪唑嘧啶基。在式3a至式3e中,d可為1、2或3。舉 例來說,在式3a至式3e中,人1"4可為一伸苯基且d可為1或 2,但本實施例並不限於此。 [0059] 100111378 在式3a至式3e中,由 1003273214-0 表單編號A0101 第39頁/共88頁 201204728 )f—Ar16]表示的第三取代基的 N[ (Ar5)e一Ar15] [_(Ar6)f-Ar16]可由式6A至式6K之 任何之一者所表示。在式%至3(1中,\及、可各自為, 例如:第一取代基,且"a"在第一取代基中為〇。舉例來 。兒,在式3a至式3d中,R〗及、可各為第一取代基,” a"在 第取代基可為〇,且Au可為一經取代或未經取代的c$_ Cu芳基及/或一經取代或未經取代的\_Ci4雜芳基。詳 細說來,在式3a至式3d中,\及1?3可各為一笨基。 [0060] [0061] 在式3e中,、可為,例如:第一取代基,且"a"在第一取 代基可為0。舉例來說,在式3e中’、可為第一取代基, "a"在第-取絲可為〇,且、可為一經取代或未經取代 的C5_Cu芳基及/或一經取代或未經取代的C 雜芳基 JL、, 3 14 ,詳細說來,在式3e中,\及%可各為一苯基。 在實施時,由式1所表示的縮合環狀化合物可為以下的化 合物1至27,但並不限於此: 100111378Ar13, Arl5, Ar16, a, b, c, d, e and f can be as defined above. In Formulae 3a to 3e, Ar4 may, for example, be a phenyl group, a Ci-C^ phenyl group, a hexa(crcl{)alkyl group), a phenyl group, a (c6-c14 aryl) phenyl group, 100111378 Form No. A0101 Page 38 / 88 pages 1003273214-0 [0058] 201204728 One (C6-C14 aryl) stretch phenyl, one stretch. Carboxy, a Ci-Cu-based carbazolyl, a bis ((: (1) alkyl) carbazole group, a C6-C14 aryl group. 圭 基, 一二 (C6_C14 aryl ) 嗤 嗤 , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Aryl) anthracenyl, an extended naphthyl group, a monoalkylnaphthyl group, a di(Ci-C1Q alkyl) anthranyl group, a (C6_C14 aryl) anthranyl group, a bis(C6-C14 aryl) group Naphthyl, anthracene, hydrazine, hydrazine, hydrazine, hydrazine, hydrazino, hydrazino, hydrazino, hydrazino Di(c6-c14 aryl) thiol group, one extension ratio than bite base, one base extension ° bite base, one (, - (: 14 aryl) extension. than bite base, one or two (c6-c14 aryl Stretching "pyridyl, a quinolinyl, a C1_C1Q alkyl quinolinyl group, a bis(h-Cu alkyl) quinolinyl group, a (crc14 aryl) quinolinyl group, a two (c6) -c14 aryl) quinolinyl, benzoimidazolyl, monoalkylbenzimidazolyl, hexa(crc1Q alkyl) Stupid imidazolyl, mono(C6-C14 aryl)-benzimidazolyl, mono-(C6-C14 aryl)-benzimidazolyl, imidazolidinylpyridyl, monoalkylexidazolidinyl, monoalkyl An imidazolidine pyridyl group, a (C6-C14 aryl) extended imidazolium pyridyl group, a di-(C6-C14 aryl) exemplified by a bite base, a stretched σ meter spit bite base, a q-Cio alkyl stretch Imidazopyrimidinyl, monodialkyl)imidazolidinyl, mono(C-Caryl)thidium imidazolyl or bis(c-Cuarylυ1^ 614) an imidazolidine group. In Formula 3a to Formula 3e In the formula 3a to the formula 3e, the person 1"4 may be a phenyl group and d may be 1 or 2, but the embodiment is not limited thereto. 0059] 100111378 In the formula 3a to the formula 3e, N[(Ar5)e-Ar15] [_(3) of the third substituent represented by 1003273214-0 Form No. A0101 Page 39/88 page 201204728)f-Ar16] Ar6)f-Ar16] may be represented by any one of Formulas 6A to 6K. In Formulae % to 3 (1, \ and , each may be, for example, a first substituent, and "a" In the case of a substituent, it is 〇. For example, In the formulae 3a to 3d, R and may each be a first substituent, "a" may be a hydrazine in the substituent, and Au may be a substituted or unsubstituted c$_Cu aryl group and/or A substituted or unsubstituted \_Ci4 heteroaryl group. In detail, in the formulae 3a to 3d, \ and 1?3 may each be a stupid base. [0060] In Formula 3e, for example, a first substituent may be used, and "a" may be 0 at the first substituent. For example, in Formula 3e, 'which may be the first substituent, "a" may be 〇, and may be a substituted or unsubstituted C5_Cu aryl group and/or substituted or Unsubstituted C heteroaryl JL,, 3 14 , in detail, in Formula 3e, \ and % may each be a phenyl group. In the implementation, the condensed cyclic compound represented by Formula 1 may be the following Compounds 1 to 27, but is not limited thereto: 100111378

式1Formula 1

表單編號A0101Form number A0101

式4 第40頁/共88頁 1003273214-0 201204728Equation 4 Page 40 of 88 1003273214-0 201204728

式9 式10Equation 9

100111378 表單編號A0101 第41頁/共88頁 1003273214-0 201204728100111378 Form No. A0101 Page 41 of 88 1003273214-0 201204728

ό 式15ό 15

式19Equation 19

100111378 表單編號Α0101 第42頁/共88頁 1003273214-0 201204728100111378 Form NumberΑ0101 Page 42/Total 88 Page 1003273214-0 201204728

Ο [0062]Ο [0062]

Ο 使用於後文中的未經取代的基的案例可包含甲 基、乙基、丙基、異丁基、二級丁基、戊基、異戊基、 己基’以及其它類似物。在經取代Ά。烷基,如上 所述未經取代的C -C 烷美的25 ,丨、长 i 沉基的至少—氫原子可由,例如 :一重氫原子、—自素原子、—硝基、-氰基、-胺基 、甲肺基、聯胺、膝、1基或其鹽、俩基或其鹽、 一磷酸或其鹽、一 W基、-Crc3。烯基、一 c2_c30炔基、一c6-c3〇芳基、一 v、雜芳基、 _Ν(ν(ν或_Si(V(V(V,其中1气可各獨自 為一氫原子、-重氫原子、—。絲、稀基、一 W芳基以及-c2-c2G雜芳基。經取代或未經 取代的w伸烧基可為,例如:—具有結構與上文敛 述之經取代絲經取朗縣相⑽二價連接基 100111378 未經取代的烷氧基可為由_0A所表示之基團,其中 A為如上所述的一未經取代的Ci_c扑烷基。未經取代的 表單編號A0I01 第43頁/共肋頁 1003273214-0 [0063] 201204728 -c3()烷氧基的例子可包含一曱氧基、一乙氧基以及一異 丙氧基。至少一氫原子在烷氧基中可由如上所述的取代 基,連同經取代的^乂^烷基所取代。 [0064] 未經取代的C2_C3()烯基可為一具有在中心的碳-碳雙鍵或 未經取代之c2-c3()烷基的終端的碳氫鏈。烯基的例子可 包含一乙烯基、一丙烯基、一丁烯基以及其它類似物等 。至少一氫原子在未經取代的(:2-(:3{)烯基中可由所述之 取代基,連同經取代的(^-(:3()烷基所取代。經取代或未 經取代的伸烯基可為一具有結構與上文敘述之經案例 Examples of the unsubstituted group used hereinafter may include methyl group, ethyl group, propyl group, isobutyl group, secondary butyl group, pentyl group, isopentyl group, hexyl group, and the like. After the replacement. The alkyl group, as described above, of the unsubstituted C-C alkylene 25, at least one hydrogen atom of the hydrazine, long i sinkyl group may be, for example, a heavy hydrogen atom, a self atom, an atom, a nitro group, a cyano group, or Amino, methyl lung, hydrazine, knee, 1 base or a salt thereof, a bis or a salt thereof, a monophosphoric acid or a salt thereof, a W group, a -Crc3. Alkenyl, a c2_c30 alkynyl, a c6-c3 aryl, a v, a heteroaryl, _Ν (ν(ν or _Si(V(V(V, where 1 gas may each be a hydrogen atom, - a heavy hydrogen atom, a silk, a dilute group, a W aryl group, and a -c2-c2G heteroaryl group. The substituted or unsubstituted w-extension group may be, for example, a structure having the structure described above. Substituting the silk by the langxian phase (10) divalent linking group 100111378 The unsubstituted alkoxy group may be a group represented by _0A, wherein A is an unsubstituted Ci_c pentane group as described above. Substitute Form No. A0I01 Page 43 / Total Ribs 1003273214-0 [0063] Examples of 201204728-c3() alkoxy groups may include monomethoxy, monoethoxy and isopropoxy. At least one hydrogen atom The alkoxy group may be substituted by a substituent as described above, together with a substituted alkyl group. [0064] The unsubstituted C2_C3() alkenyl group may have a carbon-carbon double bond at the center or The terminal hydrocarbon chain of the unsubstituted c2-c3() alkyl group. Examples of the alkenyl group may include a monovinyl group, a propylene group, a butenyl group, and the like. At least one hydrogen atom is not present. The substituted (:2-(:3{) alkenyl group may be substituted by the substituted (^-(:3()) alkyl group. The substituted or unsubstituted alkenyl group may be a structure with the above described

L ϋ U 取代或未經取代的C2-C3()烯基相同的二價連接基。 [0065] 未經取代的c9-cqn炔基可為一具有在中心的至少一碳-碳L ϋ U A substituted or unsubstituted C2-C3() alkenyl group having the same divalent linking group. [0065] The unsubstituted c9-cqn alkynyl group can be at least one carbon-carbon having a center

u ϋ U 三鍵或C2-C3()烷基的終端的碳氫鏈。未經取代的C2-C2() 炔基的例子可包含乙炔基、丙炔基,以及其類似物等。 至少一氫原子於炔基中可由上述之取代基,連同 烧基所取代。 [0066] 未經取代的CR-CQn#基可為一具有碳環芳香族系統之單 5 3 0 價基團,該碳環芳香族系統具有包含至少一芳香環的5至 30碳原子。未經取代的CK-CQn伸芳基可為一具有碳環芳u ϋ U triple bond or the hydrocarbon chain of the terminal of C2-C3() alkyl. Examples of the unsubstituted C2-C2() alkynyl group may include an ethynyl group, a propynyl group, an analog thereof, and the like. At least one hydrogen atom in the alkynyl group may be substituted with the above substituents, together with the alkyl group. The unsubstituted CR-CQn# group may be a mono 5 30 valent group having a carbocyclic aromatic system having 5 to 30 carbon atoms containing at least one aromatic ring. Unsubstituted CK-CQn extended aryl group can be a carbon ring aromatic

ο 〇 U 香族系統之雙價基團,該碳環芳香族系統具有包含至少 一芳香環的5至30碳原子。當芳基及伸芳基具有二環時, 它們可相互融合。至少一氫原子於芳基及伸芳基可由上 述之取代基,連同CfCM烷基所取代。 [0067] 經取代或未經取代的L-Cm芳基的例子可包含一苯基、ο 〇 U The divalent group of the aromatic system having 5 to 30 carbon atoms containing at least one aromatic ring. When the aryl group and the extended aryl group have a bicyclic ring, they may be fused to each other. The at least one hydrogen atom at the aryl group and the extended aryl group may be substituted with the above substituents, together with the CfCM alkyl group. [0067] Examples of the substituted or unsubstituted L-Cm aryl group may include a phenyl group,

b 〇 U 一(^-(:1()烷基苯基(例如:一乙基苯基)、一(^-(:1()烷基 100111378 表單編號A0101 第44頁/共88頁 1003273214-0 201204728 Q 二笨基(例如:一乙基二笨基)、—由苯基(例如:一鄰位 、間位或對位氟苯基以及—二氣苯基)、二氰苯基、一三 氟甲烷基苯基、一鄰位、間值或對位曱苯基(t〇lyl group)、一鄰位、間位或對位異丙基苯基(cumenyl group)、二甲苯基(mesityl group)、_ 笨氧基苯基、 一(α,α-二甲苯)苯基、—(N,N,_二甲基)胺基苯基、 —(N,N -一笨基)胺基苯基、一並環戊二烯基 (pentalenyl group)、一茚基、一萘基、一.萘基(例 如:-氟萘基)、-crc1G貌基萘基(例如:一甲基萘基) 、一Ci_Cio炫氧基萘基(例如:-甲氧基萘基)、-慧基 、-奠基、-並環庚三稀基、合萘基…魅基、 -第基、-蒽醌基、-甲基蒽基菲基、一三葩基、 -范基、-m、-乙基-孩基、—起基、一錄、一氯 絲、-五苯基、-稍五苯基、—聯四苯基、—六苯基 、一稠六苯基、一茹基(rubicenyl gr〇up)、一六聯苯 基(C〇r〇nenyl group)、—聯伸三萘基、一稠七苯基、 ❹ -異稠七苯基、-荐基(pyranthrenyl gr。叩)及/或一 莪基(ovalenyi group)。經取代的(:5-(:3()芳基的例子 可基於上«縣餘代的基及經取代的 CrC3〇烧基所推論。經取代或未經取代的c「c⑼伸芳基 的例子可基於經取代或未經取代的c _c芳基所推論。 5 〇 〇 [0068] 未經取代的C3-C3〇雜芳基可為一具有至少一芳香環之單 價基團’該芳香環具有包含氮、氣、磷及硫之至少之一 者的至少一雜原子。未經取代的〔-(:⑼雜伸芳基可為一 〇 〇 U 具有至少一芳香環之二價基團’該芳香環具有至少一雜 100111378 表單編號A0101 第45頁/共88買 1003273214-0 201204728 原子,讀雜原子包含,例如:氮、氧、磷及硫。關於這 ,j當雜芳基及雜伸芳基具有至少二環時,它們可相互 融合。至少一氫原子在雜芳綠雜伸芳基中可由上述之 取代基,連同crc3。烷基所取代。 [0069] [0070] [0071] [0072] 未、、星取代的C;TC3()雜芳基的例子可包含一吡唑基、一咪 坐基、—噁唑基、—噻唑基一三唑基、一四唑基一 。坐基、一〇比<基、一塔啡基gr〇up) 嘧啶基、一二啡基、一咔唑基、一吲哚基、一喹啉 基、—異喹啉基、一苯並咪唑基、一咪唑吡啶基及/或一 米唾喷咬基。未經取代的c「、雜伸芳基可基於經取代 或未經取代的c6-c3()伸芳基的例子所推論。 式1的縮合環狀化合物可透過利用有機合成來合成。合成 縮合環狀化合物之方法可基於將於後論述的例子所推論 〇 式1的縮合壞狀化合物可被用於有機發光裝置。根據另一 實施例,-有機發光装置可包含—第一電極、一第二電 極,係設置相對於第—電極以及—第一層,係設置於第 -電極與第二電極之間,其中第—層包含上述式i的縮合 環狀化合物。 第—層可為一電洞傳輸層、一電洞注入層、一具有電洞 注入功能及電洞傳輪功能之功能層、一發射層、—電子 傳輸層以及-電子注入層之至少之—者,但並不限於此 。舉例來說,第-層可為—電洞傳輪層、一電洞注入層 、-具有電洞注人功能及電洞傳輪功能之功能層、一發 100111378 表單編號A0101 第46頁/共88頁 1003273214-0 201204728 射層,但並不限於此。此外,根據一有機發光裝置可被 具體實現之結構,各種已知層可作為第一層。 [0073] 第1圖係根據一實施例繪示一有機發光裝置(OLED) 1 0的 剖面示意圖。後文中,根據一實施例製造有機發光裝置 的方法以及根據一實施例之有機發光裝置現在將參照第1 圖所敘述。 [0074] Ο 參照第1圖,根據本實施例,有機發光裝置10可包含一基 板11、一第一電極13、一有機層15以及一第二電極17, 其依序以此次序堆疊。基板11,其可為用於傳統有機發 光裝置之任何合適的基板,可為,例如:一玻璃基板或 一有出色的機械強度、熱穩定性、穿透性、表面平滑度 、易於處理以及防水之透明塑膠基板。 [0075]b 〇U a (^-(:1() alkylphenyl (for example: monoethylphenyl), one (^-(:1()) alkyl 100111378 Form No. A0101 Page 44 / Total 88 Page 1003273214- 0 201204728 Q diphenyl (for example: monoethyldiphenyl), - by phenyl (for example: an ortho, meta or parafluorophenyl and diphenyl), dicyanophenyl, a Trifluoromethylphenyl, an ortho, meta or para-p曱lyl group, an ortho, meta or para cumenyl group, xylyl Group), _ phenyloxyphenyl, mono(α,α-xylene)phenyl, —(N,N,-dimethyl)aminophenyl, —(N,N-phenyl)amino Phenyl, pentalenyl group, monodecyl, mononaphthyl, mononaphthyl (eg, -fluoronaphthyl), -crc1Gmorphinyl (eg, monomethylnaphthyl) , a Ci_Cio oxynaphthyl group (for example: -methoxynaphthyl), - fluorenyl, -founding, - and cycloheptyl, naphthyl, ..., aryl, - fluorenyl ,-methylmercaptophenylidene, tris-decyl, -normyl, -m,-ethyl-child,-based One recorded, monochlorofilament, -pentaphenyl, -pentaphenyl, -tetraphenyl, hexaphenyl, hexaphenyl, rubicenyl gr〇up, hexamethylene (C〇r〇nenyl group), - a stretched trinaphthyl group, a fused heptaphenyl group, a fluorene-isohexaphenyl group, a -pyrythrenyl gr. and/or an ovalenyi group. Examples of substituted (:5-(:3())aryl groups can be inferred based on the upper and lower substituted CrC3 fluorenyl groups. Examples of substituted or unsubstituted c"c(9) extended aryl groups It can be inferred based on a substituted or unsubstituted c-c aryl group. 5 〇〇 [0068] The unsubstituted C3-C3 doped aryl group may be a monovalent group having at least one aromatic ring. At least one hetero atom comprising at least one of nitrogen, gas, phosphorus and sulfur. The unsubstituted [-(:(9) heteroaryl group may be a divalent group having at least one aromatic ring] The aromatic ring has at least one impurity 100111378 Form No. A0101 Page 45 / Total 88 Buy 1003273214-0 201204728 Atom, read heteroatoms containing, for example: nitrogen, oxygen, phosphorus and sulfur. When the heteroaryl group and the heteroaryl group have at least two rings, they may be fused to each other. At least one hydrogen atom may be substituted by the above substituent in the heteroaryl green heteroaryl group together with the crc3. Examples of non-, star-substituted C; TC3()heteroaryl groups may include a pyrazolyl group, an imidazolyl group, an oxazolyl group, a thiazolyl-triazole. Base, one tetrazolyl group. Sitrate, oxime ratio <yl, taphthyl gr〇up) pyrimidinyl, monomorphyl, monooxazolyl, monodecyl, monoquinolyl, isoquinolyl, monobenzo Imidazolyl, monoimidazolidinyl and/or one meter saliva. The unsubstituted c", heteroaryl group can be inferred based on the substituted or unsubstituted c6-c3() extended aryl group. The condensed cyclic compound of the formula 1 can be synthesized by using organic synthesis. The method of the cyclic compound can be based on an example to be discussed later. The condensed bad compound of Formula 1 can be used for an organic light-emitting device. According to another embodiment, the organic light-emitting device can include a first electrode, a first The two electrodes are disposed between the first electrode and the second electrode with respect to the first electrode and the first layer, wherein the first layer comprises the condensed cyclic compound of the above formula i. The first layer may be an electric , but not limited to, a hole transport layer, a hole injection layer, a functional layer having a hole injection function and a hole transfer function, an emission layer, an electron transport layer, and an electron injection layer For example, the first layer can be a hole transmission layer, a hole injection layer, a functional layer having a hole injection function and a hole transfer function, and a 100111378 form number A0101 page 46/ A total of 88 pages 1003273214-0 201204728 shot In addition, according to a structure in which an organic light-emitting device can be embodied, various known layers can be used as the first layer. [0073] FIG. 1 illustrates an organic light-emitting device according to an embodiment. A cross-sectional view of an OLED) 10. Hereinafter, a method of fabricating an organic light-emitting device according to an embodiment and an organic light-emitting device according to an embodiment will now be described with reference to Fig. 1. [0074] Ο Referring to FIG. For example, the organic light-emitting device 10 can include a substrate 11, a first electrode 13, an organic layer 15, and a second electrode 17, which are sequentially stacked in this order. The substrate 11, which can be used for a conventional organic light-emitting device Any suitable substrate may be, for example, a glass substrate or a transparent plastic substrate having excellent mechanical strength, thermal stability, penetration, surface smoothness, ease of handling, and water resistance. [0075]

第一基板13可由,例如:沉積或濺鍍一用於形成第一電 極13於基板上的材料。當第一電極13構成一陽級,用於 形成第一電極13的材料可為一高功函數材料,以促進電 洞注入。第一電極13可為一反射電極或一傳輸電極。透 明且導電材料,例如:氧化銦錫(ΙΤΟ)、氧化銦鋅(ΙΖΟ) 、二氧化錫(Sn〇2)以及氧化鋅(ΖηΟ),可用來形成第一 電極13。第一電極13可作為反射電極使用,例如:鎂 (Mg)、銘(Α1)、ί呂-裡(Al-Li)、約(Ca)、鎂-銦 (Mg-Ιη)、鎮銀(Mg-Ag)或其它類似物等。 有機層15可設置在第一電極13上。術語”有機層”用於 後文中係指插置於第一電極13與第二電極17之任一層。 有機層15可能無法由純的有機材料形成,且亦可包含: 100111378 表單編號A0101 第47頁/共88頁 1003273214-0 [0076] 201204728 例如一金屬複合物。 [0077] [0078] [0079] [0080] 有機層15可包含第—層,係包含式丨的縮合環狀化合物。 有機層可更進/歩包含一電洞注入層(HIL)、一電洞傳輪 層(HTL>、〆具有電洞注入功能及電洞傳輸功能之功能層 、〜發射層、一電洞阻擋層(HBL)、一電子傳輸層 (ETL)以及〆電子注入層(EIL)之至少之一者。舉例來二 ,第一層為〆電洞傳輸層,除了第一層之外,有機層15 可更進一步包含—電洞注入層、一發射層、一電子傳輸 層以及一電孑江入層,但並不限於此。 電洞注入層<透過,例如:真空沉積、旋轉塗佈、燒鑄 、朗繆爾-♦洛傑特(langmuir-blodgett,LB)沉積或 其它等方式’形成在第一電極13上。 當電洞注入層利用真空沉積而形成時,真空沉積條件可 根據用來形成電海注入層的化合物及其所需之結構及電 洞注入層的熱性質而改變。舉例來說,真空沉積可在約 1〇〇。(:至約5〇0°c的溫度、大約1〇-8至約10_3托爾的壓力 ,以及沉積速率約100埃/秒的條件下進行。然而,沉積 條件並不限於此。 電洞'主入層利用旋轉塗伟形成時,塗佈條件可根據用 來形成電洞Ά層的化合物及所需之結構及電洞注入層 的熱性質而改變。舉例來說,塗佈速率可大約為2000至 5000轉/分鐘的範圍,以及在範圍約80t至200。(:的範圍 塗佈之後,進行熱處理以移除一溶劑。然而,塗佈條件 並不限於此。 100111378 表單煸號A0101 第48頁/共88頁 1003273214-0 201204728 [0081] 電洞注入層可由式1所表示的至少一縮合環狀化合物所形 成,且任何適合的材料係可共同地用來形成一電洞注入 層。可用來形成電洞注入層的已知材料的例子可包含, 但不限於,Ν,Ν’ -二苯基-Ν,Ν’ -雙-[4-(苯基-間-曱苯 基-胺基)-苯基]-二苯基-4, 4’ -二胺(DNTPD)、酞花青 化合物,例如:銅欧青(copper phthalocyanine)、 Ο 4, 4’,4’ 参(3-甲基笨基笨基胺基)三苯基胺基 (m-MTDATA)、Ν,Ν’ -二(1-萘基)-N-N’ -二苯基聯苯胺 (NPB)、TDATA、2T-NATA、聚苯胺/十二烷基苯磺酸 (dodecy1 benzenesulfonic acid, Pani/DBSA)、聚 (3, 4-伸乙基二氧基噻吩 (e thy lenedioxy thiophene ))/聚(4-苯乙烯磺酸鹽 )(PED0T/PSS)、聚苯胺/樟腦磺酸(pani/cSA)以及聚苯 胺/聚(4-苯乙烯磺酸鹽(pani/pss)) »The first substrate 13 may be, for example, deposited or sputtered with a material for forming the first electrode 13 on the substrate. When the first electrode 13 constitutes a positive level, the material for forming the first electrode 13 may be a high work function material to facilitate hole injection. The first electrode 13 can be a reflective electrode or a transmission electrode. A transparent and electrically conductive material such as indium tin oxide (iridium), indium zinc oxide (niobium), tin dioxide (Sn〇2), and zinc oxide (?n) can be used to form the first electrode 13. The first electrode 13 can be used as a reflective electrode, for example, magnesium (Mg), Ming (Α1), ίLu-Li (Al-Li), about (Ca), magnesium-indium (Mg-Ιη), and silver (Mg) -Ag) or other analogs and the like. The organic layer 15 may be disposed on the first electrode 13. The term "organic layer" is used hereinafter to mean that either one of the first electrode 13 and the second electrode 17 is interposed. The organic layer 15 may not be formed of a pure organic material, and may also include: 100111378 Form No. A0101 Page 47 of 88 1003273214-0 [0076] 201204728 For example, a metal composite. [0080] The organic layer 15 may comprise a first layer comprising a condensed cyclic compound of the formula 。. The organic layer can further include a hole injection layer (HIL), a hole transfer layer (HTL), a functional layer having a hole injection function and a hole transmission function, an emission layer, and a hole blocking. At least one of a layer (HBL), an electron transport layer (ETL), and a germanium electron injection layer (EIL). For example, the first layer is a germanium hole transport layer, and the organic layer 15 is in addition to the first layer. The method further includes a hole injection layer, an emission layer, an electron transport layer, and an electron transfer layer, but is not limited thereto. The hole injection layer <transmission, for example, vacuum deposition, spin coating, burning Casting, Langmuir-blodgett (LB) deposition or the like is formed on the first electrode 13. When the hole injection layer is formed by vacuum deposition, vacuum deposition conditions can be used according to The compound forming the electric sea injection layer and its desired structure and the thermal properties of the hole injection layer are changed. For example, the vacuum deposition may be at about 1 Torr. (: to a temperature of about 5 〇 0 ° C, approximately a pressure of from 1 〇 8 to about 10 _ 3 Torr, and a deposition rate of about 100 angstroms per second However, the deposition conditions are not limited to this. When the main hole of the hole is formed by spin coating, the coating conditions may be based on the compound used to form the hole layer and the desired structure and hole injection layer. The thermal properties vary. For example, the coating rate can range from about 2000 to 5000 rpm, and after a range of from about 80 t to 200. (A range of coatings, heat treatment is performed to remove a solvent. The coating conditions are not limited thereto. 100111378 Form nickname A0101 Page 48/88 page 1003273214-0 201204728 [0081] The hole injection layer may be formed of at least one condensed cyclic compound represented by Formula 1, and any suitable The materials may be used collectively to form a hole injection layer. Examples of known materials that may be used to form the hole injection layer may include, but are not limited to, Ν, Ν'-diphenyl-Ν, Ν'-double -[4-(Phenyl-m-nonylphenyl-amino)-phenyl]-diphenyl-4,4'-diamine (DNTPD), phthalocyanine compound, for example: copper phthalocyanine ), Ο 4, 4', 4' ginseng (3-methyl phenylamino) triphenylamine (m -MTDATA),Ν,Ν'-bis(1-naphthyl)-N-N'-diphenylbenzidine (NPB), TDATA, 2T-NATA, polyaniline/dodecylbenzenesulfonic acid (dodecy1 benzenesulfonic Acid, Pani/DBSA), poly(3,4-ethylenedioxythiophene)/poly(4-styrenesulfonate) (PED0T/PSS), polyaniline/camphorsulfonic acid (pani/cSA) and polyaniline/poly(4-styrene sulfonate (pani/pss)) »

[0082] 電洞注入層之厚度可為,例如:約100埃至約1 0, 000埃。 維持電職入層之厚度約100埃至1〇, _埃可幫助確認 電洞’主人層在驅動電壓無實質增加時具有出色的電洞注 入能力。在實施時’電洞注人層之厚度可為,例如:約 1〇〇埃至1,0〇〇埃。 然後’電洞傳輪層可透過,例如:真空沉積、旋轉塗饰 、燒錯、朗谬爾-布洛傑特(langmuir_bi〇dgett,⑻ 100111378 表單編號A0101 第49頁/共88頁 1003273214-0 [0083] 201204728 沉積或其它等方式形成在電洞注入層上。當電洞傳輸層 利用真空沉積或旋轉塗佈形成時,雖然用以沉積及塗佈 的條件可根據用來形成電洞注入層的材料而改變,用以 沉積或塗佈的條件可與形成電洞注入層的條件類似。 [0084] 電洞傳輸層可包含,或可由上述式1所表示的縮合環狀化 合物所形成。包含由式1所表示的縮合環狀化合物的第一 層可為電洞傳輸層。若第一層不為電洞傳輸層,此電洞 傳輸層可利用任何適合的電洞傳輸材料形成。已知的電 洞傳輸材料的例子可包含:一吟α圭衍生物,例如:N -苯 基味吐或乙稀基。卡β坐;一具有芳香環之胺類衍生物,例如 以下所繪示的:Ν,Ν’-雙(3-曱基苯基)-Ν,Ν’-二曱基-[1,1_二甲基]_4,4’-二胺(TPD);以及一三甲基胺基材 料,例如:4, 4’,4’ ’ -参(Ν-咔唑基)三曱基胺(TCTA)。 在這些材料之令,TCTA可不僅傳輸電洞,更亦可抑制激 子擴散入發射層。[0082] The thickness of the hole injection layer may be, for example, about 100 angstroms to about 1,000,000 angstroms. Maintaining the thickness of the electrical entry layer is approximately 100 angstroms to 1 〇. _Eco helps to confirm that the hole's master layer has excellent hole injection capability when there is no substantial increase in drive voltage. In practice, the thickness of the hole injection layer can be, for example, from about 1 angstrom to about 1,0 angstrom. Then 'the hole transmission layer is permeable, for example: vacuum deposition, spin coating, burnt, Langmuir_bi〇dgett, (8) 100111378 Form No. A0101 Page 49 / 88 pages 1003273214-0 [0083] 201204728 deposition or other manner is formed on the hole injection layer. When the hole transport layer is formed by vacuum deposition or spin coating, although conditions for deposition and coating may be used to form a hole injection layer The material is changed, and the conditions for deposition or coating may be similar to the conditions for forming the hole injection layer. [0084] The hole transport layer may include, or may be formed of, a condensed cyclic compound represented by the above formula 1. The first layer of the condensed cyclic compound represented by Formula 1 may be a hole transport layer. If the first layer is not a hole transport layer, the hole transport layer may be formed using any suitable hole transport material. Examples of the hole transporting material may include: a 圭 圭 derivative, for example: N-phenyl odor or ethylene group. Card β sitting; an amine derivative having an aromatic ring, such as shown below :Ν,Ν'-double (3- Phenyl)-fluorene, Ν'-dimercapto-[1,1-dimethyl]_4,4'-diamine (TPD); and monotrimethylamine-based materials, for example: 4, 4', 4' '-Find (Ν-carbazolyl) tridecylamine (TCTA). In these materials, TCTA can not only transmit holes, but also inhibit excitons from diffusing into the emissive layer.

[0085] 電洞傳輸層之厚度可為大約50埃至約1,000埃。維持電洞 傳輸層的厚度於大約50埃至約1, 000埃可幫助確認電洞傳 輸層在驅動電壓無實質增加時具有出色的電洞傳輸能力 。實施時,電洞傳輸層可為,例如:大約100埃至大約 800 埃。 [0086] 又或者,具有一電洞注入功能及一電洞傳輸功能的功能 100111378 表單編號Α0101 第50頁/共88頁 1003273214-0 201204728 層可不由電洞注入層及電洞傳輸層形成。功能層可由已 知的材料形成’用以形成功能層。 [0087] 電洞注入層、電洞傳輸層以及功能層之至少之一者可更 進一步包含電荷產生材料,以使得改善一層之導電性, 除了式1的縮合環狀化合物,此已知材料用於電洞注入層 ,且此已知材料用於電洞傳輸層。[0085] The hole transport layer may have a thickness of from about 50 angstroms to about 1,000 angstroms. Maintaining the hole transport layer thickness from about 50 angstroms to about 10,000 angstroms helps to confirm that the hole transport layer has excellent hole transport capability when there is no substantial increase in drive voltage. When implemented, the hole transport layer can be, for example, from about 100 angstroms to about 800 angstroms. [0086] Alternatively, it has a hole injection function and a hole transmission function. 100111378 Form No. 1010101 Page 50/88 Page 1003273214-0 201204728 The layer can be formed not by the hole injection layer and the hole transmission layer. The functional layer can be formed from a known material to form a functional layer. [0087] at least one of the hole injection layer, the hole transport layer, and the functional layer may further include a charge generating material to improve conductivity of the layer, except for the condensed cyclic compound of Formula 1, which is known for The hole is injected into the layer, and this known material is used for the hole transport layer.

[0088] G 電荷產生材料可為一p-摻雜劑。p-摻雜劑的例子無限制 地包含醌類衍生物,例如:四氰基奎喏二曱烷(TCNQ)及 2,3,5,6 -四氟基-四氰基-1,4 -苯並奎0若二曱烧 (F4TCNQ);氧化金屬,例如:一氧化鎢及一氧化鉬;以 及一由以下化合物100所表示的含氰基之化合物,但並不 以此為限:[0088] The G charge generating material may be a p-dopant. Examples of the p-dopant include, without limitation, an anthracene derivative such as tetracyanoquinone dioxane (TCNQ) and 2,3,5,6-tetrafluoro-tetracyano-1,4- Benzacene 0 if dioxin (F4TCNQ); oxidized metals such as: tungsten monoxide and molybdenum monoxide; and a cyano group-containing compound represented by the following compound 100, but not limited thereto:

[0089] [0090] 100111378 化合物100 當電洞注入層、電洞傳輸層或功能層更進一步包含電荷 產生材料時,此電荷產生材料可為同質性地或非均勻性 地分散於電洞注入層、電洞傳輸層或功能層。 接下來,發射層可透過利用,例如:真空沉積、旋轉濺 鍍、燒鑄、LB沉積或其它方法等形成於電洞傳輸層或功 能層上。當發射層利用真空沉積或旋轉塗佈形成時,雖 然沉積及塗佈的條件可根據用來形成發射層的材料而改 表單編號A0101 第51頁/共88頁 1003273214-0 201204728 變,沉積及塗佈條件可與形成電洞注入層的條件類似。 [0091] 發射層可由式1的縮合環狀化合物之至少之一者及任何適 合的發光材料形成(包含主劑和摻雜劑兩者)。主劑的例 子可包含Alq3、4, 4’ -N,Ν’ -二°卡唾-二苯基(CBP)、聚 (η-乙稀基味唾)(PVK)、9, 10-二(伸萘-2-基)蒽(ADN) ' TACA、1,3, 5-参(N-苯基苯井咪唑-2-基)苯(TPBI)、 3 -特丁基-9,10 -二-茶基蒽 (3-tert-buty1-9,l〇-di-2-naphthyl anthracene, TBADN)、E3以及二笨乙烯基伸芳基 (distyrylarylene, DSA),但並不限於此。[0090] 100111378 Compound 100 When the hole injection layer, the hole transport layer or the functional layer further contains a charge generating material, the charge generating material may be homogeneously or non-uniformly dispersed in the hole injection layer , hole transport layer or functional layer. Next, the emissive layer can be formed on the hole transport layer or the functional layer by utilizing, for example, vacuum deposition, spin sputtering, firing, LB deposition, or the like. When the emissive layer is formed by vacuum deposition or spin coating, although the conditions of deposition and coating may be changed according to the material used to form the emissive layer, Form No. A0101, page 51 / 88 pages 1003273214-0 201204728 change, deposition and coating The cloth condition can be similar to the conditions for forming the hole injection layer. [0091] The emissive layer can be formed from at least one of the fused cyclic compounds of Formula 1 and any suitable luminescent material (including both a host agent and a dopant). Examples of the main agent may include Alq3, 4, 4'-N, Ν'-di-ca-ca-diphenyl (CBP), poly(η-ethylene-based saliva) (PVK), 9, 10-two (萘Naphthalene-2-yl)anthracene (ADN) 'TACA, 1,3, 5-paran (N-phenylphthalimidazol-2-yl)benzene (TPBI), 3-tert-butyl-9,10-di - 3-tert-buty 1-9, l〇-di-2-naphthyl anthracene (TBADN), E3, and dipyryl vinyl styrene (DSA), but are not limited thereto.

PVK ANDPVK AND

[0092] 適合的紅色摻雜劑的例子可包含:PtOEP、Ir(piq)3# 及Btp2Ir(acac),但並不限於此。 100111378 表單編號A0101 第52頁/共88頁 1003273214-0 201204728Examples of suitable red dopants may include: PtOEP, Ir(piq)3#, and Btp2Ir(acac), but are not limited thereto. 100111378 Form No. A0101 Page 52 of 88 1003273214-0 201204728

[0093] 適合的綠色掺雜劑的例子可包含:Ir(ppy)3(ppy =苯基 口比咬)、Ir(ppy) (acac)以及Ir(mpyp),但並不限於 L «5 此。Examples of suitable green dopants may include: Ir(ppy) 3 (ppy = phenyl mouth bite), Ir (ppy) (acac), and Ir (mpyp), but are not limited to L «5 .

[0094] 適合的藍色摻雜劑的例子可包含:F2Irpic、[0094] Examples of suitable blue dopants may include: F2Irpic,

(卩2??7)211'(七111£1)、11'((1【??2)3、第三-苐、4,4’-雙 (4-二苯基胺基苯乙烯基)聯笨基(DPAVBi)以及 2,5,8,11-四-第三-丁基伸苯基,但並不限於此。 100111378(卩2??7) 211' (seven 111 £1), 11' ((1[??2)3, third-苐, 4,4'-bis(4-diphenylaminostyryl) ) is a combination of DPAVBi and 2,5,8,11-tetra-tert-butylphenyl, but is not limited thereto.

DPAVBi 第53頁/共88頁 TBPe 表單編號A0101 1003273214-0 201204728 [0095] 當發射層包括主劑與摻雜劑時,在主劑之重量為1 0 0份的 基準下,摻雜劑的重量可約為0. 01份至15份,但並不限 於此。 [0096] 發射層的厚度可為約100埃至約1,000埃。維持發射層的 厚度在約100埃至約1,000埃可幫助確認發射層在驅動電 壓未實質增加時具有出色的發光能力。在實施時,發射 層的厚度可為,例如:約200埃至約600埃。 [0097] 當螢光摻雜劑亦被用來形成發射層時,一電洞阻擋層可 透過利用,例如:真空沉積、旋轉塗佈、燒鑄、LB沉積 或其它類似方式等形成於電洞傳輸層與發射層之間,以 防止三重激子或電洞擴散入電洞傳輸層。當電洞阻擋層 利用真空沉積或旋轉塗佈形成時,雖然沉積及塗佈的條 件可根據用來形成電洞阻擋層的材料而改變,沉積或塗 佈的條件可與形成電洞注入層的條件類似。任何共同用 來形成電洞阻擋層的適合材料都可被使用。用以形成電 洞阻擋層的材料的例子可包含一噁二唑衍生物、一三唑 衍生物以及一啡淋(口11611&111;111'〇1丨116)衍生物,但並不 限於此。 [0098] 電洞阻擋層的厚度可約50埃至約1,000埃。在實施時,電 洞阻擋層的厚度可為,例如:約100埃至約300埃。維持 電洞阻擋層的厚度在約50埃至約1,000埃可幫助確認電洞 阻擋層具有出色的電洞阻擋能力而不需實質增加驅動電 壓。 [0099] 接下來,一電子傳輸層可透過,例如··真空沉積、旋轉 100111378 表單編號A0101 第54頁/共88頁 1003273214-0 201204728 塗佈、燒鎢或其它類似方法等形成於電洞阻擋層或發射 層上w電子傳輸層彻真空沉積或旋轉塗佈形成時, …:/儿積及塗佈的條件可根據用來形成電子傳輸屠的材 料而改變’沉積及塗佈的條件可與形成電洞注入層的條 件a似。用來形成電子傳輪層的材料可為穩定地傳輸電 子的材料,該些電子可由電子注入電極(陰極)注入,且 任何適合的材料可被使用。形成電子傳輸層的材料的例 子可包含啥琳衍生物,例如:參(8-經基喹淋)铭 Ο (tris(8-quin〇linorate)alumnium * Alq3) ' TAZ > BAlq及雙(苯並喹淋_i〇_油酸)皱(Be ),但並不限於此DPAVBi Page 53 of 88 TBPe Form No. A0101 1003273214-0 201204728 [0095] When the emissive layer comprises a main agent and a dopant, the weight of the dopant is based on the weight of the main agent of 100 parts. It may be from about 0.01 to 15 parts, but is not limited thereto. [0096] The emissive layer may have a thickness of from about 100 angstroms to about 1,000 angstroms. Maintaining the thickness of the emissive layer from about 100 angstroms to about 1,000 angstroms can help confirm that the emissive layer has excellent illuminating power when the driving voltage is not substantially increased. In practice, the thickness of the emissive layer can be, for example, from about 200 angstroms to about 600 angstroms. [0097] When a fluorescent dopant is also used to form the emissive layer, a hole blocking layer can be formed in the hole by utilizing, for example, vacuum deposition, spin coating, firing, LB deposition, or the like. Between the transmission layer and the emission layer to prevent triple excitons or holes from diffusing into the hole transport layer. When the hole blocking layer is formed by vacuum deposition or spin coating, although the conditions of deposition and coating may vary depending on the material used to form the hole blocking layer, the conditions of deposition or coating may be combined with the formation of the hole injection layer. The conditions are similar. Any suitable material that is commonly used to form the barrier layer of the hole can be used. Examples of the material for forming the hole blocking layer may include a oxadiazole derivative, a triazole derivative, and a morphine (mouth 11211 &111; 111'〇1丨116) derivative, but are not limited thereto. . [0098] The hole barrier layer may have a thickness of from about 50 angstroms to about 1,000 angstroms. In practice, the thickness of the barrier layer can be, for example, from about 100 angstroms to about 300 angstroms. Maintaining the thickness of the hole barrier layer from about 50 angstroms to about 1,000 angstroms can help confirm that the hole barrier layer has excellent hole blocking capability without substantially increasing the drive voltage. [0099] Next, an electron transport layer is permeable, for example, vacuum deposition, rotation 100111378 Form No. A0101 Page 54 / 88 pages 1003273214-0 201204728 Coating, burning tungsten or the like is formed in the hole blocking When the w electron transport layer on the layer or the emissive layer is formed by vacuum deposition or spin coating, the conditions of ... and / or the coating may be changed according to the material used to form the electron transport but the conditions of deposition and coating may be The condition a of forming the hole injection layer is similar. The material used to form the electron transport layer may be a material that stably transports electrons, which may be injected by an electron injecting electrode (cathode), and any suitable material may be used. Examples of the material forming the electron transport layer may include a phthalocyanine derivative, for example, ginseng (8-quinoquinone) alumnium * Alq3) 'TAZ > BAlq and bis(benzene And quinoline _i〇_oleic acid) wrinkle (Be), but not limited to this

[0100] ο 電子傳輸層的厚度可為,例如:約100埃至1,000埃。在 實施時’電子傳輸層的厚度可為,例如:約150埃至500 埃。維持電子傳輸層的厚度在約100埃至1,000埃可幫助 確認電子傳輸層具有令人滿意的電子傳輸能力而不需實 質增加驅動電壓。 [0101] 又或者,電子傳輸層可包含一電子傳輸有機化合物及一 含金屬材料。電子傳輸有機化合物的例子可無限制的包 含由以下化合物101或102所表示的AND(9, 10-二(萘-2-基)蔥)及蔥基化合物,但並不以此為限。 100111378 表單編號A0101 第55頁/共88頁 1003273214-0 201204728[0100] The thickness of the electron transport layer may be, for example, about 100 angstroms to 1,000 angstroms. The thickness of the electron transport layer may be, for example, about 150 angstroms to 500 angstroms. Maintaining the thickness of the electron transport layer at about 100 angstroms to 1,000 angstroms helps to confirm that the electron transport layer has satisfactory electron transport capability without substantially increasing the driving voltage. Still alternatively, the electron transport layer may comprise an electron transporting organic compound and a metal containing material. Examples of the electron transporting organic compound may include, without limitation, AND(9, 10-bis(naphthalen-2-yl) onion) and onion-based compound represented by the following compound 101 or 102, but are not limited thereto. 100111378 Form No. A0101 Page 55 of 88 1003273214-0 201204728

化合物101 化合物102 [0102] 含金屬材料可包含一裡複合物。此鐘複合物之例子無限 制地包含:啥琳裡(lithium quino late,Li Q)或以下 的化合物10 3。 [0103]Compound 101 Compound 102 [0102] The metal-containing material may comprise a one-in-one composite. An example of this bell complex includes, in an infinitely limited form, compound 10 3 of lithium quino late (Li Q) or below. [0103]

化合物103 [0104] 接下來,一電子注入層可形成於電子傳輸層上。電子注 入層可由任何有助於從陰極注入電子的適合材料形成。 [0105] 用以形成電子注入層的材料的例子可包含:氟化鋰、氯 化鈉、氟化鉋、氧化鋰、氧化鋇。雖然沉積及塗佈的條 件可根據用來形成電子注入層的材料而改變,電子注入 層的沉積及塗佈的條件可與形成電洞注入層的條件類似 〇 [0106] 電洞注入層的厚度可為約1埃至約100埃。維持電子注入 層的厚度在約1埃至約100埃可幫助確認電子注入層在驅 動電壓未實質增加時具有令人滿意的電子注入能力。在 實施時,電子注入層的厚度可為,例如:約3埃至約90埃 100111378 表單編號A0101 第56頁/共88頁 1003273214-0 201204728 ο [0107] 最後,第二電極17可設置於有機層15上。第二電極17可 為陰極,其係一電子注入電極。一形成第二電極之金屬 可為一具有低功率之金屬、一具有低功率之合金、一導 電性化合物或其混合物。在這方面,第二電極17可由, 例如:鋰(Li)、鎂(Mg)、鋁(Α1)、鋁(Α1)-鋰(Li)、鈣 (Ca)、鎖(Mg)-銦( In)、鎮(Mg)-銀(Ag)或其他類似物 等形成,以及可形成為薄膜型式的傳輸電極。在實施時 ,傳輸電極可由,例如:氧化姻錫(ITO)或氧化銦鋅 (ΙΖ0)形成以製造一頂發射型發光裝置。 [0108] 當有機發光裝置中的第一層為電洞注入層、電洞傳輸層 或功能層時,除了上述式1的縮合環狀化合物,第一層可 更進一步包含上述的電荷產生材料。又或者,當第一層 為發射層時,除了式1的縮合環狀化合物,第一層可更進 一步包含上述的螢光掺雜劑。如此說來,第一層並不限 於上文所述。 [0109] 後文中,一或多個實施例將配合以下的例子做更詳細的 敘述。這些例子並不意欲限制一或多個實施例的目的和 範圍。 [0110] 實例 合忐.實伤丨1 :彳匕合物1之合志. 化合物F係透過以下的反應流程la合成: 100111378 表單編號A0101 第57頁/共88頁 1003273214-0 201204728Compound 103 Next, an electron injection layer may be formed on the electron transport layer. The electron injecting layer can be formed of any suitable material that facilitates electron injection from the cathode. Examples of the material for forming the electron injecting layer may include lithium fluoride, sodium chloride, fluorinated planer, lithium oxide, and cerium oxide. Although the conditions of deposition and coating may vary depending on the material used to form the electron injecting layer, the conditions of deposition and coating of the electron injecting layer may be similar to those for forming the hole injecting layer. [0106] Thickness of the hole injecting layer It can be from about 1 angstrom to about 100 angstroms. Maintaining the thickness of the electron injecting layer from about 1 angstrom to about 100 angstroms helps to confirm that the electron injecting layer has a satisfactory electron injecting ability when the driving voltage is not substantially increased. In practice, the thickness of the electron injecting layer may be, for example, about 3 angstroms to about 90 angstroms 100111378. Form No. A0101 Page 56 / Total 88 pages 1003273214-0 201204728 ο [0107] Finally, the second electrode 17 may be disposed in an organic On layer 15. The second electrode 17 may be a cathode which is an electron injecting electrode. A metal forming the second electrode may be a metal having a low power, an alloy having a low power, an electrically conductive compound or a mixture thereof. In this regard, the second electrode 17 may be, for example, lithium (Li), magnesium (Mg), aluminum (Α1), aluminum (Α1)-lithium (Li), calcium (Ca), lock (Mg)-indium (In ), a town (Mg)-silver (Ag) or the like, and a transfer electrode which can be formed into a film type. In practice, the transfer electrode may be formed of, for example, oxidized oxalate (ITO) or indium zinc oxide (ITO) to produce a top emission type light-emitting device. When the first layer in the organic light-emitting device is a hole injection layer, a hole transport layer or a functional layer, in addition to the condensed cyclic compound of the above formula 1, the first layer may further contain the above-described charge generating material. Alternatively, when the first layer is an emissive layer, in addition to the condensed cyclic compound of Formula 1, the first layer may further comprise the above-described fluorescent dopant. As such, the first layer is not limited to the above. [0109] Hereinafter, one or more embodiments will be described in more detail in conjunction with the following examples. These examples are not intended to limit the purpose and scope of one or more embodiments. Example 忐 忐 实 实 实 实 实 实 实 实 实 实 实 . . . . . . . 化合物 化合物 化合物 化合物 化合物 化合物 化合物 化合物 化合物 化合物 化合物 化合物 化合物 化合物 化合物 化合物 化合物 化合物 化合物 化合物 化合物 化合物 化合物 化合物 化合物 化合物 化合物 化合物 化合物 化合物 化合物 化合物 化合物 化合物 化合物

E FE F

[0111] 化合物B之厶忐 1,4-環己二酮34. 9克(0· 31莫耳)、90克(0. 62莫耳)的 苯肼·鹽酸以及醋酸1毫升放進1公升的圓頸燒瓶,且加 入60 0毫升的乙醇《此生成混合物以50°c加熱1小時,並 冷卻至室溫。將此生成固體過濾,以乙醇清洗數次,並 在真空下乾燥以收集73克、產率為80%的粉紅色化合物a 。600毫升的醋酸及120毫升的硫酸放進5公升的圓頸燒瓶 ,且以冰浴冷卻。217. 5克(0. 74莫耳)的化合物a加入生 成混合物,且強烈地在Ot:攪拌10分鍾。移除冰浴,所生 成混合物在室溫下攪拌10分鍾。接著,所生成混合物由 加熱包加熱。在約45°c時停止加熱,且攪拌所產生之混 合物。當產生之混合物穩定時,將其緩慢地冷卻至室溫 ,並在室溫下攪拌。過濾所生成之固體,按照醋酸、水 、乙醚之順序清洗,並在真空下乾燥以收集51克產率 為26. 7%的化合物b。 100111378 表單編號A0101 第58頁/共88頁 1003273214-0 201204728 [0112] !Η NMR (300MHz, DMSO-d6) 5 11.01 (2H), 8.19 (2H), 8.10 (2H), 7.45 (2H), 7.36 (2H), 7.12 (2H)。 [0113] Ο [0114]❹ 化厶物C之合成 將30克(0. 117莫耳)的化合物b與1公升的i,2 -二氣苯混 合以獲得一混合物。將6· 2克(0. 2當量)的18-冠-6、 129. 5克(8當量)的碳酸卸、29. 8克(4當量)的銅以及 99. 4克(3當ΐ)的溴笨加至此混合物中,並加熱至溫度 180°C。此生成混合物維持於溫度約ι7〇至約i8(rc兩天 以獲得一混合物。然後’將生成混合物冷卻至室溫,且 當以矽膠墊過濾時’以甲苯清洗數次。此過濾溶液經過 濃縮。將甲醇加至經過濾的溶液以沉降一固體,然後過 濾此經沉降之固體化合物。以乙酸乙酯清洗前述生成混 合物,並在真空下乾燥,即可收集到14. 4克、產率 21. 7%的化合物C。 ^ NMR (300MHz, DMSO) δ 8.31 (2Η), 8.21 (2Η), 7.90 (6Η), 7.72 (4Η), 7. 40 (4Η), 7.24 (2Η)。 [0115] 化合物Ϊ)之合 將4. 08克(10毫莫耳)的化合物C加至80%的醋酸(100毫 升)’然後將1.357克(5. 35毫莫耳)的碘(12)及0.333克 (1.46毫莫耳)的固態過碘酸(ΗΙ〇)加至前述混合物。 〇 6 然後此混合物於氮氣環境80eC下攪拌2小時。在反應完成 之後’反應產物用50毫升的二氣甲烷萃取三次以收集該 些有機層。該些有機層以硫酸鎂乾燥,並蒸發殘留的溶 100111378 表單編號A0101 第59頁/共88頁 1003273214-0 201204728 劑。利用矽膠管柱層析分離及純化剩餘物以獲得6. 14克 、產率87%的化合物D。 [0116] ]H NMR (300MHz, DMSO) 5 8.28 (1H), 8.25 (1H), 8.Q6 (1H), 7.90-7.86 (6H), 7.71 (4H), 7·38-7.32 (4H), 7.21(2H)。 [0117] 化合物F夕厶忐 將5. 34克(10毫莫耳)的化合物D、0.5毫莫耳的[ι,Γ -雙(二苯基膦基)二茂鐵]二氯鈀(π):二氣化鈀(dppf) 、2. 66克(10. 5毫莫耳)的雙(皮納可酸)二硼及3. 92克 的醋酸鉀加至200毫升的二甲基亞砜(DMS0),且在氮氣 環境下於9 0 °C视拌6小時。將生成混合物冷卻至室溫,然 後將其放在300毫升的水中以形成白色沉澱物。當以水清 洗數次以收集固體化合物時,將此白色沉澱物過濾,然 後用減壓乾燥以收集4. 65克、產率87%的化合物E。化合 物E溶解於150毫升的甲苯、2. 46克(8. 7毫莫耳)的卜溴 -4-碘苯、200毫克(2莫耳百分比)的肆(三甲基磷烷)鈀 (〇):把(三苯基磷)4,及將2.4克(17.4毫莫耳)的碳酸 鉀水溶液加至所生成混合物。在8〇°c下維持此生成混合 物6小時°反應完成之後,反應產物以50毫升的二氯甲烷 萃取3次以收集該些有機層。該些有機層以硫酸鎂乾燥, 並蒸發殘留的溶劑。利用矽膠管柱層析分離及純化剩餘 物以獲得6. 2克、產率79%的化合物F。 [0118] 100111378 ]H NMR (3〇〇MHz, DMSO) ά 8.25 (1H), 8.17 OH), 8.10 (iH), 7.99 (2H), 7.95-7.87 (5H), 7.83-7.80 (6H), 7. 76-7. 72(4H), 7. 70-7. 58(3H) 表單編Sfe A0101 第 60 頁/共 88 胃 1003273214-0 201204728 [0119] 化合物1之么命 化合物1係透過下列的反應流程lb合成: 反應流程lbB 1,4-cyclohexanedione of Compound B: 3.4 g (0·31 mol), 90 g (0.62 mol) of phenylhydrazine·hydrochloric acid and 1 ml of acetic acid in 1 liter A round neck flask was charged with 60 ml of ethanol. This mixture was heated at 50 ° C for 1 hour and cooled to room temperature. The resultant solid was filtered, washed with ethanol several times, and dried under vacuum to collect 73 g of a pink compound a in a yield of 80%. 600 ml of acetic acid and 120 ml of sulfuric acid were placed in a 5 liter round neck flask and cooled in an ice bath. 217. 5 g (0.74 mol) of compound a was added to the resulting mixture and stirred vigorously at Ot: for 10 minutes. The ice bath was removed and the resulting mixture was stirred at room temperature for 10 minutes. Next, the resulting mixture is heated by a heating pack. Heating was stopped at about 45 ° C and the resulting mixture was stirred. When the resulting mixture was stable, it was slowly cooled to room temperature and stirred at room temperature. The resulting solid was filtered, washed in the order of acetic acid, water, and diethyl ether, and dried under vacuum to yield 51 g of compound b. 100111378 Form No. A0101 Page 58 of 88 1003273214-0 201204728 [0112] !Η NMR (300MHz, DMSO-d6) 5 11.01 (2H), 8.19 (2H), 8.10 (2H), 7.45 (2H), 7.36 (2H), 7.12 (2H). [0114] Synthesis of hydrazine c. 30 g (0.1117 mol) of compound b was mixed with 1 liter of i,2-dibenzene to obtain a mixture. 6克(3当ΐ), 6.2 g (2. 2 eq.) of 18-crown-6, 129. 5 g (8 equivalents) of carbonic acid, 29.8 g (4 equivalents) of copper, and 99.4 g (3 ΐ) The bromine was added to the mixture and heated to a temperature of 180 °C. This resulting mixture was maintained at a temperature of about io 7 Torr to about i8 (rc for two days to obtain a mixture. Then 'the resulting mixture was cooled to room temperature, and when filtered with a silicone pad' was washed several times with toluene. This filtered solution was concentrated. The product was added to the filtered solution to precipitate a solid, and then the precipitated solid compound was filtered. The resulting mixture was washed with ethyl acetate and dried under vacuum to give 14.4 g, yield 21 7% of compound C. NMR (300MHz, DMSO) δ 8.31 (2Η), 8.21 (2Η), 7.90 (6Η), 7.72 (4Η), 7. 40 (4Η), 7.24 (2Η). [0115] The compound Ϊ) is combined with 4. 08 g (10 mmol) of compound C to 80% acetic acid (100 ml)' then 1.357 g (5. 35 mM) of iodine (12) and 0.333 g. (1.46 mmol) of solid periodic acid (ΗΙ〇) was added to the aforementioned mixture. 〇 6 This mixture was then stirred under a nitrogen atmosphere at 80 ° C for 2 hours. After the reaction was completed, the reaction product was extracted three times with 50 ml of dioxane to collect the organic layers. The organic layers were dried over magnesium sulphate and evaporated to a residue of 100111378 Form No. A0101, page 59 / 88 pages 1003273214-0 201204728. The residue was separated and purified using a silica gel column chromatography to afford 6.14 g, yield 87% of Compound D. [0116] H NMR (300MHz, DMSO) 5 8.28 (1H), 8.25 (1H), 8.Q6 (1H), 7.90-7.86 (6H), 7.71 (4H), 7·38-7.32 (4H), 7.21 (2H). Compound F 厶忐 5.34 g (10 mmol) of compound D, 0.5 mmol of [ι, Γ-bis(diphenylphosphino)ferrocene] dichloropalladium (π) ): palladium dihydrate (dppf), 2. 66 g (10.5 mmol) of bis(pinamic acid) diboron and 3.92 g of potassium acetate added to 200 ml of dimethyl sulfoxide (DMS0), and mixed at 90 ° C for 6 hours under a nitrogen atmosphere. The resulting mixture was cooled to room temperature and then placed in 300 ml of water to form a white precipitate. The white precipitate was filtered, and then dried under reduced pressure to yield 4.65 g, yield 87% of Compound E. Compound E was dissolved in 150 ml of toluene, 2.46 g (8.7 mM) of bromo-4-iodobenzene, 200 mg (2 mol%) of ruthenium (trimethylphosphane) palladium (〇) ): (triphenylphosphine) 4, and 2.4 g (17.4 mmol) of aqueous potassium carbonate solution were added to the resulting mixture. After maintaining the resulting mixture for 6 hours at 8 ° C, the reaction product was extracted three times with 50 ml of dichloromethane to collect the organic layers. The organic layers were dried over magnesium sulfate and the residual solvent was evaporated. The residue was separated and purified by a silica gel column chromatography to obtain 6.2 g of a compound F of a yield of 79%. 100111378 ]H NMR (3〇〇MHz, DMSO) ά 8.25 (1H), 8.17 OH), 8.10 (iH), 7.99 (2H), 7.95-7.87 (5H), 7.83-7.80 (6H), 7 76-7. 72(4H), 7. 70-7. 58(3H) Form Sfe A0101 Page 60 of 88 Stomach 1003273214-0 201204728 [0119] Compound 1 is a compound that passes through the following reactions. Process lb synthesis: Reaction process lb

NaOffiuNaOffiu

ό 化合物I ❹ 將3克(5. 32毫莫耳)的化合物F及1. 08克(6. 38毫莫耳) 的二苯基胺溶解於甲苯,且在一氮氣環境下將97.4毫克 (〇. Π毫莫耳)的參(二亞苄丙酮)二鈀:Pd (dba)及22 2 3化合物 Compound I 3 3 g (5.32 mmol) of compound F and 1.08 g (6.38 mmol) of diphenylamine were dissolved in toluene and 97.4 mg under a nitrogen atmosphere ( 〇. Π 莫 )) 参 (dibenzylideneacetone) dipalladium: Pd (dba) and 22 2 3

G 毫克(0· 11毫莫耳)的三(t-丁基)膦加至前述生成混合物 。然後,將1. 62克(15· 96毫莫耳)的NaOBu加至此生成 混合物中,然後在80°C下攪拌4小時。將此生成混合物冷 卻至室溫再以二氣甲烷萃取三次以收集該些有機層。該 些有機層以硫酸鎂乾燥,且將殘留的溶劑蒸發,分離剩 餘物且利用石夕膝管柱層析純化以獲得2. 6 4克、產率7 6 %的 化合物1。 [0120] !H NMR (300MHz, DMSO) δ 8.25(1H), 8.14(2H), 8. 06(1H), 7. 97(2H), 7. 88-7. 79(1 1H), 7. 73(2H), 7. 58-7. 41 (6H), 7.37(2H), 7.24(2H), 7.08-6.96(4H)。 [0121] 佥成竇例2 :化合物3之厶志 化合物3係透過下列的反應流程2合成: 100111378 表單編號A0I01 第61頁/共88頁 1003273214-0 201204728 反應流程2G mg (0·11 mmol) of tris(t-butyl)phosphine was added to the aforementioned mixture. Then, 1.62 g (15·96 mmol) of NaOBu was added to the resulting mixture, followed by stirring at 80 ° C for 4 hours. The resulting mixture was cooled to room temperature and extracted three times with di-methane to collect organic layers. The organic layer was dried over magnesium sulfate, and the residual solvent was evaporated, and the residue was purified and purified by silica gel column chromatography to obtain 2.6 g of Compound 1 in a yield of 76%. !H NMR (300MHz, DMSO) δ 8.25(1H), 8.14(2H), 8. 06(1H), 7. 97(2H), 7. 88-7. 79(1 1H), 7. 73(2H), 7. 58-7. 41 (6H), 7.37(2H), 7.24(2H), 7.08-6.96(4H). Example 2: Compound 3: Compound 3 was synthesized by the following Reaction Scheme 2: 100111378 Form No. A0I01 Page 61 of 88 1003273214-0 201204728 Reaction Scheme 2

化合物3 將3克(5. 32毫莫耳)的化合物1?及2 31克(6 38毫莫耳) 的胺化合物加至曱苯,然後在一氮氣環境下將97.4毫克 (0. 11毫莫耳)的參(二亞苄丙酮)二鈀:pd^dba)3&22 毫克(0. 11毫莫耳)的三(t_丁基)膦加至前述生成混合物 。然後,將1. 62克(15. 96毫莫耳)_a0Bu加至此生成 混合物中,然後在8(TC下攪拌4小時。此生成混合物冷卻 至至溫再以二氣甲烷萃取三次以收集該些有機層。該些 有機層以硫酸鎂乾燥,且將殘留的溶劑蒸發。分離剩餘 物且利用矽膠管柱層析純化以獲得3.丨丨克、產率69%的化 合物3。 [0122] !H NMR (300MHz, DMSO) d 8.34(1H), 8.27(1H), 8.06-8.03C4H), 7. 98-7. 94(3H), 7. 90-7. 88(3H), 7.82-7.78(14H), 7.73-7.70(5H), 7.37-7.50(2H), 7.23-7.08(6H), 1.78(6H)。 [0123] 全成f例3 :彳h合物9之合成 化合物9係透過下列的反應流程3合成: 反應流程3 100111378 表單編號A0101 第62頁/共88頁 1003273214-0 201204728Compound 3 3 g (5. 32 mmol) of compound 1? and 2 31 g (6 38 mmol) of amine compound were added to toluene, and then 97.4 mg (0. 11 mils) under a nitrogen atmosphere. Moss (dibenzylideneacetone) dipalladium: pd^dba) 3 & 22 mg (0.11 mmol) of tris(t-butyl)phosphine was added to the aforementioned resulting mixture. Then, 1.62 g (15.96 mmol) of _a0Bu was added to the resulting mixture, followed by stirring at 8 (TC for 4 hours. This resulting mixture was cooled to warmness and then extracted three times with di-methane to collect the The organic layer was dried over magnesium sulfate, and the residual solvent was evaporated. The residue was separated and purified using silica gel column chromatography to obtain 3. gram, yield 69% of compound 3. [0122] H NMR (300MHz, DMSO) d 8.34 (1H), 8.27 (1H), 8.06-8.03C4H), 7. 98-7. 94(3H), 7. 90-7. 88(3H), 7.82-7.78 ( 14H), 7.73-7.70(5H), 7.37-7.50(2H), 7.23-7.08(6H), 1.78(6H). Synthesis Example 3: Synthesis of 彳h Compound 9 Compound 9 was synthesized by the following Reaction Scheme 3: Reaction Scheme 3 100111378 Form No. A0101 Page 62 of 88 1003273214-0 201204728

化合物9係利用與合成化合物1相同的方式合成,除了利 用1,3-環己二酮來代替合成實例1的合成實例B中的1,4-環己二酮以合成化合物G而非化合物F,且利用化合物G代 替化合物F。Compound 9 was synthesized in the same manner as in the synthesis of Compound 1, except that 1,3-cyclohexanedione was used instead of 1,4-cyclohexanedione in Synthesis Example B of Synthesis Example 1 to synthesize Compound G instead of Compound F. And using compound G instead of compound F.

[0124] !H NMR (300MHz, DMSO) δ 8.37(1Η), 8.03(1Η), 7. 96-7. 89(3Η), 7. 53-7. 34( 1 1Η), 7. 28(2Η), 7.21-7.09(7Η),7.05-6.9K4H),6.87(4Η)。 [0125] 合志f你Μ :化合物〗1之合忐 化合物11係透過下列的反應流程4合成: 反應流程4!H NMR (300MHz, DMSO) δ 8.37 (1Η), 8.03 (1Η), 7. 96-7. 89(3Η), 7. 53-7. 34( 1 1Η), 7. 28(2Η ), 7.21-7.09 (7Η), 7.05-6.9K4H), 6.87 (4Η). [0125] Hezhi f you Μ: Compound 11 化合物 Compound 11 is synthesized by the following reaction scheme 4: Reaction Scheme 4

化合物11 化合物11係利用與合成化合物2相同的方式合成,除了利 用1,3-環己二酮來代替合成實例2的合成實例Β中的1,4-環己二酮以合成化合物G而非化合物F,且利用化合物G代 替化合物F。 [0126] !H NMR (300MHz, DMSO) ά 8.36(1H), 8.28(1H), 8.11-7.96(6H), 7.90(3H), 7.93-7.80(13H), 100111378 表單編號A0101 第63頁/共88頁 1003273214-0 201204728 7.78-7.66(6H), 7.58-7.50(3H), 7(2H), 1.78(6H)。 [0127] 奋忐管例5 :化合物之合忐 化合物26係透過下列的反應流程5合成: 反應流程5Compound 11 Compound 11 was synthesized in the same manner as in the synthesis of Compound 2 except that 1,3-cyclohexanedione was used instead of 1,4-cyclohexanedione in the synthesis example of Synthesis Example 2 to synthesize Compound G instead of Compound F, and Compound G is used instead of Compound F. !H NMR (300MHz, DMSO) ά 8.36(1H), 8.28(1H), 8.11-7.96(6H), 7.90(3H), 7.93-7.80(13H), 100111378 Form No. A0101 Page 63 of 88 pages 1003273214-0 201204728 7.78-7.66(6H), 7.58-7.50(3H), 7(2H), 1.78(6H). Example 5: Compound 忐 Compound 26 is synthesized by the following Reaction Scheme 5: Reaction Scheme 5

化合物26係利用與合成化合物2相同的方式合成,除了透 過利用4, 4’ -二溴聯苯合成的化合物Η代替在合成實例1 合成化合物F時的1-溴-4-碘苯;在合成實例2,利用化合 物Η代替化合物F,並利用反應流程5的胺化合物代替反應 流程2的胺化合物。 [0128] !H NMR (300MHz, DMSO) 5 8.36 (1H), 8.27 (1H), 7.96-7.82 (4H), 7.73-7.56 (9H), 7.52-7.47 (6H), 7.37-7.25 (8H), 7.19 (2H), 7.07-6.91 (4H),6.86-6.63 (4H),1.78 (6H)。 [0129] 合成化会物ft :化合物27之合成 化合物27係利用透過下列的反應流程6合成: 反應流程6 100111378 表單編號A0101 第64頁/共88頁 1003273214-0 201204728Compound 26 was synthesized in the same manner as in the synthesis of Compound 2 except that the compound synthesized using 4,4'-dibromobiphenyl was substituted for 1-bromo-4-iodobenzene in the synthesis of Compound F in Synthesis Example 1; In Example 2, the compound Η was used instead of the compound F, and the amine compound of the reaction scheme 2 was replaced with the amine compound of the reaction scheme 5. !H NMR (300MHz, DMSO) 5 8.36 (1H), 8.27 (1H), 7.96-7.82 (4H), 7.73-7.56 (9H), 7.52-7.47 (6H), 7.37-7.25 (8H), 7.19 (2H), 7.07-6.91 (4H), 6.86-6.63 (4H), 1.78 (6H). Synthesis of Compound ft: Synthesis of Compound 27 Compound 27 was synthesized by the following Reaction Scheme 6: Reaction Scheme 6 100111378 Form No. A0101 Page 64 of 88 1003273214-0 201204728

化合物27係利用與合成化合物2相同的方式合成,除了透 過利用1,4-二溴萘代替在合成實例1合成化合物F時的1-溴-4-碘苯;在合成實例2,利用化合物I代替化合物F, 並利用反應流程6的胺化合物代替反應流程2的胺化合物 〇 [0130] !H NMR (300MHz, DMSO) (5 8.53 (1H), 8.42 (1H), 8.12-7.99 (4H), 7.82-7.74 (3H), 7.68-7.59 (5H), 7.52-7.50 (8H), 7.53-7.42 (3H), 7.37-7.23 (6H), 7.11-6.73 (5H), 6.62 (1H), 1.78 (6H)。 [0131] 比鲂合忐例A :化合物A之会忐 化合物A係透過下列的反應流程7合成: 反應流程7Compound 27 was synthesized in the same manner as in the synthesis of Compound 2 except that 1-bromo-4-iodobenzene was synthesized by using 1,4-dibromonaphthalene instead of Compound F in Synthesis Example 1. In Synthesis Example 2, Compound I was used. Substituting compound F, and replacing the amine compound of reaction scheme 2 with the amine compound of reaction scheme 〇[0130] !H NMR (300MHz, DMSO) (5 8.53 (1H), 8.42 (1H), 8.12-7.99 (4H), 7.82-7.74 (3H), 7.68-7.59 (5H), 7.52-7.50 (8H), 7.53-7.42 (3H), 7.37-7.23 (6H), 7.11-6.73 (5H), 6.62 (1H), 1.78 (6H Comparative Example A: Compound A is obtained by the following Reaction Scheme 7: Reaction Scheme 7

化合物A 化合物A(2. 85克及產率70%)的合成係利用與合成實例2 相同的方式合成,除了利用化合物D代替化合物F。 100111378 表單編號A0101 第65頁/共88頁 1003273214-0 201204728 [0132] !H MNM (3ΠηΜΗ7. DMSO^ δ 8. 34 (1 Η),8. 05 (1H),7.89 (1H),7,90-7.64 (3H),7.61-7.55 (8H), 7.73-7.55 (8H), 7.48-7.35 (6H), 7.31-7.28 (2H), 6.81-6.73 (3H), 6.71 (1H), 6.13 (1H), 1.78 (6H)。 [0133] 比較合成例R :化厶物B之奋成 化合物B係透過下列的反應流程8合成: 反應流程8Synthesis of Compound A Compound A (2.85 g and yield 70%) was synthesized in the same manner as in Synthesis Example 2 except that Compound D was used instead of Compound F. 100111378 Form No. A0101 Page 65/88 Page 1003273214-0 201204728 [0132] !H MNM (3ΠηΜΗ7. DMSO^ δ 8. 34 (1 Η), 8. 05 (1H), 7.89 (1H), 7,90 -7.64 (3H), 7.61-7.55 (8H), 7.73-7.55 (8H), 7.48-7.35 (6H), 7.31-7.28 (2H), 6.81-6.73 (3H), 6.71 (1H), 6.13 (1H) 1.78 (6H) [0133] Comparative Synthesis Example R: Compound B of the hydrazine B is synthesized by the following Reaction Scheme 8: Reaction Scheme 8

將5克(13. 5毫莫耳)的3-蛾-9-苯基叶·《»坐及2. 2.克(1〇 t 莫耳)的 5-溴苯基硼酸(4-bromopheny 1 boronoc acid)溶解於THF,鈀(三苯基磷)4(2莫耳百分比),然後 加入碳酸鉀水溶液於其中,並使前述混合物於8(rc下反 應4小時。反應後,此混合物以15〇毫升的二氯甲烷萃取3 次,然後藉由硫酸鎂乾燥有機層及蒸發溶劑所獲得的剩 餘物係透過矽膠管層析來分離及純化。將前述獲得的4. 2 克(10. 6毫莫耳)的化合物及2. 2克(12· 7毫莫耳)的二笨 基胺溶解於甲苯,並在一氮氣環境下加入〗95毫克(〇·22 毫莫耳)的參(二苄亞基丙酮)二鈀·· ?(^((11)3)3及44毫克 (0. 22毫莫耳)的三(t —丁基)膦。然後,將3. 24克的 NaOtBu加入此混合物,並於8(rc攪拌4小時如此獲得 之混合物在室溫冷卻’以二氣甲烧萃取3次然後藉由硫 100111378 表單編號A0101 第66頁/共88 ϊ 1003273214-0 201204728 酸鎮乾燥有機狀所㈣關餘祕透過石夕朦 管層析來分離及純化,因而獲得化合物B(4.5克產率 859〇。 [0134] [0135] ]H NMR (300MHz, DMSO) (2H), 7. 84-7. 78 (2H), (4H), 7.46-7.31 (4H), (2H), 6.89-6.71 (2H), 营你11 ^ 8.54 (1H), 7.95 7. 66 (2H),7.62-7.58 7.28-7.21 (5H), 7.06 6.67 (2H)。5 g (13.5 mmol) of 3-Moth-9-phenyl leaf · "Sit and 2. 2. g (1 〇 t Mo) 5-bromophenylboronic acid (4-bromopheny 1 Boronoc acid was dissolved in THF, palladium (triphenylphosphine) 4 (2 mol%), then an aqueous solution of potassium carbonate was added thereto, and the mixture was reacted at 8 (rc for 4 hours). After the reaction, the mixture was 15 2 克。 (1. 6 克。 The above obtained 2. 2 grams (10. 6 mM) obtained by the extraction of the organic layer and the evaporation of the solvent was separated and purified by silica gel chromatography. The compound of Mox) and 2.2 g (12·7 mmol) of dimethaneamine are dissolved in toluene, and a 95 mg (〇·22 mmol) of ginseng (dibenzyl) is added under a nitrogen atmosphere.亚 丙酮 ) ) ) 二 ^ ^ ^ ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( The mixture was stirred at 8 (rc for 4 hours, the mixture thus obtained was cooled at room temperature) and extracted 3 times with two gas burners and then with sulfur 100111378 Form No. A0101 Page 66 / Total 88 ϊ 1003273214-0 20120472 8 Acid-free dry organic form (4) Guan Yu secret was separated and purified by Shixi tube chromatography, thus obtaining compound B (4.5 g yield 859 〇. [0135] ]H NMR (300 MHz, DMSO) ( 2H), 7. 84-7. 78 (2H), (4H), 7.46-7.31 (4H), (2H), 6.89-6.71 (2H), Camp 11 ^ 8.54 (1H), 7.95 7. 66 ( 2H), 7.62-7.58 7.28-7.21 (5H), 7.06 6.67 (2H).

一 15Ω/平方公分( 1 200埃)氧化銦錫玻璃基板[自c〇rn_ ing Co.(康寧公司)購得]裁切成5〇毫米χ5〇毫米χ〇 7毫 米的大小,以異丙基醇超音波清洗5分鐘,然後以水超音 波清洗5分鐘,接著以UV臭氧再一次清洗30分鐘。然後, 將m-MTDATA真空沉積於氧化銦錫上以形成具有厚度75〇 埃的電洞注入層,接著將上述的化合物1真空沉積於電洞 注入層上以形成具有厚度15〇埃的電洞傳輸層◊將作為主 劑的97wt%的DSA以及作為摻雜劑的3wt%的TBPe沉積於 電洞傳輸層上以形成一具有厚度300埃的發射層。將A1(} 3 真空沉積於發射層上以形成具有厚度2〇〇埃的電子傳輸層 。將氟化鋰真空沉積於電子傳輸層上以形成一具有厚度 80埃的電子注入層’並將鋁真空沉積於電子注入層上以 形成一具有厚度3, 000埃的陰極。 [0136] 實你丨? 以和實例1相同的方式製造一有機發光裝置,除了利用化 合物代替化合物1作為電洞傳輸層的材料。 100111378 表單編號A0101 第67頁/共88頁 1003273214-0 201204728 [0137] Ψ #1 3 以和實例1相同的方式製造一有機發光裝置,除了利用化 合物9代替化合物1作為電洞傳輸層的材料。 [0138] f 例 4 以和實例1相同的方式製造一有機發光裝置,除了利用化 合物11代替化合物1作為電洞傳輸層的材料。 [0139] 眚例 5 以和實例1相同的方式製造一有機發光裝置,除了利用化 合物2 6代替化合物1作為電洞傳輸層的材料。 [0140] 营例 fi 以和實例1相同的方式製造一有機發光裝置,除了利用化 合物27代替化合物1作為電洞傳輸層的材料。 [0141] 比齡例1 以和實例1相同的方式製造一有機發光裝置,除了利用α -NPD代替化合物1作為電洞傳輸層的材料'。 [0142] 比鲂例2 以和實例1相同的方式製造一有機發光裝置,除了利用化 合物Α代替化合物1作為電洞傳輸層的材料。 [0143] 比較柄3 以和實例1相同的方式製造一有機發光裝置,除了利用化 合物B代替化合物1作為電洞傳輸層的材料。 [0144] 评估f例 利用 PR650 Spectroscan Source Measurement 100111378 表單編號A0101 第68頁/共88頁 1003273214-0 201204728 〇A 15 Ω/cm 2 (1 200 Å) indium tin oxide glass substrate [available from c〇rn_ ing Co. (Corning)] cut into 5 mm, 5 mm, 7 mm, with isopropyl The alcohol was ultrasonicated for 5 minutes, then washed with water for 5 minutes, followed by UV ozone for another 30 minutes. Then, m-MTDATA was vacuum deposited on indium tin oxide to form a hole injection layer having a thickness of 75 Å, and then the above-mentioned compound 1 was vacuum deposited on the hole injection layer to form a hole having a thickness of 15 Å. The transport layer 沉积 deposited 97 wt% of DSA as a main agent and 3 wt% of TBPe as a dopant on the hole transport layer to form an emission layer having a thickness of 300 angstroms. A1(} 3 was vacuum deposited on the emissive layer to form an electron transport layer having a thickness of 2 μA. Lithium fluoride was vacuum deposited on the electron transport layer to form an electron injecting layer having a thickness of 80 Å and aluminum was Vacuum deposition on the electron injecting layer to form a cathode having a thickness of 3,000 angstroms. [0136] Actually, an organic light-emitting device was fabricated in the same manner as in Example 1, except that a compound was used instead of Compound 1 as a hole transport layer. 100111378 Form No. A0101 Page 67/88 Page 1003273214-0 201204728 [0137] Ψ #1 3 An organic light-emitting device was fabricated in the same manner as in Example 1, except that Compound 9 was used instead of Compound 1 as a hole transport layer. [Example 4] An organic light-emitting device was produced in the same manner as in Example 1, except that Compound 11 was used instead of Compound 1 as a material for the hole transport layer. [Example No. 5] In the same manner as in Example 1. An organic light-emitting device was fabricated except that Compound 26 was used instead of Compound 1 as a material for the hole transport layer. [0140] Camp Example fi An organic hair was produced in the same manner as in Example 1. Means, except that Compound 27 was used instead of Compound 1 as a material for the hole transport layer. [0141] Specific Age Example 1 An organic light-emitting device was manufactured in the same manner as in Example 1, except that α-NPD was used instead of Compound 1 as a hole transport layer. Material [Example 2] An organic light-emitting device was fabricated in the same manner as in Example 1, except that the compound Α was used instead of the compound 1 as a material for the hole transport layer. [0143] The comparative handle 3 was the same as in Example 1. The method of manufacturing an organic light-emitting device, except that Compound B is used instead of Compound 1 as a material for the hole transport layer. [0144] Evaluation of f example using PR650 Spectroscan Source Measurement 100111378 Form No. A0101 Page 68 / 88 Page 1003273214-0 201204728 〇

Unit評估(自 PhotoReasearch company 購得)實例 1 至6 及比較實例1至3所製造的該些有機發光裝置的發光效率 及半衰期(初始亮度為1000尼特)。其結果如以下的表1所 示: [0145] 表 1 [0146] 電洞傳輸層化 合物 發光效率 (cd/A) 半衰期(時間) @1 000尼特 實例1 化合物1 4. 39 1 0000 實例2 化合物3 4. 76 8900 實例3 化合物9 4. 63 7900 實例4 化合物11 4. 75 9500 實例5 化合物26 4. 25 9600 實例6 化合物2 7 4. 59 8200 比較例1 a-NPD 3. 86 4600 比較例2 化合物A 4. 03 2000 比較例3 化合物B 3. 12 5300 [0147] 請參閱表1,與比較例1至3的有機發光裝置比較之下,可 發現實例1至6的該些有機發光裝置已改善發光效率及半 衰期特性。 [0148] 包含如式1所表示的縮合環狀化合物的有機發光裝置可具 有出色的效能,舉例來說,高的發光效率及壽命。 [0149] 例示性實施例已於文中所述,雖然已採用特定的術語, 但它們僅被使用於一般性及陳述性的理解,而非為限制 100111378 表單編號A0101 第69頁/共88頁 1003273214-0 201204728 性。於是,在此領域之技術人士將可理解對其進行之型 式及細節上的變更,並未脫離本發明之精神與範疇,且 均應闡明於後附之申請專利範圍中。 【圖式簡單說明】 [0150] 藉由參照附圖來詳細說明例示性實施例將讓此技術領域 之工作者更明白上述及其他特徵與優點,其中: 第1圖係根據一實施例所繪示之一有機發光裝置(OLED)之 剖面示意圖。 【主要元件符號說明】 [0151] 10:有機發光裝置 11 :基板 13 :第一電極 15 :有機層 17 :第二電極 100111378 表單編號A0101 第70頁/共88頁 1003273214-0The Unit evaluated (available from PhotoReasearch company) the luminous efficiency and half-life (initial brightness of 1000 nits) of the organic light-emitting devices manufactured in Examples 1 to 6 and Comparative Examples 1 to 3. The results are shown in Table 1 below: Table 1 [0146] Electron hole transport layer compound luminous efficiency (cd/A) Half-life (time) @1 000 nits Example 1 Compound 1 4. 39 1 0000 Example 2 Compound 3 4. 76 8900 Example 3 Compound 9 4. 63 7900 Example 4 Compound 11 4. 75 9500 Example 5 Compound 26 4. 25 9600 Example 6 Compound 2 7 4. 59 8200 Comparative Example 1 a-NPD 3. 86 4600 Comparison Example 2 Compound A 4. 03 2000 Comparative Example 3 Compound B 3. 12 5300 [0147] Referring to Table 1, the organic light-emitting examples of Examples 1 to 6 were found in comparison with the organic light-emitting devices of Comparative Examples 1 to 3. The device has improved luminous efficiency and half-life characteristics. The organic light-emitting device comprising the condensed cyclic compound represented by Formula 1 can have excellent performance, for example, high luminous efficiency and longevity. [0149] The illustrative embodiments have been described herein, and although specific terms have been employed, they are only used in a generic and declarative understanding, and are not intended to be limiting. FIG. -0 201204728 Sex. Thus, those skilled in the art will understand that the form and details of the invention may be modified without departing from the spirit and scope of the invention. BRIEF DESCRIPTION OF THE DRAWINGS [0012] The above-described and other features and advantages will be apparent to those skilled in the art from a detailed description of the embodiments of the invention. A schematic cross-sectional view of an organic light-emitting device (OLED) is shown. [Description of Main Element Symbols] [0151] 10: Organic Light Emitting Device 11: Substrate 13: First Electrode 15: Organic Layer 17: Second Electrode 100111378 Form No. A0101 Page 70 of 88 1003273214-0

Claims (1)

201204728 七、申請專利範圍: 係由以下的式1所表示 1 . 一種縮合環狀化合物201204728 VII. Patent application scope: It is expressed by the following formula 1. 1. A condensed cyclic compound 式1 其中,在式1中:Formula 1 where, in Equation 1: A環係由以下的式2或式3所表示:The A ring system is represented by the following Formula 2 or Formula 3: \ Rt 式3 Ri至R12係各獨自為一氫原子、一重氫原子、一函素原子 、一羥基、一氰基、一經取代或未經取代的Ci — c”烷基、 —經取代或未經取代的縣、—經取代或未經取代 的CrC3〇炔基、一經取代或未經取代的C^-Cu烷氧基、— 1 〇 U 1Ί"' 由-(Ari)rAru所表示的第一取代基、一由 N[ (Ar2)b_Ar12] [-(Ar3)c_Ar13]所表示的第二取代基 ^-^(Ar4VN[-(Ar5)e-Ar15][-(Ar6)rAr16],^ 不的第三取代基, \至1?12之至少之一者為該第三取代基; 該第一取代基至該第三取代基中的Aq至Ar6係各獨自為一 經取代或未經取代的Ci_CM伸烷基(alky】ene gr〇up)、 100111378 表單編號A0J0I 第71頁/共88頁 1003273214-0 201204728 一經取代或未經取代的〇2-(^30伸稀基(alkenylene group)、一經取代或未經取代的(:厂(^伸芳基(arylene D 〇 U group)、一經取代或未經取代的C -(:9„雜伸芳基 0 o U (heteroarylene group); 呑亥第^一取代基至該第二取代基中的Ar 、Ar 、Ar 、 1 1 12 13 Ar15以及Ar16係各獨自為一氫原子、一重氫原子、一鹵素 原子、一羥基、一氰基、一經取代或未經取代的C -C烷 1 3 0 基、一經取代或未經取代的c2-c3Q烯基、一經取代或未經 取代的C2-C3Q炔基、一經取代或未經取代的[c烷氧基 1 〇 U 、一經取代或未經取代的C5-C3Q芳基或一經取代或未經取 代的C3-C3{)雜芳基; a、b、c、e及f係各獨自為〇至1〇之一整數; d為0至10之一整數;以及 八^的‘V’群在該第一取代基的_(A ) _Ar的基團中 la 11 係彼此相同或不同;41*2的“b”群在該第二取代基的 _Ur2)b-Ar12基團中係彼此相同或不同;Ar的“c”群 0 在該第二取代基的~(紅3)(;41'13基團中係彼此相同或不 同,△、的e,群在該第三取代基的—(Ar ) -Ar, ^基團 5 e 15 中係彼此相同或不同;Ar6的“f”群在該第三取代基的 ~(Ar6)f-Ar16基團中係彼此相同或不同。 如申請專利範圍第1項所述之縮合環狀化合物,其中Ar_i至 Αι*6係各獨自為一經取代或未經取代的c _c伸芳 一 5 14 ^ 經取代或未經取代的c:3-Ci4雜伸芳基。 100111378 如申凊專利範圍第1項所述之縮合環狀化合物,其中Ar至 Are係各獨自為一伸苯基、一Ci_CM烷基伸苯基、一二 (Cl-ci〇烷基)伸苯基'一(c6_Ci4芳基)伸苯基、一二 1003273214-0 表單蝙號A0101 第72頁/共88頁 _CU芳基)伸苯基、一伸°卡°坐基(carbazolylene group)、一(^-(:1()烷基伸咔唑基、一二(crC1〇烷基)伸 咔唑基、一c6-c14芳基伸咔唑基、一二(c6-ci4芳基)伸 咔嗤基、一伸苐基(fluorenylene group)、一{^-C^ 烷基伸篥基、一二烷基)伸篥基、一(c6-c14芳基 )伸苐基、一二(C6_C14芳基)伸第基、一伸萘基 (naphthylene group)、一(:,-(:,„烷基伸萘基、一二 (Ci-Cm烧基)伸萘基、一(C6_C14芳基)伸蔡基、一二 (C6_C14芳基)伸萘基、一伸蒽基(anthrylene group) 、一烷基伸蒽基、一二((:「(:〗〇烷基)伸蒽基、一 (c6-c14芳基)伸蒽基、一二(c6-c14芳基)伸蒽基、一伸 吡啶基(pyridinylene group)、一烷基伸吡啶 1 10 基、一二烷基)伸吡啶基、一(c6-c14芳基)伸吡 咬基、一二(C6-C14芳基)伸11比咬基、一伸啥琳基 (quinolinylene group)、一(^-Ch烧基伸喹啉基、一 二(C^Cio烧基)伸啥琳基、一(C6-Ci4芳基)伸喧琳基、 一二(C6_C14芳基)伸喧啦基、一伸笨並味嗤基 (benzoimidazolylene group)、一烷基伸苯並 咪唑基、一二(C-Cin烷基)伸苯並咪唑基、一(Ce-C芳 1 1 u 6 14 基)伸苯並°米唾基、一二(〇6-〇14芳基)伸苯並咪峻基、一 伸咪嗤。比^*(imidazopyrimidinylenegroup)、一 C1 - C丨❹院基伸β米°坐β比咬基、一二(C丨-C】q烧基)伸b米嗤吼 咬基、一(C6_C14芳基)伸味》坐°比咬基、一二(C6-C14芳基 )伸°米嗤吼咬基、一伸味唾嘴唆基 (imidazopyrimidinylene group)、一烧基伸 咪唑嘧啶基、一二烷基)伸咪唑嘧啶基、一 表單編號A0101 第73頁/共88頁 i〇〇s 201204728 14芳基)伸》米唾喷咬基或一三(W芳基)伸味唾射基 •如申請專利範圍第1項所述之縮合環狀化合物’ ’、Λ1 ] | Ari2、Ari3、Ari5以及Aru係各獨自為該氫原子、該重 氣原子、該鹵素原子、該經基、該氰基、一經取代或未經 取代的\-Cig烷基、一經取代或未經取代的c 2 1〇'^ 一經取代或未經取代的c2-ci()炔基、—經取代或未經取代 的C厂C10燒氧基、一經取代或未經取代的(:5-(:14芳基或一 經取代或未經取代的(:3_(:14雜芳基。 .如申請專利範圍第1項所述之縮合環狀化合物,其中Ar Ari2、Ari3、Ari5以及Ari6係各獨自為該氫原子、該重 氫原子'該鹵素原子、該羥基、該氰基'一甲基、—乙基 、一丙基、一丁基、一戊基'一乙烯基、一丙烯基、一丁 烯基、一戊烯基、一乙醯基、一甲氧基、一乙氧基、一丙 氧基、一丁氧基、一戊氧基' 一苯基、一Ci_Cu烷基苯基 、一二(Ci-Cu烷基)苯基、一(C6-C14芳基)苯基 '一二 (C6-C14 芳基)苯基、—咔唑基(carbazolyl group)、 — Ci—C1()烷基咔唑基、一二((^-ί:1()烷基)咔唑基、一 ce-cl4芳基咔唑基、一二(c6_Ci4芳基)咔唑基、一第基 (fluorenyl group)、烷基第基、一二 (\-(:1〇院基)第基、—(c —C芳基)第基、—二(c -c b 14 6 14 芳基)第基、一萘基(naphthyl group)' —C-C焓其 1 1 〇 u ^ 萘基、一二(q-c1〇烷基)萘基、一(c6-c14芳基)萘基、 一二(C6-C14 芳基)萘基、一蒽基(anthryl group)、一 匸1。1〇烧基蒽基、一 一(C!-烧基)蒽基、一(C^-C^芳 基)蒽基、一二(C6-C14芳基)蒽基、一η比咬基 1D0111378 1003273214-0 表單編號Α0101 第74頁/共88頁 201204728 (pyridinyl group)、一伸°比咬基、—比咬 基、一二(q-c^烷基)吡啶基、一(crcu芳基)吡啶基 、一二(Cc-C1/t 芳基)°比咬基、一01嚇·基(quinolinyl 0 14 Ο\ Rt Formula 3 Ri to R12 are each a hydrogen atom, a heavy hydrogen atom, a single atom, a hydroxyl group, a cyano group, a substituted or unsubstituted Ci - c" alkyl group, a substituted or not Substituted county, substituted or unsubstituted CrC3 decynyl, substituted or unsubstituted C^-Cu alkoxy, - 1 〇U 1Ί"' by -(Ari)rAru a substituent, a second substituent represented by N[(Ar2)b_Ar12][-(Ar3)c_Ar13](Ar4VN[-(Ar5)e-Ar15][-(Ar6)rAr16],^ a third substituent, at least one of \ to 1 to 12, is the third substituent; and the Aq to Ar6 groups in the first substituent to the third substituent are each independently substituted or unsubstituted Ci_CM alkyl (alky) ene gr〇up), 100111378 Form No. A0J0I Page 71 of 88 1003273214-0 201204728 A substituted or unsubstituted 〇2-(^30) alkenylene group, Once substituted or unsubstituted (: arylene D 〇 U group, once substituted or unsubstituted C - (: 9 „ 伸 aryl 0 o U (heteroarylene group); 呑The first substituent to the Ar, Ar, Ar, 1 1 12 13 Ar15 and Ar16 in the second substituent are each a hydrogen atom, a mono hydrogen atom, a halogen atom, a hydroxyl group, a cyano group, Substituted or unsubstituted C-C alkane 1 3 0 group, monosubstituted or unsubstituted c2-c3Q alkenyl group, substituted or unsubstituted C2-C3Q alkynyl group, substituted or unsubstituted [c Alkoxy 1 〇U, a substituted or unsubstituted C5-C3Q aryl group or a substituted or unsubstituted C3-C3{) heteroaryl group; a, b, c, e and f are each independently 〇 An integer of one to one; d is an integer from 0 to 10; and the 'V' group of 八 is the same or different from each other in the group of _(A)_Ar of the first substituent; 41* The "b" group of 2 is identical or different from each other in the _Ur2)b-Ar12 group of the second substituent; the "c" group of Ar is at the (~3) of the second substituent (;41 The '13 group is the same or different from each other, and the Δ, e, group is the same or different in the -(Ar)-Ar, ^ group 5 e 15 of the third substituent; the "f" group of Ar6 In the third substituent of ~( The Ar6)f-Ar16 groups are the same or different from each other. The condensed cyclic compound according to claim 1, wherein Ar_i to Αι*6 are each a substituted or unsubstituted c _c aryl- 5 14 ^ substituted or unsubstituted c: 3 -Ci4 heteroaryl. The condensed cyclic compound according to claim 1, wherein each of Ar to Are is a monophenyl group, a Ci_CM alkyl phenyl group, and a bis (Cl-ci 〇 alkyl) phenyl group. One (c6_Ci4 aryl) stretch phenyl, one two 1003273214-0 form bat number A0101 page 72 / 88 pages _ CU aryl) stretch phenyl, one stretch ° card ° carbazolylene group, one (^- (: 1 () alkyl extended carbazolyl, one (two (crC1 alkyl)) carbazolyl, a c6-c14 aryl extended carbazolyl, one (two (c6-ci4 aryl)), one stretch Fluorylene group, a {^-C^ alkylalkylene group, a dialkyl group), a (c6-c14 aryl) thiol group, a bis(C6_C14 aryl) group, a stretch Naphthylene group, one (:, -(:, „alkyl-naphthyl, one-two (Ci-Cm alkyl)-naphthyl, one (C6_C14 aryl)), one or two (C6_C14 aryl) An anthranyl group, an anthranylene group, an alkyl group, a bis ((: "(:: 〇 alkyl)) thiol group, a (c6-c14 aryl) thiol group, one or two (c6-c14 aryl) stretching base, one Pyridinylene group, monoalkyl pyridine 1 10 base, monodialkyl) pyridyl group, one (c6-c14 aryl) thiophene, one (two (C6-C14 aryl)) 11 ratio a bite base, a quinolinylene group, a (^-Ch-based quinolinyl group, a 1-2 (C^Cio alkyl) 啥 啥 基, a (C6-Ci4 aryl) 喧 喧 基, One (two (C6_C14 aryl)), benzoimidazolylene group, monoalkylbenzimidazolyl, mono-(C-Cin alkyl)benzimidazolyl, one (Ce- C aryl 1 1 u 6 14 )) Benzene 米 唾 唾 一 一 一 一 一 一 一 一 并 咪 咪 咪 咪 咪 咪 比 比 比 比 比 比 比 比 比 比 比 比 比 比 比 比 比 比 比 比 比 比 比 比 比 比 比 比 比 比 比 比 比 比丨❹院基伸β米° sit β bite base, one two (C丨-C) q base) stretch b m 嗤吼 bite base, one (C6_C14 aryl) stretch taste sit ° bite base, one two (C6-C14 aryl) stretching ° rice 嗤吼 base, an imidazopyrimidinylene group, a pyridyl imidazolyl group, a dialkyl) imidazolyl group, a form number A0101 page 73 / 88 pages i〇〇s 201204728 14 aryl) stretch "rice spray bite base or a three (W aryl) stretch scent base; as claimed in the scope of claim 1 of the condensed cyclic compound ' ', Λ 1 ] Ari 2 , Ari 3 , Ari 5 and Aru are each independently a hydrogen atom, a heavy gas atom, the halogen atom, the mesogenic group, the cyano group, a substituted or unsubstituted \-Cig alkyl group, a substituted or Unsubstituted c 2 1〇'^ A substituted or unsubstituted c2-ci() alkynyl group, a substituted or unsubstituted C plant C10 alkoxy group, substituted or unsubstituted (:5 - (: 14 aryl or once substituted or unsubstituted (: 3_(: 14 heteroaryl). The condensed cyclic compound according to claim 1, wherein Ar Ari2, Ari3, Ari5 and Ari6 are each independently a hydrogen atom, and the heavy hydrogen atom 'the halogen atom, the hydroxyl group, the cyano group' Methyl, ethyl, monopropyl, monobutyl, monopentyl 'monovinyl, monopropenyl, monobutenyl, monopentenyl, monoethylidene, monomethoxy, monoethoxy , a propoxy group, a monobutoxy group, a pentyloxy group, a phenyl group, a Ci_Cu alkylphenyl group, a di(Ci-Cu alkyl)phenyl group, a (C6-C14 aryl)phenyl group '1-2 (C6-C14 aryl) phenyl, carbazolyl group, —C—C1()alkylcarbazolyl, bis((^-ί:1()alkyl)carbazole a ce-cl4 arylcarbazolyl group, a bis(c6_Ci4 aryl)carbazolyl group, a fluorenyl group, an alkyl group, and a bis(\-(:1 〇院) base —(c—Caryl)diyl, —di(c-cb 14 6 14 aryl)diyl, naphthyl group′ —CC焓1 1 〇u ^naphthyl, one or two ( Q-c1 decyl)naphthyl, one (c6-c14 aryl)naphthyl, one or two (C6-C1) 4 aryl)naphthyl, an anthryl group, a 匸1 〇 〇 蒽, a one (C!-alkyl) fluorenyl, a (C^-C^ aryl) fluorenyl group , one or two (C6-C14 aryl) fluorenyl group, one η ratio bite base 1D0111378 1003273214-0 Form No. Α0101 Page 74 / Total 88 pages 201204728 (pyridinyl group), one extension than bite base, - than bite base, one Bis(qc^alkyl)pyridinyl, mono(crcu aryl)pyridinyl, di-(Cc-C1/t aryl)° ratio biting group, a 01 scare base (quinolinyl 0 14 Ο group)、一烷基喹啉基、一二((^-〇:1()烷基)喹啉 基、一(c6-c14芳基)喹啉基、一二(c6-c14芳基)喹啉基 、一笨並咪峻基(benzoimidazolyl group)、一(^-(^0 烧基苯並β米°坐基、一二烧基)笨並味*1坐基、一 (C6_C14芳基)笨並咪吐基、一二芳基)笨並味嗤 基、一咪嗤°比咬基(imidazopyridinyl group)、一 C^-Cw院基味••坐°比咬基、一二(C^-C^炫基)味嗤>»比咬基 、一(C6_C14芳基)味。坐°比咬基、一二(C6_C14芳基)味峻 0比咬基、一味0坐,咬基(imidazopyrimidinyl group) 、一[厂C1Q烧基咪峻》密咬基、一二院基)咪吐 啶基、一((^-(:丨4芳基)咪唑嘧啶基或一二(ce-ci4芳基) 米唆喊咬基。 6 .如申請專利範圍第1項所述之縮合環狀化合物,其中Arn 、Ari2、Ari3、Ari5以及Aru係各獨自由以下的式4八至 4 G之任何之一所表示:Group), monoalkylquinolinyl, mono-((^-〇:1()alkyl)quinolinyl, mono(c6-c14 aryl)quinolinyl, mono-(c6-c14 aryl) quin Benzyl group, benzoimidazolyl group, one (^-(^0 benzoyl benzo-β-methane, one or two base) stupid and taste *1 sitting base, one (C6_C14 aryl) Stupid and imiline, one or two aryl) stupid and miso base, one imi 比 im im im im im im im im im im im im im im im im im im im im im im im im im im im im im im im im im im im im im im im im im im im -C^Hyun base) miso>> than bite base, one (C6_C14 aryl) taste. Sitting at a bite than base, one or two (C6_C14 aryl) tastes jun 0 than bite base, one tastes 0 sitting, bite base ( Imidazopyrimidinyl group), a [factory C1Q 烧基米峻] 密基基,一二院基)imiridinyl, one ((^-(:丨4 aryl)imidazolylpyridyl or one or two (ce-ci4fang) 6. The condensed cyclic compound according to claim 1, wherein Arn, Ari2, Ari3, Ari5, and Aru are each independently of any of the following formulas 4-8 to 4G. One said: 式4AFormula 4A 式4BEquation 4B (Zl)p(Zl)p *(2ι)ρ 式4C*(2ι)ρ 4C 式4G 表單編號A0101 100111378 第75頁/共88頁 1003273214-0 201204728 以及 其中,在式4A至4G中: 1 Z2 Zu以及Z12係各獨自子、―重氫原子 C10燒氧基或-C6-Cu芳基,p及 以及*為一與Ar,、Ar„、Ar, Q係各獨自為一 1至8的整數, 、入^或八、的鍵結位置。 L 11 如申请專利範圍第1項所述之縮合環狀化合物,其中Ar Ar12、Ari3、Ar15以及Ar〗6係各獨自由以下的式5八至 5E之任何之—所表示:Form 4G Form No. A0101 100111378 Page 75/88 Page 1003273214-0 201204728 and therein, in Formulas 4A to 4G: 1 Z2 Zu and Z12 are each alone, "heavy hydrogen atom C10 alkoxy or -C6-Cu The aryl group, p and * are a combination with Ar, Ar, Ar, and Q, each of which is an integer of 1 to 8, and a bonding position of ^ or VIII. L 11 The condensed cyclic compound, wherein each of Ar Ar12, Ari3, Ar15 and Ar 6 is represented by any of the following formulas 5-8 to 5E: 式5BEquation 5B 式5C 式5AEquation 5C Equation 5A 以及 其中,式5A至5E中,*為一與a A a a或八 1 Z J 5 6 的鐽結位置。 .如申請專利範圍第l項所述之縮合環狀化合物,其中: a、b、c、e及f係各獨自為〇、1、2或3 ’以及d為1、2或And wherein, in the formulas 5A to 5E, * is a kneading position with a A a a or 八 1 Z J 5 6 . The condensed cyclic compound of claim 1, wherein: a, b, c, e, and f are each independently 〇, 1, 2, or 3' and d is 1, 2 or .如申請專利範圍第1項所述之縮合環狀化合物,其中該第 —取代基以及該第三取代基的 ~N[_(Ar5)e_Ari5]卜(Ar6)f-Ar16]係各獨自由以下式6A 100111378 表單編號A0101 第76頁/共88頁 1003273214-0 201204728The condensed cyclic compound according to claim 1, wherein the first substituent and the third substituent -N[_(Ar5)e_Ari5] (Ar6)f-Ar16 are each independently The following formula 6A 100111378 Form No. A0101 Page 76 / Total 88 Page 1003273214-0 201204728 至6K之任何之一者所表示:To any one of 6K: 式6ΑEquation 6Α 式6ΒEquation 6Β 以及as well as 其中,在式6Α至6Κ中: 21至24以及Ζη至Zu係各獨自為一氫原子、一重氫原子、 一(^-(:1()烧基、一c1()烧氧基或 一芳基,p、q、r以及s係各獨自為一 1至8的整數 b 14 ,以及*為一與Ar4或與一構成式1之一主幹的環原子的鍵 結位置。Wherein, in the formula 6Α to 6Κ: 21 to 24 and Ζη to Zu each are each a hydrogen atom, a heavy hydrogen atom, a (^-(:1() alkyl group, a c1() alkoxy group or a aryl group) The radicals, p, q, r and s are each an integer b 14 of from 1 to 8, and * is a bonding position with Ar4 or a ring atom of one of the constituents of Formula 1. 10 .如申請專利範圍第1項所述之縮合環狀化合物,其中^至 Ri2係各獨自為該氫原子、該重氫原子、該齒素原子、該 羥基、該氰基、該第一取代基、該第二取代基或該第三取 代基;na”在該第一取代基為0 ; "b"及"c"在該第二取代 基各為0或1 ; d在該第三取代基為1或2,以及"e"和"f” 在該第三取代基係各獨自為0或1 ;在該第一取代基至該第 三取代基之中的△1*9至41'(!係各獨自為一經取代或未經取代 Z b 的k-Cu伸芳基或是一經取代或未經取代的(:,-(:,,雜伸芳 b 14 3 14 基;以及在該第一取代基至該第三取代基之中的Arn、 Ari2、A' Q、Ar, κ及Ar, e係各獨自為該氫原子、該重氫原 1 ό 15 1 〇 100111378 表單編號Α0101 第77頁/共88頁 1003273214-0 201204728 子、該鹵素原子、該羥基、該氰基、一經取代或未經取代 院基、一經取代或未經取代的c -c烯基、一經 2 10 土 取代或未經取代的c2-ci()炔基 '一經取代或未經取代的 Ci~C1G烷氧基、一經取代或未經取代的C5-Cu芳基或一經 取代或未經取代的C _ci/t雜芳基。 〇 14 11 .如申請專利範圍第丨項所述之縮合環狀化合物其中h至 Ri2係各獨自為該氫原子、該重氫原子、該齒素原子、該 羥基、該氰基、該第一取代基、該第二取代基或該第三取 代基;"a"在該第一取代基為〇 ; "b"及”c"在該第二取代 基各為0或1 ; d在該第三取代基為1或2,以及” e”和” 在該第三取代基係各獨自為〇或丨;在該第一取代基至該第 三取代基之中的△1*2至八1'6係各獨自為一伸苯基、一 C厂Cio炫基伸笨基 '一二(c厂烧基)伸苯基、一 (Cg-Cu芳基)伸苯基、一二芳基)伸苯基、一伸 咔唑基、一(:厂(:1()烷基伸咔唑基、一二(Ci_Cm烷基)伸 咔唑基、一c6_c14芳基伸咔唑基、一二(C6-C14芳基)伸 咔唑基、一伸篥基、一c c烷基伸苐基、一二(c _c 1 i u 110 烷基)伸第基、一(C -C芳基)伸第基、一二(c c芳 ^ 6 14 基)伸第基、一伸萘基、一烷基伸萘基、一二 (C1_C10烷基)伸萘基、一(crc14芳基)伸萘基、一二 (C6_C14芳基)伸萘基、一伸蒽基、一 烷基伸蒽基 、一二(¢^-%院基)伸蒽基、一(c6_ci4芳基)伸蒽基、 一二(c6-c14芳基)伸蒽基、一伸吡啶基、一烷基 伸吡啶基、一二(c^-Cm烷基)伸吡啶基、一(c6-c14芳基 )伸°比咬基、一一(Cg-方基)伸°比咬基、一伸啥琳基、 烷基伸喹啉基、一二(CrC1G烷基)伸喹啉基、 100111378 表單編號A0101 第78頁/共88頁 1003273214-0 201204728 Ο ο 一(CrCi4芳基)伸喹啉基 '一二(C6-C14芳基)伸喹啉基 、一伸苯並咪唑基、一Ci-C1Q烷基伸苯並咪唑基、一二 (Ci-Cig烷基)伸苯並咪唑基、一(C6-CH芳基)伸苯並咪 唑基、一二(c6_c14芳基)伸苯並咪唑基、一伸咪唑吡啶 基、一C1_C10烷基伸咪唑吡啶基、一二(CrC1Q烷基)伸 咪唑吡啶基、一(crcl4芳基)伸咪唑吡啶基、一二 (C6-Cu芳基)伸咪唑吡啶基、一伸咪唑嘧啶基、一 C^-Cio烷基伸咪唑嘧啶基、一二(c厂烷基)伸咪唑嘧 啶基、一(C6_C〗4芳基)伸咪唑嘧啶基或一二(c -C芳A 6 14^·^ )伸咪唑嘧啶基;在該第一取代基至該第三取代基之中的 Aril、Ari2、Ari3、Ar15以及訐16係各獨自為該氫原子、 該重氫原子、該鹵素原子、該羥基、該氰基、—甲基― 乙基、一丙基、一丁基、一戊基、一乙烯基、一丙烯基、 一丁烯基、一戊烯基、一乙醯基、一甲氧基、一乙氧基、 一丙氧基、一丁氧基、一戊氧基、一苯基、一 Ci_C烷基 苯基、一二(CrCi〇烷基)苯基、一(C6-C14芳基)笨基、 一二(C6_C14芳基)笨基、一咔唑基、一烷基咔唑 基、一二(Cl-C1()烷基)咔唑基、一c6-c14芳基咔唑基、 一二(CrCi4芳基)咔唑基、一苐基、一、-(:1〇烷基第基 、一二(crc1〇烧基)第基、一(c6-c14芳基)第基、一二 (C6_C14芳基)蕹基、一萘基、一 CrC10烷基萘基、一二 100111378 炫基)萘基、一(C6_C14芳基)萘基、—二(c 一ς 6 14 芳基)萘基、一蒽基、一〔10炫>基蒽基、一二(c 烧基)蒽基、一(C6-C14芳基)葱基、一二(C6-Cl4芳基)蒽 基、一吡啶基、一炫基》比啶基、一二烧基 )吡啶基、一(C6_C14芳基)吡啶基、一二(CrC14芳基)吡 * 單編號 A0101 ”9 頁/共 88 1 1003273214-0 201204728 咬基、一啥琳基、一c _ 一 Ci—C10烷基喹啉基、 基)喹琳基、一(c -C 啥琳基、一苯並咪嗤基、 坑巷 暴、一二(Ci_Ci〇燒 芳基)喹啉基、一二(ce-cl4芳基〕 、一 C^-CiG^基苯並咪唑基、一二 芳基) (Ci_Cio烷基)笨並咪唑基、一(C6-C14芳基)苯並咪唑基 、一二(C6-C14芳基)苯並咪唑基、一咪唑吡啶基、一 CrC1Q烷基咪唑吡啶基、一二(C1_C1Q烷基)咪唑吡啶基 、一(C6_C14芳基)咪唑°比咬基、一二(C6_c14芳基)咪唑 吡啶基、一咪唑嘧啶基、一Ci_Cifl烷基咪唑嘧啶基、一二 (Ci_C1()烧基)咪°坐哺咬基'一(C6-C14芳基)°米唾喷咬基 或一一(C6-C14芳基米峻嘴咬基。10. The condensed cyclic compound according to claim 1, wherein each of the two to the Ri2 is independently the hydrogen atom, the heavy hydrogen atom, the dentate atom, the hydroxyl group, the cyano group, the first substitution a second substituent or the third substituent; na" is 0 in the first substituent; "b" and "c" in the second substituent each being 0 or 1; d in the The trisubstituted group is 1 or 2, and "e" and "f" are each independently 0 or 1 in the third substituent; Δ1* among the first substituent to the third substituent 9 to 41' (! are each a k-Cu extended aryl group which is substituted or unsubstituted Z b or a substituted or unsubstituted (:, -(:,, hetero-aromatic b 14 3 14 group) And Arn, Ari2, A'Q, Ar, κ, and Ar, among the first substituent to the third substituent, each of which is the hydrogen atom alone, the heavy hydrogen source 1 ό 15 1 〇100111378 Form No. 1010101 Page 77/88 Page 1003273214-0 201204728 Subunit, the halogen atom, the hydroxyl group, the cyano group, a substituted or unsubstituted compound, a substituted or unsubstituted c-cene a substituted or unsubstituted c2-ci() alkynyl group - a substituted or unsubstituted Ci~C1G alkoxy group, a substituted or unsubstituted C5-Cu aryl group or a substituted or unsubstituted The condensed cyclic compound according to the above-mentioned claim, wherein each of h to Ri2 is independently the hydrogen atom, the heavy hydrogen atom, and the dentate atom. , the hydroxyl group, the cyano group, the first substituent, the second substituent or the third substituent; "a" in the first substituent is 〇; "b" and "c" The disubstituted groups are each 0 or 1; d is 1 or 2 in the third substituent, and "e" and "in the third substituent are each independently oxime or fluorene; in the first substituent to the first Among the three substituents, Δ1*2 to 八1'6 are each a phenyl group, a C plant Cio 炫 base, a bis-c (c plant base) phenyl, one (Cg-Cu fang) a phenyl group, a diaryl group, a phenyl group, a carbazolyl group, a (: 1 (1) alkyl carbazole group, a bis (Ci_Cm alkyl) carbazole group, a c6_c14 Base carbazole group, a bis(C6-C14 aryl) carbazolyl group, a hydrazine group, a cc alkyl group, a bis(c _c 1 iu 110 alkyl group), a (C-C aryl) group Base, one or two (cc aryl 6 14 base) extended base, an extended naphthyl group, a monoalkylnaphthyl group, a di(C1_C10 alkyl) anthranyl group, a (crc14 aryl) anthranyl group, a two ( C6_C14 aryl) anthranyl, an exomethyl, monoalkyl fluorenyl, a hydrazine, a (c6_ci4 aryl) fluorenyl group, a bis(c6-c14 aryl group) a thiol group, a pyridine group, a monoalkyl pyridyl group, a bis(c^-Cm alkyl) pyridine group, a (c6-c14 aryl group) stretching ratio, a one-to-one (Cg-square group) ) ° ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( Aryl) quinolinyl '-di(C6-C14 aryl) quinolinyl, benzoimidazolyl, a Ci-C1Q alkyl-benzimidazolyl, a di-(Ci-Cig alkyl) benzene Imidazolyl, mono(C6-CH aryl) extension Imidazolyl, bis(c6_c14 aryl)benzimidazolyl, an imidazolium pyridyl, a C1_C10 alkyl extended imidazolium, a di(CrC1Q alkyl) imidazolidine, a (crcl4 aryl) exionazole Pyridyl, mono-(C6-Cu aryl) imidazolidine pyridyl, imidazolidinyl, mono-C--Cio alkyl imidazolyl pyridyl, mono-(c-alkyl)-imidazolidine, one (C6_C) 4 aryl) an imidazolyl pyridyl or a di-(c-C aryl A 6 14^·^) an imidazolidine group; Aril, Ari2, Ari3, Ar15 among the first substituent to the third substituent And the 讦16 series are each independently a hydrogen atom, the heavy hydrogen atom, the halogen atom, the hydroxyl group, the cyano group, the methyl group, the ethyl group, the monopropyl group, the monobutyl group, the monopentyl group, the monovinyl group, a propylene group, a butenyl group, a pentenyl group, an ethyl group, a monomethoxy group, an ethoxy group, a propoxy group, a monobutoxy group, a pentyloxy group, a phenyl group, a Ci_C Alkylphenyl, bis(CrCi decyl)phenyl, mono(C6-C14 aryl)phenyl, bis(C6-C14 aryl)phenyl, monooxazolyl, monoalkyl Azyl, bis(Cl-C1()alkyl)carbazolyl, a c6-c14 arylcarbazolyl, a bis(CrCi4 aryl)carbazolyl, a fluorenyl, a, -(:1〇 Alkyl, di(crc1)alkyl, a (c6-c14 aryl) group, a di(C6-C14 aryl) fluorenyl group, a naphthyl group, a CrC10 alkylnaphthyl group, a second 100111378 Hyunyl)naphthyl, mono(C6_C14 aryl)naphthyl, -di(c-indenyl)6-aryl)naphthyl, fluorenyl, hydrazone, hydrazino a fluorenyl group, a (C6-C14 aryl) onion group, a bis(C6-Cl4 aryl) fluorenyl group, a pyridyl group, a fluorenyl group, a pyridyl group, a pyridyl group, a pyridyl group, a (C6_C14) Aryl)pyridyl, bis(CrC14 aryl)pyridyl*, single number A0101 ”9 pages/total 88 1 1003273214-0 201204728 bite base, monoterpenoid, a c _ a Ci—C10 alkyl quinolyl group, a quinolinyl group, a (c-C cylinyl group, a benzoindole group, a pit lane, a 1-2 (Ci_Ci aryl group) quinolyl group, a bis (ce-cl4 aryl group), a C^-CiG^-benzimidazolyl, mono-diaryl) (Ci_Cioalkyl) , (C6-C14 aryl) benzimidazolyl, mono-(C6-C14 aryl) benzimidazolyl, monoimidazolidinyl, mono-CrC1Q alkylimidazolidinyl, mono-(C1_C1Q alkyl)imidazole Pyridyl, mono(C6_C14 aryl)imidazole ° bite group, mono-(C6_c14 aryl)imidazolidinyl, monoimidazolidinyl, a Ci_Cifl alkylimidazopyrimidinyl, mono-(Ci_C1()alkyl) Sit and feed the base 'a (C6-C14 aryl) ° meter squirt bite or one (C6-C14 aryl rice squirt bite base. 12 .如申請專利範圍第1項所述之縮合環狀化合物,其中由式1 所表示的該縮合環狀化合物係由以下的式2a至2d之任何 之一者所表一 100111378 表單編號A010112. The condensed cyclic compound according to claim 1, wherein the condensed cyclic compound represented by Formula 1 is represented by any one of the following Formulas 2a to 2d. 100111378 Form No. A0101 式2d 第80頁/共88頁 1003273214-0 201204728 其中,在式2a至式2d : 係各獨自為該氫原子、該重氫原子、該鹵素原子 、該羧基、該氰基、該經取代或未經取代的(:厂'^烷基、 该绥取代或未經取代的C2~C3Q烯基、該經取代或未經取代 的Cf C30炔基、該經取代或未經取代的(:厂(:3()烷氧基、該 第一取代基、該第二取代基或該第三取代基; 該第〆取代基至該第三取代基中的係各獨自為該 經取代或未經取代的(:广(:3()伸烷基、該經取代或未經取代 Ο 的匸2<3〇伸烯基、該經取代或未經取代的C5_C3〇伸芳基、 該經取代或未經取代的c3_C3()雜伸芳基; 該第一取代基至該第三取代基中的A Ar Ar 、 1 i 1L 13 ❹ Αι-丨5以及Αι*ιβ係各獨自為該氫原子、該重氫原子、該鹵素 原子、該羥基、該氰基、該經取代或未經取代的c 烷 基:該經取代或未經取代的q、。烯基、該經取經 取代的炔基、該經取代或未經取代的Crc烷氧基 、該經取代或未經取代的VS。芳基或該經二:未經: 代的C3~C30雜芳基; a、b、c、e及f係各獨自為〇至1〇之一整數; d為〇至10之一整數;以及 A的"3"群在該第一取代基的-(Ai^-A、的基團中係 彼此相同或不同;Ar2的"b"群在該第二取代基的 -(ArPb-A、2基團中係彼此相同或不同;Ar的、"群在 該第二取代基的-(^3)^13基團中係彼此相同或不同 ;Ar5的"e"群在該第三取代基的〜(Aye'#團中係 彼此相同或不同;Ar6的'T群在該第三取代基的 -(Are:)rAr16基團中係彼此相同或不同。 100111378 1003273214-0 表單编號A〇1〇1 帛81頁/共88頁 201204728 13 .如申請專利範圍第12項所述之縮合環狀化合物,其中: Ar4包含一伸苯基、一c厂ClQ烷基伸苯基、一二(c 1 10 烷基)伸苯基、一(C -C芳基)伸苯基、一二(c _c韦 1 q 6 14^ 基)伸苯基、一伸咔唑基、一c -(:1(^烷基伸咔唑基、_ _ (Ci-Cio烷基)伸咔唑基、一C6-Cu芳基伸咔唑基、—二 (CrCi4芳基)伸咔唑基、一伸第基、一(:厂(:1()烷基伸苐 基、一二(c厂c1〇院基)伸第基、一(c6-c14芳基)伸第基 、一二(Crh4芳基)伸蕹基、一伸萘基 '一(:厂(:1{)烷基 伸萘基、—二(CrCiQ烷基)伸萘基、一(C6-Cl4芳基)伸 萘基、一二(C6_C14芳基)伸萘基、一伸蒽基、一c广C 烷基伸蒽基、一二((:厂(:1()烷基)伸蒽基、一(C6_C芳基 )伸蒽基及一二(CrCl4芳基)伸蒽基之至少之一者;以及 d為1、2或3。 14 .如申請專利範圍第1項所述之縮合環狀化合物其中該第 二取代基以及該第三取代基的 4[_Ur5)e-Ar15][-(Ar6)厂ΑΓΐ6]係各獨自由以下式 6A 至6K之任何之一所表示: 100111378Formula 2d Page 80 / 88 pages 1003273214-0 201204728 wherein, in Formula 2a to Formula 2d: each is a hydrogen atom, the heavy hydrogen atom, the halogen atom, the carboxyl group, the cyano group, the substituted or Unsubstituted (: plant's alkyl group, the oxime substituted or unsubstituted C2~C3Q alkenyl group, the substituted or unsubstituted Cf C30 alkynyl group, the substituted or unsubstituted (: plant (: 3 () alkoxy group, the first substituent, the second substituent or the third substituent; the substituents in the third substituent to the third substituent are each independently substituted or not Substituted (: broad (:3()alkyl), substituted or unsubstituted anthracene 2<3〇 extended alkenyl, substituted or unsubstituted C5_C3〇 extended aryl, the substituted or An unsubstituted c3_C3() heteroaryl group; the first substituent to the third substituent, A Ar Ar , 1 i 1L 13 ❹ Αι-丨5, and Αι*ιβ are each independently a hydrogen atom, The heavy hydrogen atom, the halogen atom, the hydroxyl group, the cyano group, the substituted or unsubstituted c alkyl group: the substituted or unsubstituted q, alkenyl group, the a substituted alkynyl group, the substituted or unsubstituted Crc alkoxy group, the substituted or unsubstituted VS.aryl group or the second: unsubstituted C3~C30 heteroaryl group; b, c, e, and f are each an integer of 〇 to 1〇; d is an integer from 〇 to 10; and the "3" of A is in the first substituent -(Ai^-A, The groups in the group are the same or different from each other; the "b" group of Ar2 is the same or different in the ArPb-A, 2 group of the second substituent; the Ar, " group is in the second The -(^3)^13 groups of the substituent are the same or different from each other; the "e" group of Ar5 is the same or different from each other in the ~(Aye'# group of the third substituent; 'T of the Ar6 The group is identical or different from each other in the -(Are:)rAr16 group of the third substituent. 100111378 1003273214-0 Form No. A〇1〇1 帛81 pages/ Total 88 pages 201204728 13 . The condensed cyclic compound according to the item 12, wherein: Ar4 comprises a phenyl group, a C plant, a CQ alkyl phenyl group, a bis(c 1 10 alkyl) phenyl group, and a (C-C aryl) benzene group. Base, one or two (c _c Wei 1 q 6 14^ base) phenyl, carbazolyl, c-(:1(^alkyl carbazolyl, _ _ (Ci-Cio alkyl) carbazolyl, a C6-Cu aryl extension Carbazolyl, bis(CrCi4 aryl) extended carbazole, one extended base, one (: factory (: 1 () alkyl thiol base, one two (c plant c1 〇院 base) stretched base, one ( C6-c14 aryl) extended base, one (two (Crh4 aryl)) fluorenyl group, one stretched naphthyl 'one (: plant (: 1 {) alkyl-naphthyl, - bis(CrCiQ alkyl) anthracenyl, a (C6-Cl4 aryl) anthranyl group, a bis(C6_C14 aryl) anthranyl group, a fluorenyl group, a c-C alkyl group, a bis ((:: (1) alkyl) At least one of a thiol group, a (C6_C aryl) fluorenyl group and a bis(CrCl4 aryl) fluorene group; and d is 1, 2 or 3. 14. The condensed cyclic compound according to claim 1, wherein the second substituent and the third substituent 4[_Ur5)e-Ar15][-(Ar6) ΑΓΐ6] are each independently Expressed by any of Equations 6A through 6K: 100111378 表單編號A0101 第82頁/共88頁 1003273214-0 201204728 在式6A至6K中: /,至?,以及Ζη至Ζ,,係各獨自為一氫原子、一重氫原子、 1 4 11 14 一 c i - C丨^炫基、一 C ^ - c i ^院氧基或 一C6-C14芳基,p、q、r以及s係各獨自為一 1至8的整數 ,以及*為一與A。或與一構成式1的一主幹之環原子的鍵 4 結位置。 . 15 .如申請專利範圍第1項所述之縮合環狀化合物,其中由式1 所表示的該縮合環狀化合物係由以下式3a至3e之任何之Form No. A0101 Page 82 of 88 1003273214-0 201204728 In Equations 6A to 6K: /, to? And Ζη to Ζ, each of which is a hydrogen atom alone, a heavy hydrogen atom, 1 4 11 14 a ci - C 丨 炫 炫, a C ^ - ci ^ alkoxy or a C 6 - C 14 aryl, p The q, r, and s are each an integer from 1 to 8, and * is one and A. Or a bond junction with a ring atom of a backbone of formula 1. The condensed cyclic compound according to claim 1, wherein the condensed cyclic compound represented by Formula 1 is any one of the following Formulas 3a to 3e 式3c 其中,在式3a至3e中: 1^至1?12係各獨自為該氫原子、該重氫原子、該鹵素原子 、該羥基、該氰基 '該經取代或未經取代的烷基、 1 〇 U 該經取代或未經取代的(:2-(:3()烯基、該經取代或未經取代 的(:2-(:3()炔基、該經取代或未經取代的(^-C^烷氧基、該 第一取代基、該第二取代基或該第三取代基; 100111378 表單編號A0101 第83頁/共88頁 1003273214-0 201204728 该第—取代基至該第三取代基中的Ar〗至A%係各獨自為該 經取代或未經取代的Ci_c3()伸烷基、該經取代或未經取代 的CrC3G伸烯基、該經取代或未經取代的C5-C3Q伸芳基或 是該經取代或未經取代的C3-C3()雜伸芳基; Αϊπ、Ari2、Ar13、紅15以及八1*16係各獨自為該氫原子、 該重氫原子、該A素原子、該羥基、該氰基、該經取代或 未經取代的烷基、該經取代或未經取代的c2_c烯 基、該經取代或未經取代的CrCM炔基、該經取代或=經 取代的Ci~C3〇烷氧基、該經取代或未經取代的C5-C芳基 或該經取代或未經取代的(;c雜芳基; ° ο 〇 0 a、b、c ' e及f係各獨自為〇至1〇之一整數; d為0至1〇之—整數;以及 八1'1的、"群在該第一取代基的_(訐】)厂紅11的基團中係 彼此相同或不同;A、的"b"群在該第二取代基的 (Ar2)b Ar!2基團中係彼此相同或不同;Aj^的“c”群 在該第二取代基的-(紅3)厂虹13基團中係彼此相同或不 同;A%的"e"群在該第三取代基的_(Ar5)e_Ar】5基團中 係彼此相同或不同;A%的” f"群在該第三取代基的 一(ΑΓ6)厂Ai*16基團中係彼此相同或不同。 16 .如申請專利範圍第15項所述之縮合環狀化合物其中: Ar4包含一伸苯基、一Ci_Cu烷基伸苯基、一二(c _c 1 1〇 100111378 烷基)伸笨基、一(C^-C!4芳基)伸苯基、一二(CfC"芳 基)伸苯基、一伸咔唑基、一crCM烷基伸咔唑基、二二 (C】-C]0烷基)伸咔唑基、一c6—芳基伸咔唑基、—二 (c6-c14芳基)伸吟唆基、一伸第基、一c「(^炫基伸第 基、一二(crc1〇烧基)伸第基、一(c6-c14芳基)伸苐基 表單編號A0101 第84頁/共88頁 1003273214-0 201204728 、一二(C6-C14芳基)伸蕗基、一伸萘基、一Ci_Ci0烷基 伸萘基、一二(CrCu烷基)伸萘基、一(C6-C14芳基)伸 萘基、一二(C6-C14芳基)伸萘基、一伸蒽基、一 烷基伸蒽基、一二(Crc10烷基)伸蒽基、一(C6-C14芳基 )伸葱基及一二(C6-C14芳基)伸蒽基之至少之一者;以及 d為1、2或3 〇 17 .如申請專利範圍第15項所述之縮合環狀化合物其中該第 二取代基以及該第三取代基的Wherein, in the formulae 3a to 3e: 1^ to 1?12 are each independently a hydrogen atom, the heavy hydrogen atom, the halogen atom, the hydroxyl group, the cyano group, the substituted or unsubstituted alkane a substituted or unsubstituted (:2-(:3() alkenyl group, the substituted or unsubstituted (:2-(:3)) alkynyl group, the substituted or unsubstituted Substituted (^-C^alkoxy, the first substituent, the second substituent or the third substituent; 100111378 Form No. A0101 Page 83 of 88 Page 1003273214-0 201204728 The first substituent Ar to A% in the third substituent are each independently substituted or unsubstituted Ci_c3() alkyl, the substituted or unsubstituted CrC3G extended alkenyl group, the substituted or unsubstituted a substituted C5-C3Q extended aryl group or the substituted or unsubstituted C3-C3() heteroaryl group; Αϊπ, Ari2, Ar13, red 15 and VIII 1*16 are each independently a hydrogen atom, The heavy hydrogen atom, the A atom, the hydroxyl group, the cyano group, the substituted or unsubstituted alkyl group, the substituted or unsubstituted c2_c alkenyl group, the substituted or unsubstituted C rCM alkynyl, the substituted or = substituted Ci~C3 nonyloxy, the substituted or unsubstituted C5-C aryl or the substituted or unsubstituted (;c heteroaryl; ο 〇0 a, b, c ' e and f are each an integer of 〇 to 1〇; d is 0 to 1〇—an integer; and 八1'1, " group is at the first substituent _(讦)) The group of plant red 11 is the same or different from each other; the group of A, "b" is identical or different from each other in the (Ar2)b Ar!2 group of the second substituent; The "c" group of Aj^ is identical or different from each other in the -(Red 3) plant rainbow 13 group of the second substituent; A% of the "e" group is at the third substituent _(Ar5) The e_Ar]5 groups are the same or different from each other; the A% "f" group is identical or different from each other in the Ai*16 group of the first (ΑΓ6) plant of the third substituent. The condensed cyclic compound according to item 15, wherein: Ar4 comprises a phenyl group, a Ci_Cu alkyl group, a phenyl group (c _c 1 1 〇 100111378 alkyl group), and a (C^-C! 4 aryl group). ) phenyl, one or two (CfC " aryl) Phenyl, benzoxazole, acrCM alkyl carbazolyl, di-(C)-C]0 alkyl) oxazolyl, a c6-aryl carbazolyl, -di(c6-c14 aryl) ) 吟唆 base, one extension base, one c" (^ 炫 base extension base, one two (crc1 〇 〇 base) extension base, one (c6-c14 aryl) extension base form number A0101 page 84 / 88 pages 1003273214-0 201204728, one (two (C6-C14 aryl)), a naphthyl group, a Ci_Ci0 alkylnaphthyl group, a bis(CrCu alkyl) anthranyl group, a (C6-C14 aryl group) An anthranyl group, a di-(C6-C14 aryl) anthranyl group, a fluorenyl group, a monoalkyl fluorenyl group, a bis(Crc10 alkyl) hydrazino group, a (C6-C14 aryl group) And at least one of a C2-C14 aryl group; and d is 1, 2 or 3 〇17. The condensed cyclic compound of claim 15 wherein the second substituent And the third substituent 以(^1'5\"^1'15][-(八1'6)厂八1:16]係各獨自由以下式6八 至6K之任何之一所表示:The (^1'5\"^1'15][-(eight 1'6) factory VIII:16] is represented by any one of the following formulas 6-8 to 6K: 式讯 ,以及 在式6A至6K中: z,z4以及zn至z14係各獨自為—氫原子、—重氫原子、 一Ci_Cig炫基、一Ci-C1G烧氧基或 一C「C14芳基,p、q、r以及s係各獨自為—】至8的整數 ’以及*為-與、或與-構成式W一主幹之環原子的鍵 結位置。 18 .一種有機發光裝置,包含: 100111378 表單編號A0101 第85頁/共88頁 1003273214-0 201204728 —第一電極, 一第二電極,係相對於該第—電極,以及 -介於該第一電極與該第二電極之第一層,該第一層係包 含申請專利範圍第1項的該縮合環狀化合物。 19 .如申请專利範圍第18項所述之有機發光裝置其中該第一 層包含-電洞注入層、一電洞傳輸層、一具有電洞注入功 能及電洞傳輸功能兩者的功能層、一發射層、一電子傳輸 層以及一電子注入層之至少之一者。 2〇 .如申清專利範圍第18項所述之有機發光裝i,更進-歩包 含:一電洞注入層、一電洞傳輸層、一具有電洞注入功能 及電洞傳輸功能兩者的功能層、一發射層、一電洞阻擋層 電子傳輸層以及一電子注入層之至少之一者介於該第 —電極與該第二電極之間。 21 .如申請專利範圍第2〇項所述之有機發光裝置其中該電洞 /主入層、該電洞傳輸層或該功能層之至少之一者更包含一 電%產生材料(charge-generating material)。 22 .如申請專利範圍第2〇項所述之有機發光裝置其中該發射 層包含一主劑及一掺雜劑,其中該摻雜劑為一螢光摻雜劑 或一墙光摻雜劑。 23 ·如申請專利範圍第22項所述之有機發光裝置,其中該磷光 摻雜劑為一包含銀、鉑、蛾 '鍊、欽、錯以及給之至少一 者之有機金屬複合物。 24 . 如申請專利範圍第20項所述之有機發光裝置,其中該電子 輸入層包含一電子傳輪有機材料及一含金屬材料 (metal-containing material) 〇 100111378 25 . 如申清專利範圍第24項所述之有機發光裝置,其中該含金 表單編號A0101 第86頁/共88頁 1003273214-0 201204728 屬材料包含一經複合物。 26 . 如申請專利範圍第18項所述之有機發光裝置,其中該第一 層係一電洞注入層、一電洞傳輸層或一具有電洞注入功能 及電洞傳輸功能兩者的功能層,且更進一歩包含一電荷產 生材料。 27 . 如申請專利範圍第18項所述之有機發光裝置,其中該第一 層為一發射層,且更包令—鱗光摻雜劑。 Ο C) 100111378 表單編號A0101 第87頁/共88頁 1003273214-0In the formulas, and in the formulae 6A to 6K: z, z4 and zn to z14 are each independently a hydrogen atom, a heavy hydrogen atom, a Ci_Cig dalyl group, a Ci-C1G alkoxy group or a C "C14 aryl group". , p, q, r, and s are each an integer - to an integer of 8 and * is - and or or - a bonding position of a ring atom constituting the main axis of the formula W. 18. An organic light-emitting device comprising: 100111378 Form No. A0101, page 85/88, 1003273214-0 201204728 - a first electrode, a second electrode, relative to the first electrode, and - a first layer between the first electrode and the second electrode The first layer includes the condensed cyclic compound of claim 1, wherein the first layer comprises a hole injection layer and a hole. The transmission layer, a functional layer having both a hole injection function and a hole transmission function, at least one of an emission layer, an electron transport layer, and an electron injection layer. 2〇. The organic light-emitting device i, further-incorporating comprises: a hole injection At least one of a layer, a hole transport layer, a functional layer having both a hole injection function and a hole transfer function, an emission layer, a hole barrier layer electron transport layer, and an electron injection layer An organic light-emitting device according to the second aspect of the invention, wherein the hole/main entrance layer, the hole transport layer or the functional layer is at least one of The organic light-emitting device of claim 2, wherein the emissive layer comprises a main agent and a dopant, wherein the dopant is A phosphorescent dopant or a wall light dopant. The organic light-emitting device of claim 22, wherein the phosphorescent dopant is a silver, platinum, moth' chain, And an organic light-emitting device according to claim 20, wherein the electron input layer comprises an electron-transporting organic material and a metal-containing material. ) 〇100 The invention relates to an organic light-emitting device according to claim 24, wherein the gold-containing form number A0101 page 86/88 pages 1003273214-0 201204728 belongs to a material comprising a composite. 26 . The organic light-emitting device of claim 18, wherein the first layer is a hole injection layer, a hole transmission layer or a functional layer having both a hole injection function and a hole transmission function, and further includes a layer Charge generating material. 27. The organic light-emitting device of claim 18, wherein the first layer is an emissive layer and further comprises a scale-emitting dopant. Ο C) 100111378 Form No. A0101 Page 87 of 88 1003273214-0
TW100111378A 2010-04-01 2011-03-31 Condensed-cyclic compound and organic light-emitting device including the same TWI491611B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR20100029992 2010-04-01
KR1020110028212A KR101328976B1 (en) 2010-04-01 2011-03-29 A condensed-cyclic compound and an organic light emitting diode comprising the same

Publications (2)

Publication Number Publication Date
TW201204728A true TW201204728A (en) 2012-02-01
TWI491611B TWI491611B (en) 2015-07-11

Family

ID=45027158

Family Applications (1)

Application Number Title Priority Date Filing Date
TW100111378A TWI491611B (en) 2010-04-01 2011-03-31 Condensed-cyclic compound and organic light-emitting device including the same

Country Status (2)

Country Link
KR (1) KR101328976B1 (en)
TW (1) TWI491611B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102052070B1 (en) * 2012-11-19 2019-12-05 삼성디스플레이 주식회사 Amine-based compound and organic light emitting diode comprising the same
KR102167039B1 (en) * 2013-04-10 2020-10-19 삼성디스플레이 주식회사 Compound and organic light emitting device comprising same
KR101551895B1 (en) * 2013-09-04 2015-09-10 희성소재 (주) Polycyclic compound including pyrazole and organic light emitting device using the same
KR102067854B1 (en) 2016-01-07 2020-01-17 주식회사 엘지화학 Amine-based compound and organic light emitting device comprising the same

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5843607A (en) * 1997-10-02 1998-12-01 Xerox Corporation Indolocarbazole photoconductors
US5952115A (en) * 1997-10-02 1999-09-14 Xerox Corporation Electroluminescent devices

Also Published As

Publication number Publication date
KR101328976B1 (en) 2013-11-13
TWI491611B (en) 2015-07-11
KR20110110718A (en) 2011-10-07

Similar Documents

Publication Publication Date Title
KR101202347B1 (en) A condensed-cyclic compound and an organic light emitting diode employing an organic layer comprising the same
JP6703376B2 (en) Fused ring compound and organic light emitting device containing the same
CN107001292B (en) Compound for organic photoelectric element, and display element
EP2940018B1 (en) Condensed-cyclic compound and organic light-emitting diode comprising the same
EP2371828B1 (en) Condensed-Cyclic Compound and Organic Light-Emitting Device Including the Same
KR101950474B1 (en) Organic light emitting diode
KR101954980B1 (en) Heterocyclic compound and organic light-emitting diode comprising the same
US9150496B2 (en) Condensed-cyclic compound and organic light-emitting device including the same
KR101821256B1 (en) Heterocyclic compound and organic light-emitting diode comprising the same
CN107129471B (en) Organic compound, organic photoelectric device and display device
KR20150023174A (en) Organic light-emitting device
TWI654167B (en) Organic light-emitting diode containing condensed cyclic compound
KR20140137708A (en) Organic light emitting diode
KR101930848B1 (en) Heterocyclic compound and organic light-emitting diode comprising the same
TWI577779B (en) Heterocyclic compound and organic light-emitting diode including the same
TW201416347A (en) Compound and organic light emitting device including the same
TWI538906B (en) Condensed-cyclic compound and organic light-emitting diode comprising the same
TW201508003A (en) Anthracene-based compounds and organic light-emitting device including the same
JP2019069976A (en) Condensed ring compound and organic light emitting element containing the same
KR20130048634A (en) Condensed cyclic compound, and organic light emitting diode comprising the same
KR102203099B1 (en) Condensed compound and organic light emitting diode comprising the same
KR102131960B1 (en) Condensed cyclic compound and organic light-emitting diode comprising the same
TW201416409A (en) Compound and organic light emitting device including the same
KR20140089259A (en) Carbazole-based compound and organic light emitting diode comprising the same
TWI627164B (en) Condensed-cyclic compound and organic light emitting diode including the same